id	sid	tid	token	lemma	pos
ajlm-2374	1	1	abstract	abstract	ADJ
ajlm-2374	1	2	introduction	introduction	NOUN
ajlm-2374	1	3	methods	method	NOUN
ajlm-2374	1	4	results	result	VERB
ajlm-2374	1	5	discussion	discussion	NOUN
ajlm-2374	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2374	1	7	references	reference	NOUN
ajlm-2374	1	8	about	about	ADP
ajlm-2374	1	9	the	the	DET
ajlm-2374	1	10	author(s	author(s	NOUN
ajlm-2374	1	11	)	)	PUNCT
ajlm-2374	1	12	frank	frank	PROPN
ajlm-2374	1	13	ssedyabane	ssedyabane	PROPN
ajlm-2374	1	14	department	department	PROPN
ajlm-2374	1	15	of	of	ADP
ajlm-2374	1	16	medical	medical	ADJ
ajlm-2374	1	17	laboratory	laboratory	NOUN
ajlm-2374	1	18	science	science	NOUN
ajlm-2374	1	19	,	,	PUNCT
ajlm-2374	1	20	faculty	faculty	NOUN
ajlm-2374	1	21	of	of	ADP
ajlm-2374	1	22	medicine	medicine	NOUN
ajlm-2374	1	23	,	,	PUNCT
ajlm-2374	1	24	mbarara	mbarara	PROPN
ajlm-2374	1	25	university	university	PROPN
ajlm-2374	1	26	of	of	ADP
ajlm-2374	1	27	science	science	NOUN
ajlm-2374	1	28	and	and	CCONJ
ajlm-2374	1	29	technology	technology	NOUN
ajlm-2374	1	30	,	,	PUNCT
ajlm-2374	1	31	mbarara	mbarara	PROPN
ajlm-2374	1	32	,	,	PUNCT
ajlm-2374	1	33	uganda	uganda	PROPN
ajlm-2374	1	34	thomas	thomas	PROPN
ajlm-2374	1	35	c.	c.	PROPN
ajlm-2374	1	36	randall	randall	PROPN
ajlm-2374	1	37	department	department	PROPN
ajlm-2374	1	38	of	of	ADP
ajlm-2374	1	39	global	global	ADJ
ajlm-2374	1	40	health	health	NOUN
ajlm-2374	1	41	and	and	CCONJ
ajlm-2374	1	42	social	social	ADJ
ajlm-2374	1	43	medicine	medicine	NOUN
ajlm-2374	1	44	,	,	PUNCT
ajlm-2374	1	45	massachusetts	massachusetts	PROPN
ajlm-2374	1	46	general	general	PROPN
ajlm-2374	1	47	hospital	hospital	PROPN
ajlm-2374	1	48	,	,	PUNCT
ajlm-2374	1	49	harvard	harvard	PROPN
ajlm-2374	1	50	medical	medical	PROPN
ajlm-2374	1	51	school	school	PROPN
ajlm-2374	1	52	,	,	PUNCT
ajlm-2374	1	53	boston	boston	PROPN
ajlm-2374	1	54	,	,	PUNCT
ajlm-2374	1	55	massachusetts	massachusetts	PROPN
ajlm-2374	1	56	,	,	PUNCT
ajlm-2374	1	57	united	united	PROPN
ajlm-2374	1	58	states	states	PROPN
ajlm-2374	1	59	joseph	joseph	PROPN
ajlm-2374	1	60	ngonzi	ngonzi	PROPN
ajlm-2374	1	61	department	department	PROPN
ajlm-2374	1	62	of	of	ADP
ajlm-2374	1	63	obstetrics	obstetric	NOUN
ajlm-2374	1	64	and	and	CCONJ
ajlm-2374	1	65	gynaecology	gynaecology	NOUN
ajlm-2374	1	66	,	,	PUNCT
ajlm-2374	1	67	faculty	faculty	NOUN
ajlm-2374	1	68	of	of	ADP
ajlm-2374	1	69	medicine	medicine	NOUN
ajlm-2374	1	70	,	,	PUNCT
ajlm-2374	1	71	mbarara	mbarara	PROPN
ajlm-2374	1	72	university	university	PROPN
ajlm-2374	1	73	of	of	ADP
ajlm-2374	1	74	science	science	NOUN
ajlm-2374	1	75	and	and	CCONJ
ajlm-2374	1	76	technology	technology	NOUN
ajlm-2374	1	77	,	,	PUNCT
ajlm-2374	1	78	mbarara	mbarara	PROPN
ajlm-2374	1	79	,	,	PUNCT
ajlm-2374	1	80	uganda	uganda	PROPN
ajlm-2374	1	81	rogers	rogers	PROPN
ajlm-2374	1	82	kajabwangu	kajabwangu	PROPN
ajlm-2374	1	83	department	department	NOUN
ajlm-2374	1	84	of	of	ADP
ajlm-2374	1	85	obstetrics	obstetric	NOUN
ajlm-2374	1	86	and	and	CCONJ
ajlm-2374	1	87	gynaecology	gynaecology	NOUN
ajlm-2374	1	88	,	,	PUNCT
ajlm-2374	1	89	faculty	faculty	NOUN
ajlm-2374	1	90	of	of	ADP
ajlm-2374	1	91	medicine	medicine	NOUN
ajlm-2374	1	92	,	,	PUNCT
ajlm-2374	1	93	mbarara	mbarara	PROPN
ajlm-2374	1	94	university	university	PROPN
ajlm-2374	1	95	of	of	ADP
ajlm-2374	1	96	science	science	NOUN
ajlm-2374	1	97	and	and	CCONJ
ajlm-2374	1	98	technology	technology	NOUN
ajlm-2374	1	99	,	,	PUNCT
ajlm-2374	1	100	mbarara	mbarara	PROPN
ajlm-2374	1	101	,	,	PUNCT
ajlm-2374	1	102	uganda	uganda	PROPN
ajlm-2374	1	103	alexcer	alexcer	PROPN
ajlm-2374	1	104	namuli	namuli	PROPN
ajlm-2374	1	105	department	department	PROPN
ajlm-2374	1	106	of	of	ADP
ajlm-2374	1	107	obstetrics	obstetric	NOUN
ajlm-2374	1	108	and	and	CCONJ
ajlm-2374	1	109	gynaecology	gynaecology	NOUN
ajlm-2374	1	110	,	,	PUNCT
ajlm-2374	1	111	mbarara	mbarara	NOUN
ajlm-2374	1	112	regional	regional	ADJ
ajlm-2374	1	113	referral	referral	ADJ
ajlm-2374	1	114	hospital	hospital	NOUN
ajlm-2374	1	115	,	,	PUNCT
ajlm-2374	1	116	mbarara	mbarara	PROPN
ajlm-2374	1	117	,	,	PUNCT
ajlm-2374	1	118	uganda	uganda	PROPN
ajlm-2374	1	119	joy	joy	PROPN
ajlm-2374	1	120	muhumuza	muhumuza	PROPN
ajlm-2374	1	121	department	department	NOUN
ajlm-2374	1	122	of	of	ADP
ajlm-2374	1	123	obstetrics	obstetric	NOUN
ajlm-2374	1	124	and	and	CCONJ
ajlm-2374	1	125	gynaecology	gynaecology	NOUN
ajlm-2374	1	126	,	,	PUNCT
ajlm-2374	1	127	faculty	faculty	NOUN
ajlm-2374	1	128	of	of	ADP
ajlm-2374	1	129	medicine	medicine	NOUN
ajlm-2374	1	130	,	,	PUNCT
ajlm-2374	1	131	mbarara	mbarara	PROPN
ajlm-2374	1	132	university	university	PROPN
ajlm-2374	1	133	of	of	ADP
ajlm-2374	1	134	science	science	NOUN
ajlm-2374	1	135	and	and	CCONJ
ajlm-2374	1	136	technology	technology	NOUN
ajlm-2374	1	137	,	,	PUNCT
ajlm-2374	1	138	mbarara	mbarara	PROPN
ajlm-2374	1	139	,	,	PUNCT
ajlm-2374	1	140	uganda	uganda	PROPN
ajlm-2374	1	141	josephine	josephine	PROPN
ajlm-2374	1	142	n.	n.	PROPN
ajlm-2374	1	143	najjuma	najjuma	PROPN
ajlm-2374	1	144	department	department	PROPN
ajlm-2374	1	145	of	of	ADP
ajlm-2374	1	146	nursing	nursing	NOUN
ajlm-2374	1	147	,	,	PUNCT
ajlm-2374	1	148	faculty	faculty	NOUN
ajlm-2374	1	149	of	of	ADP
ajlm-2374	1	150	medicine	medicine	NOUN
ajlm-2374	1	151	,	,	PUNCT
ajlm-2374	1	152	mbarara	mbarara	PROPN
ajlm-2374	1	153	university	university	PROPN
ajlm-2374	1	154	of	of	ADP
ajlm-2374	1	155	science	science	NOUN
ajlm-2374	1	156	and	and	CCONJ
ajlm-2374	1	157	technology	technology	NOUN
ajlm-2374	1	158	,	,	PUNCT
ajlm-2374	1	159	mbarara	mbarara	PROPN
ajlm-2374	1	160	,	,	PUNCT
ajlm-2374	1	161	uganda	uganda	PROPN
ajlm-2374	1	162	deusdedit	deusdedit	NOUN
ajlm-2374	1	163	tusubira	tusubira	PROPN
ajlm-2374	1	164	department	department	PROPN
ajlm-2374	1	165	of	of	ADP
ajlm-2374	1	166	biochemistry	biochemistry	NOUN
ajlm-2374	1	167	,	,	PUNCT
ajlm-2374	1	168	faculty	faculty	NOUN
ajlm-2374	1	169	of	of	ADP
ajlm-2374	1	170	medicine	medicine	NOUN
ajlm-2374	1	171	,	,	PUNCT
ajlm-2374	1	172	mbarara	mbarara	PROPN
ajlm-2374	1	173	university	university	PROPN
ajlm-2374	1	174	of	of	ADP
ajlm-2374	1	175	science	science	NOUN
ajlm-2374	1	176	and	and	CCONJ
ajlm-2374	1	177	technology	technology	NOUN
ajlm-2374	1	178	,	,	PUNCT
ajlm-2374	1	179	mbarara	mbarara	PROPN
ajlm-2374	1	180	,	,	PUNCT
ajlm-2374	1	181	uganda	uganda	PROPN
ajlm-2374	1	182	citation	citation	PROPN
ajlm-2374	1	183	ssedyabane	ssedyabane	PROPN
ajlm-2374	1	184	f	f	PROPN
ajlm-2374	1	185	,	,	PUNCT
ajlm-2374	1	186	randall	randall	PROPN
ajlm-2374	1	187	tc	tc	PROPN
ajlm-2374	1	188	,	,	PUNCT
ajlm-2374	1	189	ngonzi	ngonzi	PROPN
ajlm-2374	1	190	j	j	PROPN
ajlm-2374	1	191	,	,	PUNCT
ajlm-2374	1	192	et	et	PROPN
ajlm-2374	1	193	al	al	PROPN
ajlm-2374	1	194	.	.	PROPN
ajlm-2374	1	195	association	association	PROPN
ajlm-2374	1	196	between	between	ADP
ajlm-2374	1	197	dyslipidemia	dyslipidemia	NOUN
ajlm-2374	1	198	and	and	CCONJ
ajlm-2374	1	199	cervical	cervical	ADJ
ajlm-2374	1	200	intraepithelial	intraepithelial	ADJ
ajlm-2374	1	201	neoplasia	neoplasia	NOUN
ajlm-2374	1	202	:	:	PUNCT
ajlm-2374	1	203	a	a	DET
ajlm-2374	1	204	case	case	NOUN
ajlm-2374	1	205	-	-	PUNCT
ajlm-2374	1	206	control	control	NOUN
ajlm-2374	1	207	study	study	NOUN
ajlm-2374	1	208	in	in	ADP
ajlm-2374	1	209	south	south	ADJ
ajlm-2374	1	210	-	-	PUNCT
ajlm-2374	1	211	western	western	ADJ
ajlm-2374	1	212	uganda	uganda	PROPN
ajlm-2374	1	213	.	.	PUNCT
ajlm-2374	2	1	afr	afr	PROPN
ajlm-2374	2	2	j	j	PROPN
ajlm-2374	2	3	lab	lab	PROPN
ajlm-2374	2	4	med	me	VERB
ajlm-2374	2	5	.	.	PUNCT
ajlm-2374	3	1	2024;13(1	2024;13(1	NUM
ajlm-2374	3	2	)	)	PUNCT
ajlm-2374	4	1	,	,	PUNCT
ajlm-2374	4	2	a2374	a2374	PROPN
ajlm-2374	4	3	.	.	PUNCT
ajlm-2374	5	1	https://doi.org/10.4102/ajlm.v13i1.2374	https://doi.org/10.4102/ajlm.v13i1.2374	X
ajlm-2374	5	2	original	original	ADJ
ajlm-2374	5	3	research	research	NOUN
ajlm-2374	5	4	association	association	NOUN
ajlm-2374	5	5	between	between	ADP
ajlm-2374	5	6	dyslipidemia	dyslipidemia	NOUN
ajlm-2374	5	7	and	and	CCONJ
ajlm-2374	5	8	cervical	cervical	ADJ
ajlm-2374	5	9	intraepithelial	intraepithelial	ADJ
ajlm-2374	5	10	neoplasia	neoplasia	NOUN
ajlm-2374	5	11	:	:	PUNCT
ajlm-2374	5	12	a	a	DET
ajlm-2374	5	13	case	case	NOUN
ajlm-2374	5	14	-	-	PUNCT
ajlm-2374	5	15	control	control	NOUN
ajlm-2374	5	16	study	study	NOUN
ajlm-2374	5	17	in	in	ADP
ajlm-2374	5	18	south	south	ADJ
ajlm-2374	5	19	-	-	PUNCT
ajlm-2374	5	20	western	western	ADJ
ajlm-2374	5	21	uganda	uganda	PROPN
ajlm-2374	5	22	frank	frank	PROPN
ajlm-2374	5	23	ssedyabane	ssedyabane	PROPN
ajlm-2374	5	24	,	,	PUNCT
ajlm-2374	5	25	thomas	thomas	PROPN
ajlm-2374	5	26	c.	c.	PROPN
ajlm-2374	5	27	randall	randall	PROPN
ajlm-2374	5	28	,	,	PUNCT
ajlm-2374	5	29	joseph	joseph	PROPN
ajlm-2374	5	30	ngonzi	ngonzi	PROPN
ajlm-2374	5	31	,	,	PUNCT
ajlm-2374	5	32	rogers	rogers	PROPN
ajlm-2374	5	33	kajabwangu	kajabwangu	PROPN
ajlm-2374	5	34	,	,	PUNCT
ajlm-2374	5	35	alexcer	alexcer	NOUN
ajlm-2374	5	36	namuli	namuli	PROPN
ajlm-2374	5	37	,	,	PUNCT
ajlm-2374	5	38	joy	joy	NOUN
ajlm-2374	5	39	muhumuza	muhumuza	PROPN
ajlm-2374	5	40	,	,	PUNCT
ajlm-2374	5	41	josephine	josephine	PROPN
ajlm-2374	5	42	n.	n.	PROPN
ajlm-2374	5	43	najjuma	najjuma	PROPN
ajlm-2374	5	44	,	,	PUNCT
ajlm-2374	5	45	deusdedit	deusdedit	NOUN
ajlm-2374	5	46	tusubira	tusubira	PROPN
ajlm-2374	5	47	received	receive	VERB
ajlm-2374	5	48	:	:	PUNCT
ajlm-2374	5	49	20	20	NUM
ajlm-2374	5	50	nov	nov	PROPN
ajlm-2374	5	51	.	.	PROPN
ajlm-2374	5	52	2023	2023	NUM
ajlm-2374	5	53	;	;	PUNCT
ajlm-2374	5	54	accepted	accept	VERB
ajlm-2374	5	55	:	:	PUNCT
ajlm-2374	5	56	20	20	NUM
ajlm-2374	5	57	may	may	PROPN
ajlm-2374	5	58	2024	2024	NUM
ajlm-2374	5	59	;	;	PUNCT
ajlm-2374	5	60	published	publish	VERB
ajlm-2374	5	61	:	:	PUNCT
ajlm-2374	5	62	16	16	NUM
ajlm-2374	5	63	july	july	PROPN
ajlm-2374	5	64	2024	2024	NUM
ajlm-2374	5	65	copyright	copyright	NOUN
ajlm-2374	5	66	:	:	PUNCT
ajlm-2374	5	67	©	©	PROPN
ajlm-2374	5	68	2024	2024	NUM
ajlm-2374	5	69	.	.	PUNCT
ajlm-2374	6	1	the	the	DET
ajlm-2374	6	2	author(s	author(s	PROPN
ajlm-2374	6	3	)	)	PUNCT
ajlm-2374	6	4	.	.	PUNCT
ajlm-2374	7	1	licensee	licensee	NOUN
ajlm-2374	7	2	:	:	PUNCT
ajlm-2374	7	3	aosis	aosis	NOUN
ajlm-2374	7	4	.	.	PUNCT
ajlm-2374	8	1	this	this	PRON
ajlm-2374	8	2	is	be	AUX
ajlm-2374	8	3	an	an	DET
ajlm-2374	8	4	open	open	ADJ
ajlm-2374	8	5	access	access	NOUN
ajlm-2374	8	6	article	article	NOUN
ajlm-2374	8	7	distributed	distribute	VERB
ajlm-2374	8	8	under	under	ADP
ajlm-2374	8	9	the	the	DET
ajlm-2374	8	10	terms	term	NOUN
ajlm-2374	8	11	of	of	ADP
ajlm-2374	8	12	the	the	DET
ajlm-2374	8	13	creative	creative	ADJ
ajlm-2374	8	14	commons	common	NOUN
ajlm-2374	8	15	attribution	attribution	NOUN
ajlm-2374	8	16	license	license	NOUN
ajlm-2374	8	17	,	,	PUNCT
ajlm-2374	8	18	which	which	PRON
ajlm-2374	8	19	permits	permit	VERB
ajlm-2374	8	20	unrestricted	unrestricted	ADJ
ajlm-2374	8	21	use	use	NOUN
ajlm-2374	8	22	,	,	PUNCT
ajlm-2374	8	23	distribution	distribution	NOUN
ajlm-2374	8	24	,	,	PUNCT
ajlm-2374	8	25	and	and	CCONJ
ajlm-2374	8	26	reproduction	reproduction	NOUN
ajlm-2374	8	27	in	in	ADP
ajlm-2374	8	28	any	any	DET
ajlm-2374	8	29	medium	medium	NOUN
ajlm-2374	8	30	,	,	PUNCT
ajlm-2374	8	31	provided	provide	VERB
ajlm-2374	8	32	the	the	DET
ajlm-2374	8	33	original	original	ADJ
ajlm-2374	8	34	work	work	NOUN
ajlm-2374	8	35	is	be	AUX
ajlm-2374	8	36	properly	properly	ADV
ajlm-2374	8	37	cited	cite	VERB
ajlm-2374	8	38	.	.	PUNCT
ajlm-2374	9	1	abstract	abstract	ADJ
ajlm-2374	9	2	background	background	NOUN
ajlm-2374	9	3	:	:	PUNCT
ajlm-2374	9	4	altered	alter	VERB
ajlm-2374	9	5	lipid	lipid	NOUN
ajlm-2374	9	6	levels	level	NOUN
ajlm-2374	9	7	may	may	AUX
ajlm-2374	9	8	be	be	AUX
ajlm-2374	9	9	associated	associate	VERB
ajlm-2374	9	10	with	with	ADP
ajlm-2374	9	11	the	the	DET
ajlm-2374	9	12	development	development	NOUN
ajlm-2374	9	13	of	of	ADP
ajlm-2374	9	14	a	a	DET
ajlm-2374	9	15	number	number	NOUN
ajlm-2374	9	16	of	of	ADP
ajlm-2374	9	17	malignancies	malignancy	NOUN
ajlm-2374	9	18	,	,	PUNCT
ajlm-2374	9	19	including	include	VERB
ajlm-2374	9	20	cancer	cancer	NOUN
ajlm-2374	9	21	of	of	ADP
ajlm-2374	9	22	the	the	DET
ajlm-2374	9	23	cervix	cervix	NOUN
ajlm-2374	9	24	.	.	PUNCT
ajlm-2374	10	1	however	however	ADV
ajlm-2374	10	2	,	,	PUNCT
ajlm-2374	10	3	there	there	PRON
ajlm-2374	10	4	is	be	VERB
ajlm-2374	10	5	limited	limited	ADJ
ajlm-2374	10	6	understanding	understanding	NOUN
ajlm-2374	10	7	of	of	ADP
ajlm-2374	10	8	this	this	DET
ajlm-2374	10	9	relationship	relationship	NOUN
ajlm-2374	10	10	in	in	ADP
ajlm-2374	10	11	the	the	DET
ajlm-2374	10	12	rural	rural	ADJ
ajlm-2374	10	13	ugandan	ugandan	ADJ
ajlm-2374	10	14	context	context	NOUN
ajlm-2374	10	15	.	.	PUNCT
ajlm-2374	11	1	objective	objective	NOUN
ajlm-2374	11	2	:	:	PUNCT
ajlm-2374	12	1	we	we	PRON
ajlm-2374	12	2	investigated	investigate	VERB
ajlm-2374	12	3	the	the	DET
ajlm-2374	12	4	connection	connection	NOUN
ajlm-2374	12	5	between	between	ADP
ajlm-2374	12	6	dyslipidaemias	dyslipidaemia	NOUN
ajlm-2374	12	7	and	and	CCONJ
ajlm-2374	12	8	cervical	cervical	ADJ
ajlm-2374	12	9	intraepithelial	intraepithelial	ADJ
ajlm-2374	12	10	neoplasia	neoplasia	NOUN
ajlm-2374	12	11	(	(	PUNCT
ajlm-2374	12	12	cin	cin	PROPN
ajlm-2374	12	13	)	)	PUNCT
ajlm-2374	12	14	among	among	ADP
ajlm-2374	12	15	women	woman	NOUN
ajlm-2374	12	16	attending	attend	VERB
ajlm-2374	12	17	the	the	DET
ajlm-2374	12	18	cervical	cervical	ADJ
ajlm-2374	12	19	cancer	cancer	NOUN
ajlm-2374	12	20	clinic	clinic	NOUN
ajlm-2374	12	21	at	at	ADP
ajlm-2374	12	22	mbarara	mbarara	NOUN
ajlm-2374	12	23	regional	regional	ADJ
ajlm-2374	12	24	referral	referral	ADJ
ajlm-2374	12	25	hospital	hospital	NOUN
ajlm-2374	12	26	in	in	ADP
ajlm-2374	12	27	south	south	ADJ
ajlm-2374	12	28	-	-	PUNCT
ajlm-2374	12	29	western	western	ADJ
ajlm-2374	12	30	uganda	uganda	PROPN
ajlm-2374	12	31	.	.	PUNCT
ajlm-2374	13	1	methods	method	NOUN
ajlm-2374	13	2	:	:	PUNCT
ajlm-2374	13	3	this	this	DET
ajlm-2374	13	4	unmatched	unmatched	ADJ
ajlm-2374	13	5	case	case	NOUN
ajlm-2374	13	6	-	-	PUNCT
ajlm-2374	13	7	control	control	NOUN
ajlm-2374	13	8	study	study	NOUN
ajlm-2374	13	9	was	be	AUX
ajlm-2374	13	10	conducted	conduct	VERB
ajlm-2374	13	11	between	between	ADP
ajlm-2374	13	12	december	december	PROPN
ajlm-2374	13	13	2022	2022	NUM
ajlm-2374	13	14	and	and	CCONJ
ajlm-2374	13	15	february	february	PROPN
ajlm-2374	13	16	2023	2023	NUM
ajlm-2374	13	17	and	and	CCONJ
ajlm-2374	13	18	included	include	VERB
ajlm-2374	13	19	women	woman	NOUN
ajlm-2374	13	20	with	with	ADP
ajlm-2374	13	21	cin	cin	PROPN
ajlm-2374	13	22	(	(	PUNCT
ajlm-2374	13	23	cases	case	NOUN
ajlm-2374	13	24	)	)	PUNCT
ajlm-2374	13	25	and	and	CCONJ
ajlm-2374	13	26	women	woman	NOUN
ajlm-2374	13	27	without	without	ADP
ajlm-2374	13	28	intraepithelial	intraepithelial	ADJ
ajlm-2374	13	29	lesions	lesion	NOUN
ajlm-2374	13	30	(	(	PUNCT
ajlm-2374	13	31	controls	control	NOUN
ajlm-2374	13	32	)	)	PUNCT
ajlm-2374	13	33	in	in	ADP
ajlm-2374	13	34	a	a	DET
ajlm-2374	13	35	1:1	1:1	NUM
ajlm-2374	13	36	ratio	ratio	NOUN
ajlm-2374	13	37	.	.	PUNCT
ajlm-2374	14	1	participants	participant	NOUN
ajlm-2374	14	2	were	be	AUX
ajlm-2374	14	3	selected	select	VERB
ajlm-2374	14	4	based	base	VERB
ajlm-2374	14	5	on	on	ADP
ajlm-2374	14	6	cytology	cytology	NOUN
ajlm-2374	14	7	and/or	and/or	CCONJ
ajlm-2374	14	8	histology	histology	NOUN
ajlm-2374	14	9	results	result	NOUN
ajlm-2374	14	10	,	,	PUNCT
ajlm-2374	14	11	and	and	CCONJ
ajlm-2374	14	12	after	after	ADP
ajlm-2374	14	13	obtaining	obtain	VERB
ajlm-2374	14	14	written	write	VERB
ajlm-2374	14	15	informed	informed	ADJ
ajlm-2374	14	16	consent	consent	NOUN
ajlm-2374	14	17	.	.	PUNCT
ajlm-2374	15	1	demographic	demographic	ADJ
ajlm-2374	15	2	data	datum	NOUN
ajlm-2374	15	3	were	be	AUX
ajlm-2374	15	4	collected	collect	VERB
ajlm-2374	15	5	,	,	PUNCT
ajlm-2374	15	6	and	and	CCONJ
ajlm-2374	15	7	venous	venous	ADJ
ajlm-2374	15	8	blood	blood	NOUN
ajlm-2374	15	9	was	be	AUX
ajlm-2374	15	10	drawn	draw	VERB
ajlm-2374	15	11	for	for	ADP
ajlm-2374	15	12	lipid	lipid	NOUN
ajlm-2374	15	13	profile	profile	NOUN
ajlm-2374	15	14	analysis	analysis	NOUN
ajlm-2374	15	15	.	.	PUNCT
ajlm-2374	16	1	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	16	2	was	be	AUX
ajlm-2374	16	3	defined	define	VERB
ajlm-2374	16	4	as	as	ADP
ajlm-2374	16	5	:	:	PUNCT
ajlm-2374	16	6	total	total	ADJ
ajlm-2374	16	7	cholesterol	cholesterol	NOUN
ajlm-2374	16	8	>	>	X
ajlm-2374	16	9	200	200	NUM
ajlm-2374	16	10	mg	mg	PROPN
ajlm-2374	16	11	/	/	SYM
ajlm-2374	16	12	dl	dl	PROPN
ajlm-2374	16	13	,	,	PUNCT
ajlm-2374	16	14	low	low	ADJ
ajlm-2374	16	15	-	-	PUNCT
ajlm-2374	16	16	density	density	NOUN
ajlm-2374	16	17	lipoprotein	lipoprotein	X
ajlm-2374	16	18	>	>	X
ajlm-2374	16	19	160	160	NUM
ajlm-2374	16	20	mg	mg	PROPN
ajlm-2374	16	21	/	/	SYM
ajlm-2374	16	22	dl	dl	PROPN
ajlm-2374	16	23	,	,	PUNCT
ajlm-2374	16	24	triglycerides	triglyceride	NOUN
ajlm-2374	16	25	>	>	SYM
ajlm-2374	16	26	150	150	NUM
ajlm-2374	16	27	mg	mg	NUM
ajlm-2374	16	28	/	/	SYM
ajlm-2374	16	29	dl	dl	PROPN
ajlm-2374	16	30	,	,	PUNCT
ajlm-2374	16	31	or	or	CCONJ
ajlm-2374	16	32	high	high	ADJ
ajlm-2374	16	33	-	-	PUNCT
ajlm-2374	16	34	density	density	NOUN
ajlm-2374	16	35	lipoprotein	lipoprotein	NOUN
ajlm-2374	16	36	<	<	X
ajlm-2374	16	37	40	40	NUM
ajlm-2374	16	38	mg	mg	PROPN
ajlm-2374	16	39	/	/	SYM
ajlm-2374	16	40	dl	dl	PROPN
ajlm-2374	16	41	.	.	PROPN
ajlm-2374	17	1	at	at	ADP
ajlm-2374	17	2	diagnosis	diagnosis	NOUN
ajlm-2374	17	3	,	,	PUNCT
ajlm-2374	17	4	cases	case	NOUN
ajlm-2374	17	5	were	be	AUX
ajlm-2374	17	6	categorised	categorise	VERB
ajlm-2374	17	7	as	as	ADP
ajlm-2374	17	8	either	either	CCONJ
ajlm-2374	17	9	cin1	cin1	PROPN
ajlm-2374	17	10	(	(	PUNCT
ajlm-2374	17	11	low	low	ADJ
ajlm-2374	17	12	grade	grade	NOUN
ajlm-2374	17	13	)	)	PUNCT
ajlm-2374	17	14	or	or	CCONJ
ajlm-2374	17	15	cin2	cin2	NOUN
ajlm-2374	17	16	+	+	CCONJ
ajlm-2374	17	17	(	(	PUNCT
ajlm-2374	17	18	high	high	ADJ
ajlm-2374	17	19	grade	grade	NOUN
ajlm-2374	17	20	)	)	PUNCT
ajlm-2374	17	21	.	.	PUNCT
ajlm-2374	18	1	results	result	NOUN
ajlm-2374	18	2	:	:	PUNCT
ajlm-2374	18	3	among	among	ADP
ajlm-2374	18	4	the	the	DET
ajlm-2374	18	5	93	93	NUM
ajlm-2374	18	6	cases	case	NOUN
ajlm-2374	18	7	,	,	PUNCT
ajlm-2374	18	8	81	81	NUM
ajlm-2374	18	9	had	have	AUX
ajlm-2374	18	10	cin1	cin1	NOUN
ajlm-2374	18	11	,	,	PUNCT
ajlm-2374	18	12	while	while	SCONJ
ajlm-2374	18	13	12	12	NUM
ajlm-2374	18	14	had	have	VERB
ajlm-2374	18	15	cin2	cin2	NOUN
ajlm-2374	18	16	+	+	PROPN
ajlm-2374	18	17	.	.	PUNCT
ajlm-2374	19	1	controls	control	NOUN
ajlm-2374	19	2	had	have	VERB
ajlm-2374	19	3	a	a	DET
ajlm-2374	19	4	13.9	13.9	NUM
ajlm-2374	19	5	%	%	NOUN
ajlm-2374	19	6	(	(	PUNCT
ajlm-2374	19	7	13/93	13/93	NUM
ajlm-2374	19	8	)	)	PUNCT
ajlm-2374	19	9	prevalence	prevalence	NOUN
ajlm-2374	19	10	of	of	ADP
ajlm-2374	19	11	high	high	ADJ
ajlm-2374	19	12	triglycerides	triglyceride	NOUN
ajlm-2374	19	13	and	and	CCONJ
ajlm-2374	19	14	cases	case	NOUN
ajlm-2374	19	15	had	have	VERB
ajlm-2374	19	16	a	a	DET
ajlm-2374	19	17	prevalence	prevalence	NOUN
ajlm-2374	19	18	of	of	ADP
ajlm-2374	19	19	3.2	3.2	NUM
ajlm-2374	19	20	%	%	NOUN
ajlm-2374	19	21	(	(	PUNCT
ajlm-2374	19	22	3/93	3/93	NUM
ajlm-2374	19	23	;	;	PUNCT
ajlm-2374	19	24	p	p	X
ajlm-2374	19	25	=	=	PROPN
ajlm-2374	19	26	0.016	0.016	NUM
ajlm-2374	19	27	)	)	PUNCT
ajlm-2374	19	28	.	.	PUNCT
ajlm-2374	20	1	reduced	reduce	VERB
ajlm-2374	20	2	high	high	ADJ
ajlm-2374	20	3	-	-	PUNCT
ajlm-2374	20	4	density	density	NOUN
ajlm-2374	20	5	lipoprotein	lipoprotein	NOUN
ajlm-2374	20	6	was	be	AUX
ajlm-2374	20	7	the	the	DET
ajlm-2374	20	8	most	most	ADV
ajlm-2374	20	9	prevalent	prevalent	ADJ
ajlm-2374	20	10	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	20	11	among	among	ADP
ajlm-2374	20	12	cases	case	NOUN
ajlm-2374	20	13	(	(	PUNCT
ajlm-2374	20	14	40.9	40.9	NUM
ajlm-2374	20	15	%	%	NOUN
ajlm-2374	20	16	;	;	PUNCT
ajlm-2374	20	17	38/93	38/93	NUM
ajlm-2374	20	18	)	)	PUNCT
ajlm-2374	20	19	.	.	PUNCT
ajlm-2374	21	1	statistically	statistically	ADV
ajlm-2374	21	2	significant	significant	ADJ
ajlm-2374	21	3	associations	association	NOUN
ajlm-2374	21	4	were	be	AUX
ajlm-2374	21	5	found	find	VERB
ajlm-2374	21	6	between	between	ADP
ajlm-2374	21	7	high	high	ADJ
ajlm-2374	21	8	serum	serum	NOUN
ajlm-2374	21	9	triglycerides	triglyceride	NOUN
ajlm-2374	21	10	and	and	CCONJ
ajlm-2374	21	11	cin	cin	PROPN
ajlm-2374	21	12	(	(	PUNCT
ajlm-2374	21	13	odds	odd	NOUN
ajlm-2374	21	14	ratio	ratio	NOUN
ajlm-2374	21	15	:	:	PUNCT
ajlm-2374	21	16	1.395	1.395	NUM
ajlm-2374	21	17	,	,	PUNCT
ajlm-2374	21	18	95	95	NUM
ajlm-2374	21	19	%	%	NOUN
ajlm-2374	21	20	confidence	confidence	NOUN
ajlm-2374	21	21	interval	interval	NOUN
ajlm-2374	21	22	:	:	PUNCT
ajlm-2374	21	23	0.084–1.851	0.084–1.851	NOUN
ajlm-2374	21	24	,	,	PUNCT
ajlm-2374	21	25	p	p	X
ajlm-2374	21	26	=	=	NOUN
ajlm-2374	21	27	0.007	0.007	NUM
ajlm-2374	21	28	)	)	PUNCT
ajlm-2374	21	29	.	.	PUNCT
ajlm-2374	22	1	conclusion	conclusion	NOUN
ajlm-2374	22	2	:	:	PUNCT
ajlm-2374	22	3	a	a	DET
ajlm-2374	22	4	notable	notable	ADJ
ajlm-2374	22	5	association	association	NOUN
ajlm-2374	22	6	was	be	AUX
ajlm-2374	22	7	observed	observe	VERB
ajlm-2374	22	8	between	between	ADP
ajlm-2374	22	9	triglyceride	triglyceride	ADJ
ajlm-2374	22	10	dyslipidemia	dyslipidemia	NOUN
ajlm-2374	22	11	and	and	CCONJ
ajlm-2374	22	12	cin	cin	PROPN
ajlm-2374	22	13	.	.	PUNCT
ajlm-2374	22	14	further	further	ADJ
ajlm-2374	22	15	studies	study	NOUN
ajlm-2374	22	16	into	into	ADP
ajlm-2374	22	17	biochemical	biochemical	ADJ
ajlm-2374	22	18	processes	process	NOUN
ajlm-2374	22	19	and	and	CCONJ
ajlm-2374	22	20	interactions	interaction	NOUN
ajlm-2374	22	21	between	between	ADP
ajlm-2374	22	22	lipids	lipid	NOUN
ajlm-2374	22	23	and	and	CCONJ
ajlm-2374	22	24	cervical	cervical	ADJ
ajlm-2374	22	25	carcinogenesis	carcinogenesis	NOUN
ajlm-2374	22	26	are	be	AUX
ajlm-2374	22	27	recommended	recommend	VERB
ajlm-2374	22	28	through	through	ADP
ajlm-2374	22	29	prospective	prospective	ADJ
ajlm-2374	22	30	cohort	cohort	NOUN
ajlm-2374	22	31	studies	study	NOUN
ajlm-2374	22	32	.	.	PUNCT
ajlm-2374	23	1	what	what	PRON
ajlm-2374	23	2	this	this	DET
ajlm-2374	23	3	study	study	NOUN
ajlm-2374	23	4	adds	add	VERB
ajlm-2374	23	5	:	:	PUNCT
ajlm-2374	23	6	this	this	DET
ajlm-2374	23	7	research	research	NOUN
ajlm-2374	23	8	provides	provide	VERB
ajlm-2374	23	9	additional	additional	ADJ
ajlm-2374	23	10	information	information	NOUN
ajlm-2374	23	11	on	on	ADP
ajlm-2374	23	12	the	the	DET
ajlm-2374	23	13	potential	potential	ADJ
ajlm-2374	23	14	role	role	NOUN
ajlm-2374	23	15	of	of	ADP
ajlm-2374	23	16	lipids	lipid	NOUN
ajlm-2374	23	17	in	in	ADP
ajlm-2374	23	18	cervical	cervical	ADJ
ajlm-2374	23	19	carcinogenesis	carcinogenesis	NOUN
ajlm-2374	23	20	among	among	ADP
ajlm-2374	23	21	women	woman	NOUN
ajlm-2374	23	22	in	in	ADP
ajlm-2374	23	23	rural	rural	ADJ
ajlm-2374	23	24	uganda	uganda	PROPN
ajlm-2374	23	25	.	.	PUNCT
ajlm-2374	24	1	it	it	PRON
ajlm-2374	24	2	also	also	ADV
ajlm-2374	24	3	presents	present	VERB
ajlm-2374	24	4	the	the	DET
ajlm-2374	24	5	possible	possible	ADJ
ajlm-2374	24	6	prevalence	prevalence	NOUN
ajlm-2374	24	7	of	of	ADP
ajlm-2374	24	8	multimorbidity	multimorbidity	NOUN
ajlm-2374	24	9	involving	involve	VERB
ajlm-2374	24	10	cervical	cervical	ADJ
ajlm-2374	24	11	cancer	cancer	NOUN
ajlm-2374	24	12	and	and	CCONJ
ajlm-2374	24	13	cardiovascular	cardiovascular	ADJ
ajlm-2374	24	14	diseases	disease	NOUN
ajlm-2374	24	15	,	,	PUNCT
ajlm-2374	24	16	particularly	particularly	ADV
ajlm-2374	24	17	in	in	ADP
ajlm-2374	24	18	low	low	ADJ
ajlm-2374	24	19	-	-	PUNCT
ajlm-2374	24	20	resource	resource	NOUN
ajlm-2374	24	21	settings	setting	NOUN
ajlm-2374	24	22	lacking	lack	VERB
ajlm-2374	24	23	preventive	preventive	ADJ
ajlm-2374	24	24	measures	measure	NOUN
ajlm-2374	24	25	against	against	ADP
ajlm-2374	24	26	the	the	DET
ajlm-2374	24	27	increasing	increase	VERB
ajlm-2374	24	28	prevalence	prevalence	NOUN
ajlm-2374	24	29	of	of	ADP
ajlm-2374	24	30	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	24	31	.	.	PUNCT
ajlm-2374	25	1	keywords	keyword	NOUN
ajlm-2374	25	2	:	:	PUNCT
ajlm-2374	25	3	cervical	cervical	ADJ
ajlm-2374	25	4	intraepithelial	intraepithelial	ADJ
ajlm-2374	25	5	neoplasia	neoplasia	NOUN
ajlm-2374	25	6	;	;	PUNCT
ajlm-2374	25	7	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	25	8	;	;	PUNCT
ajlm-2374	25	9	total	total	ADJ
ajlm-2374	25	10	cholesterol	cholesterol	NOUN
ajlm-2374	25	11	;	;	PUNCT
ajlm-2374	25	12	low	low	ADJ
ajlm-2374	25	13	-	-	PUNCT
ajlm-2374	25	14	density	density	NOUN
ajlm-2374	25	15	lipoprotein	lipoprotein	ADJ
ajlm-2374	25	16	;	;	PUNCT
ajlm-2374	25	17	high	high	ADJ
ajlm-2374	25	18	-	-	PUNCT
ajlm-2374	25	19	density	density	NOUN
ajlm-2374	25	20	lipoprotein	lipoprotein	NOUN
ajlm-2374	25	21	;	;	PUNCT
ajlm-2374	25	22	triglycerides	triglyceride	NOUN
ajlm-2374	25	23	;	;	PUNCT
ajlm-2374	25	24	uganda	uganda	NOUN
ajlm-2374	25	25	;	;	PUNCT
ajlm-2374	25	26	cervical	cervical	ADJ
ajlm-2374	25	27	cancer	cancer	NOUN
ajlm-2374	25	28	.	.	PUNCT
ajlm-2374	26	1	introduction	introduction	NOUN
ajlm-2374	26	2	globally	globally	ADV
ajlm-2374	26	3	,	,	PUNCT
ajlm-2374	26	4	there	there	PRON
ajlm-2374	26	5	are	be	VERB
ajlm-2374	26	6	604	604	NUM
ajlm-2374	26	7	127	127	NUM
ajlm-2374	26	8	new	new	ADJ
ajlm-2374	26	9	cases	case	NOUN
ajlm-2374	26	10	of	of	ADP
ajlm-2374	26	11	cervical	cervical	ADJ
ajlm-2374	26	12	cancer	cancer	NOUN
ajlm-2374	26	13	,	,	PUNCT
ajlm-2374	26	14	ranking	rank	VERB
ajlm-2374	26	15	it	it	PRON
ajlm-2374	26	16	as	as	ADP
ajlm-2374	26	17	the	the	DET
ajlm-2374	26	18	fourth	fourth	ADJ
ajlm-2374	26	19	most	most	ADV
ajlm-2374	26	20	common	common	ADJ
ajlm-2374	26	21	cancer	cancer	NOUN
ajlm-2374	26	22	,	,	PUNCT
ajlm-2374	26	23	with	with	ADP
ajlm-2374	26	24	341	341	NUM
ajlm-2374	26	25	831	831	NUM
ajlm-2374	26	26	cervical	cervical	ADJ
ajlm-2374	26	27	cancer	cancer	NOUN
ajlm-2374	26	28	-	-	PUNCT
ajlm-2374	26	29	related	relate	VERB
ajlm-2374	26	30	deaths	death	NOUN
ajlm-2374	26	31	worldwide	worldwide	ADV
ajlm-2374	26	32	in	in	ADP
ajlm-2374	26	33	the	the	DET
ajlm-2374	26	34	year	year	NOUN
ajlm-2374	26	35	2020.1	2020.1	NUM
ajlm-2374	26	36	there	there	PRON
ajlm-2374	26	37	has	have	AUX
ajlm-2374	26	38	been	be	AUX
ajlm-2374	26	39	an	an	DET
ajlm-2374	26	40	increasing	increase	VERB
ajlm-2374	26	41	prevalence	prevalence	NOUN
ajlm-2374	26	42	of	of	ADP
ajlm-2374	26	43	cervical	cervical	ADJ
ajlm-2374	26	44	cancer	cancer	NOUN
ajlm-2374	26	45	in	in	ADP
ajlm-2374	26	46	africa	africa	PROPN
ajlm-2374	26	47	,	,	PUNCT
ajlm-2374	27	1	especially	especially	ADV
ajlm-2374	27	2	the	the	DET
ajlm-2374	27	3	sub	sub	ADJ
ajlm-2374	27	4	-	-	ADJ
ajlm-2374	27	5	saharan	saharan	ADJ
ajlm-2374	27	6	region.2	region.2	NOUN
ajlm-2374	27	7	it	it	PRON
ajlm-2374	27	8	is	be	AUX
ajlm-2374	27	9	the	the	DET
ajlm-2374	27	10	second	second	ADJ
ajlm-2374	27	11	most	most	ADV
ajlm-2374	27	12	common	common	ADJ
ajlm-2374	27	13	cancer	cancer	NOUN
ajlm-2374	27	14	(	(	PUNCT
ajlm-2374	27	15	with	with	ADP
ajlm-2374	27	16	an	an	DET
ajlm-2374	27	17	incidence	incidence	NOUN
ajlm-2374	27	18	of	of	ADP
ajlm-2374	27	19	40.1/100	40.1/100	NUM
ajlm-2374	27	20	000	000	NUM
ajlm-2374	27	21	and	and	CCONJ
ajlm-2374	27	22	mortality	mortality	NOUN
ajlm-2374	27	23	of	of	ADP
ajlm-2374	27	24	28.6/100	28.6/100	NUM
ajlm-2374	27	25	000	000	NUM
ajlm-2374	27	26	)	)	PUNCT
ajlm-2374	27	27	,	,	PUNCT
ajlm-2374	27	28	and	and	CCONJ
ajlm-2374	27	29	the	the	DET
ajlm-2374	27	30	primary	primary	ADJ
ajlm-2374	27	31	cause	cause	NOUN
ajlm-2374	27	32	of	of	ADP
ajlm-2374	27	33	cancer	cancer	NOUN
ajlm-2374	27	34	-	-	PUNCT
ajlm-2374	27	35	related	relate	VERB
ajlm-2374	27	36	deaths	death	NOUN
ajlm-2374	27	37	among	among	ADP
ajlm-2374	27	38	women	woman	NOUN
ajlm-2374	27	39	in	in	ADP
ajlm-2374	27	40	the	the	DET
ajlm-2374	27	41	east	east	ADJ
ajlm-2374	27	42	african	african	ADJ
ajlm-2374	27	43	region.1	region.1	ADJ
ajlm-2374	27	44	developed	develop	VERB
ajlm-2374	27	45	countries	country	NOUN
ajlm-2374	27	46	,	,	PUNCT
ajlm-2374	27	47	implementing	implement	VERB
ajlm-2374	27	48	screening	screen	VERB
ajlm-2374	27	49	programmes	programme	NOUN
ajlm-2374	27	50	for	for	ADP
ajlm-2374	27	51	women	woman	NOUN
ajlm-2374	27	52	aged	age	VERB
ajlm-2374	27	53	25	25	NUM
ajlm-2374	27	54	years	year	NOUN
ajlm-2374	27	55	and	and	CCONJ
ajlm-2374	27	56	above	above	ADV
ajlm-2374	27	57	,	,	PUNCT
ajlm-2374	27	58	have	have	AUX
ajlm-2374	27	59	witnessed	witness	VERB
ajlm-2374	27	60	a	a	DET
ajlm-2374	27	61	significant	significant	ADJ
ajlm-2374	27	62	reduction	reduction	NOUN
ajlm-2374	27	63	in	in	ADP
ajlm-2374	27	64	cases	case	NOUN
ajlm-2374	27	65	by	by	ADP
ajlm-2374	27	66	more	more	ADJ
ajlm-2374	27	67	than	than	ADP
ajlm-2374	27	68	a	a	DET
ajlm-2374	27	69	third	third	ADJ
ajlm-2374	27	70	,	,	PUNCT
ajlm-2374	27	71	a	a	DET
ajlm-2374	27	72	trend	trend	NOUN
ajlm-2374	27	73	not	not	PART
ajlm-2374	27	74	mirrored	mirror	VERB
ajlm-2374	27	75	in	in	ADP
ajlm-2374	27	76	less	less	ADV
ajlm-2374	27	77	-	-	PUNCT
ajlm-2374	27	78	developed	develop	VERB
ajlm-2374	27	79	nations,3	nations,3	NOUN
ajlm-2374	27	80	probably	probably	ADV
ajlm-2374	27	81	as	as	ADP
ajlm-2374	27	82	a	a	DET
ajlm-2374	27	83	result	result	NOUN
ajlm-2374	27	84	of	of	ADP
ajlm-2374	27	85	inadequate	inadequate	ADJ
ajlm-2374	27	86	interventions	intervention	NOUN
ajlm-2374	27	87	,	,	PUNCT
ajlm-2374	27	88	including	include	VERB
ajlm-2374	27	89	vaccination	vaccination	NOUN
ajlm-2374	27	90	against	against	ADP
ajlm-2374	27	91	human	human	ADJ
ajlm-2374	27	92	papillomavirus	papillomavirus	NOUN
ajlm-2374	27	93	(	(	PUNCT
ajlm-2374	27	94	hpv	hpv	NOUN
ajlm-2374	27	95	)	)	PUNCT
ajlm-2374	27	96	.	.	PUNCT
ajlm-2374	28	1	it	it	PRON
ajlm-2374	28	2	is	be	AUX
ajlm-2374	28	3	a	a	DET
ajlm-2374	28	4	scientific	scientific	ADJ
ajlm-2374	28	5	fact	fact	NOUN
ajlm-2374	28	6	that	that	SCONJ
ajlm-2374	28	7	hpv	hpv	PROPN
ajlm-2374	28	8	is	be	AUX
ajlm-2374	28	9	a	a	DET
ajlm-2374	28	10	necessary	necessary	ADJ
ajlm-2374	28	11	,	,	PUNCT
ajlm-2374	28	12	albeit	albeit	SCONJ
ajlm-2374	28	13	not	not	PART
ajlm-2374	28	14	standalone	standalone	ADJ
ajlm-2374	28	15	,	,	PUNCT
ajlm-2374	28	16	factor	factor	NOUN
ajlm-2374	28	17	in	in	ADP
ajlm-2374	28	18	cervical	cervical	ADJ
ajlm-2374	28	19	cancer	cancer	NOUN
ajlm-2374	28	20	development.4,5	development.4,5	PROPN
ajlm-2374	28	21	as	as	ADP
ajlm-2374	28	22	a	a	DET
ajlm-2374	28	23	result	result	NOUN
ajlm-2374	28	24	,	,	PUNCT
ajlm-2374	28	25	there	there	PRON
ajlm-2374	28	26	is	be	VERB
ajlm-2374	28	27	increasing	increase	VERB
ajlm-2374	28	28	research	research	NOUN
ajlm-2374	28	29	in	in	ADP
ajlm-2374	28	30	the	the	DET
ajlm-2374	28	31	area	area	NOUN
ajlm-2374	28	32	of	of	ADP
ajlm-2374	28	33	immunotherapy	immunotherapy	NOUN
ajlm-2374	28	34	for	for	ADP
ajlm-2374	28	35	advanced	advanced	ADJ
ajlm-2374	28	36	cervical	cervical	ADJ
ajlm-2374	28	37	cancer	cancer	NOUN
ajlm-2374	28	38	,	,	PUNCT
ajlm-2374	28	39	especially	especially	ADV
ajlm-2374	28	40	the	the	DET
ajlm-2374	28	41	assessment	assessment	NOUN
ajlm-2374	28	42	of	of	ADP
ajlm-2374	28	43	vaccine	vaccine	NOUN
ajlm-2374	28	44	-	-	PUNCT
ajlm-2374	28	45	related	relate	VERB
ajlm-2374	28	46	therapies	therapy	NOUN
ajlm-2374	28	47	,	,	PUNCT
ajlm-2374	28	48	t	t	NOUN
ajlm-2374	28	49	-	-	PUNCT
ajlm-2374	28	50	cell	cell	NOUN
ajlm-2374	28	51	therapy	therapy	NOUN
ajlm-2374	28	52	and	and	CCONJ
ajlm-2374	28	53	immune	immune	NOUN
ajlm-2374	28	54	-	-	PUNCT
ajlm-2374	28	55	checkpoint	checkpoint	NOUN
ajlm-2374	28	56	inhibitors	inhibitor	NOUN
ajlm-2374	28	57	in	in	ADP
ajlm-2374	28	58	patients	patient	NOUN
ajlm-2374	28	59	diagnosed	diagnose	VERB
ajlm-2374	28	60	with	with	ADP
ajlm-2374	28	61	advanced	advanced	ADJ
ajlm-2374	28	62	cervical	cervical	ADJ
ajlm-2374	28	63	cancer.6	cancer.6	NOUN
ajlm-2374	28	64	cervical	cervical	ADJ
ajlm-2374	28	65	cancer	cancer	NOUN
ajlm-2374	28	66	development	development	NOUN
ajlm-2374	28	67	occurs	occur	VERB
ajlm-2374	28	68	through	through	ADP
ajlm-2374	28	69	a	a	DET
ajlm-2374	28	70	number	number	NOUN
ajlm-2374	28	71	of	of	ADP
ajlm-2374	28	72	stages	stage	NOUN
ajlm-2374	28	73	,	,	PUNCT
ajlm-2374	28	74	starting	start	VERB
ajlm-2374	28	75	with	with	ADP
ajlm-2374	28	76	a	a	DET
ajlm-2374	28	77	persistent	persistent	ADJ
ajlm-2374	28	78	infection	infection	NOUN
ajlm-2374	28	79	with	with	ADP
ajlm-2374	28	80	any	any	PRON
ajlm-2374	28	81	of	of	ADP
ajlm-2374	28	82	the	the	DET
ajlm-2374	28	83	hpv	hpv	ADJ
ajlm-2374	28	84	genotypes	genotype	NOUN
ajlm-2374	28	85	that	that	PRON
ajlm-2374	28	86	are	be	AUX
ajlm-2374	28	87	high	high	ADJ
ajlm-2374	28	88	risk	risk	NOUN
ajlm-2374	28	89	,	,	PUNCT
ajlm-2374	28	90	then	then	ADV
ajlm-2374	28	91	cervical	cervical	ADJ
ajlm-2374	28	92	intraepithelial	intraepithelial	ADJ
ajlm-2374	28	93	neoplasia	neoplasia	NOUN
ajlm-2374	28	94	(	(	PUNCT
ajlm-2374	28	95	cin	cin	PROPN
ajlm-2374	28	96	)	)	PUNCT
ajlm-2374	28	97	,	,	PUNCT
ajlm-2374	28	98	finally	finally	ADV
ajlm-2374	28	99	leading	lead	VERB
ajlm-2374	28	100	to	to	ADP
ajlm-2374	28	101	invasive	invasive	ADJ
ajlm-2374	28	102	cervical	cervical	ADJ
ajlm-2374	28	103	cancer.7,8	cancer.7,8	NOUN
ajlm-2374	28	104	noteworthy	noteworthy	ADJ
ajlm-2374	28	105	cofactors	cofactor	NOUN
ajlm-2374	28	106	,	,	PUNCT
ajlm-2374	28	107	including	include	VERB
ajlm-2374	28	108	hiv	hiv	PROPN
ajlm-2374	28	109	infection	infection	NOUN
ajlm-2374	28	110	,	,	PUNCT
ajlm-2374	28	111	chlamydia	chlamydia	NOUN
ajlm-2374	28	112	trachomatis	trachomatis	ADJ
ajlm-2374	28	113	infection	infection	NOUN
ajlm-2374	28	114	,	,	PUNCT
ajlm-2374	28	115	smoking	smoking	NOUN
ajlm-2374	28	116	,	,	PUNCT
ajlm-2374	28	117	gravidity	gravidity	NOUN
ajlm-2374	28	118	,	,	PUNCT
ajlm-2374	28	119	oral	oral	ADJ
ajlm-2374	28	120	contraceptive	contraceptive	ADJ
ajlm-2374	28	121	use	use	NOUN
ajlm-2374	28	122	,	,	PUNCT
ajlm-2374	28	123	and	and	CCONJ
ajlm-2374	28	124	other	other	ADJ
ajlm-2374	28	125	forms	form	NOUN
ajlm-2374	28	126	of	of	ADP
ajlm-2374	28	127	immunosuppression	immunosuppression	NOUN
ajlm-2374	28	128	,	,	PUNCT
ajlm-2374	28	129	also	also	ADV
ajlm-2374	28	130	contribute	contribute	VERB
ajlm-2374	28	131	to	to	ADP
ajlm-2374	28	132	development	development	NOUN
ajlm-2374	28	133	of	of	ADP
ajlm-2374	28	134	cervical	cervical	ADJ
ajlm-2374	28	135	cancer.8,9,10,11	cancer.8,9,10,11	NOUN
ajlm-2374	28	136	our	our	PRON
ajlm-2374	28	137	prior	prior	ADJ
ajlm-2374	28	138	study	study	NOUN
ajlm-2374	28	139	revealed	reveal	VERB
ajlm-2374	28	140	a	a	DET
ajlm-2374	28	141	potential	potential	ADJ
ajlm-2374	28	142	link	link	NOUN
ajlm-2374	28	143	between	between	ADP
ajlm-2374	28	144	cin	cin	PROPN
ajlm-2374	28	145	and	and	CCONJ
ajlm-2374	28	146	obesity	obesity	NOUN
ajlm-2374	28	147	,	,	PUNCT
ajlm-2374	28	148	a	a	DET
ajlm-2374	28	149	component	component	NOUN
ajlm-2374	28	150	of	of	ADP
ajlm-2374	28	151	metabolic	metabolic	NOUN
ajlm-2374	28	152	syndrome.12	syndrome.12	VERB
ajlm-2374	28	153	other	other	ADJ
ajlm-2374	28	154	components	component	NOUN
ajlm-2374	28	155	of	of	ADP
ajlm-2374	28	156	metabolic	metabolic	NOUN
ajlm-2374	28	157	syndrome	syndrome	NOUN
ajlm-2374	28	158	include	include	VERB
ajlm-2374	28	159	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	28	160	and	and	CCONJ
ajlm-2374	28	161	insulin	insulin	NOUN
ajlm-2374	28	162	resistance	resistance	NOUN
ajlm-2374	28	163	,	,	PUNCT
ajlm-2374	28	164	which	which	PRON
ajlm-2374	28	165	have	have	AUX
ajlm-2374	28	166	been	be	AUX
ajlm-2374	28	167	shown	show	VERB
ajlm-2374	28	168	to	to	PART
ajlm-2374	28	169	be	be	AUX
ajlm-2374	28	170	associated	associate	VERB
ajlm-2374	28	171	with	with	ADP
ajlm-2374	28	172	treatment	treatment	NOUN
ajlm-2374	28	173	outcomes	outcome	NOUN
ajlm-2374	28	174	of	of	ADP
ajlm-2374	28	175	cervical	cervical	ADJ
ajlm-2374	28	176	lesions.13	lesions.13	NOUN
ajlm-2374	28	177	lipids	lipid	NOUN
ajlm-2374	28	178	play	play	VERB
ajlm-2374	28	179	a	a	DET
ajlm-2374	28	180	very	very	ADV
ajlm-2374	28	181	critical	critical	ADJ
ajlm-2374	28	182	role	role	NOUN
ajlm-2374	28	183	in	in	ADP
ajlm-2374	28	184	metabolism	metabolism	NOUN
ajlm-2374	28	185	,	,	PUNCT
ajlm-2374	28	186	potentially	potentially	ADV
ajlm-2374	28	187	serving	serve	VERB
ajlm-2374	28	188	as	as	ADP
ajlm-2374	28	189	cofactors	cofactor	NOUN
ajlm-2374	28	190	in	in	ADP
ajlm-2374	28	191	the	the	DET
ajlm-2374	28	192	development	development	NOUN
ajlm-2374	28	193	of	of	ADP
ajlm-2374	28	194	cin	cin	PROPN
ajlm-2374	28	195	and	and	CCONJ
ajlm-2374	28	196	invasive	invasive	ADJ
ajlm-2374	28	197	cervical	cervical	ADJ
ajlm-2374	28	198	cancer.14,15,16	cancer.14,15,16	ADJ
ajlm-2374	28	199	alterations	alteration	NOUN
ajlm-2374	28	200	in	in	ADP
ajlm-2374	28	201	lipids	lipid	NOUN
ajlm-2374	28	202	has	have	AUX
ajlm-2374	28	203	been	be	AUX
ajlm-2374	28	204	linked	link	VERB
ajlm-2374	28	205	to	to	ADP
ajlm-2374	28	206	development	development	NOUN
ajlm-2374	28	207	of	of	ADP
ajlm-2374	28	208	a	a	DET
ajlm-2374	28	209	wide	wide	ADJ
ajlm-2374	28	210	range	range	NOUN
ajlm-2374	28	211	of	of	ADP
ajlm-2374	28	212	disease	disease	NOUN
ajlm-2374	28	213	conditions.17,18,19,20,21	conditions.17,18,19,20,21	PROPN
ajlm-2374	28	214	moreover	moreover	ADV
ajlm-2374	28	215	,	,	PUNCT
ajlm-2374	28	216	dysregulated	dysregulated	ADJ
ajlm-2374	28	217	lipids	lipid	NOUN
ajlm-2374	28	218	have	have	AUX
ajlm-2374	28	219	been	be	AUX
ajlm-2374	28	220	shown	show	VERB
ajlm-2374	28	221	to	to	PART
ajlm-2374	28	222	occur	occur	VERB
ajlm-2374	28	223	in	in	ADP
ajlm-2374	28	224	development	development	NOUN
ajlm-2374	28	225	of	of	ADP
ajlm-2374	28	226	malignancies,16,17,22	malignancies,16,17,22	PROPN
ajlm-2374	28	227	with	with	ADP
ajlm-2374	28	228	recent	recent	ADJ
ajlm-2374	28	229	evidence	evidence	NOUN
ajlm-2374	28	230	connecting	connect	VERB
ajlm-2374	28	231	disordered	disordered	ADJ
ajlm-2374	28	232	lipid	lipid	NOUN
ajlm-2374	28	233	levels	level	NOUN
ajlm-2374	28	234	to	to	ADP
ajlm-2374	28	235	cervical	cervical	ADJ
ajlm-2374	28	236	cancer	cancer	NOUN
ajlm-2374	28	237	and	and	CCONJ
ajlm-2374	28	238	its	its	PRON
ajlm-2374	28	239	progression.21,23	progression.21,23	NOUN
ajlm-2374	28	240	our	our	PRON
ajlm-2374	28	241	previous	previous	ADJ
ajlm-2374	28	242	study	study	NOUN
ajlm-2374	28	243	in	in	ADP
ajlm-2374	28	244	an	an	DET
ajlm-2374	28	245	urban	urban	ADJ
ajlm-2374	28	246	setting	setting	NOUN
ajlm-2374	28	247	in	in	ADP
ajlm-2374	28	248	uganda	uganda	PROPN
ajlm-2374	28	249	showed	show	VERB
ajlm-2374	28	250	a	a	DET
ajlm-2374	28	251	significant	significant	ADJ
ajlm-2374	28	252	association	association	NOUN
ajlm-2374	28	253	between	between	ADP
ajlm-2374	28	254	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	28	255	and	and	CCONJ
ajlm-2374	28	256	cancerous	cancerous	ADJ
ajlm-2374	28	257	cervical	cervical	ADJ
ajlm-2374	28	258	lesions.24	lesions.24	NOUN
ajlm-2374	28	259	however	however	ADV
ajlm-2374	28	260	,	,	PUNCT
ajlm-2374	28	261	information	information	NOUN
ajlm-2374	28	262	on	on	ADP
ajlm-2374	28	263	any	any	DET
ajlm-2374	28	264	potential	potential	ADJ
ajlm-2374	28	265	association	association	NOUN
ajlm-2374	28	266	between	between	ADP
ajlm-2374	28	267	lipid	lipid	NOUN
ajlm-2374	28	268	levels	level	NOUN
ajlm-2374	28	269	and	and	CCONJ
ajlm-2374	28	270	cin	cin	PROPN
ajlm-2374	28	271	remains	remain	VERB
ajlm-2374	28	272	limited	limited	ADJ
ajlm-2374	28	273	,	,	PUNCT
ajlm-2374	28	274	especially	especially	ADV
ajlm-2374	28	275	in	in	ADP
ajlm-2374	28	276	rural	rural	ADJ
ajlm-2374	28	277	regions	region	NOUN
ajlm-2374	28	278	of	of	ADP
ajlm-2374	28	279	uganda	uganda	PROPN
ajlm-2374	28	280	.	.	PUNCT
ajlm-2374	29	1	this	this	DET
ajlm-2374	29	2	study	study	NOUN
ajlm-2374	29	3	was	be	AUX
ajlm-2374	29	4	therefore	therefore	ADV
ajlm-2374	29	5	conducted	conduct	VERB
ajlm-2374	29	6	to	to	PART
ajlm-2374	29	7	investigate	investigate	VERB
ajlm-2374	29	8	whether	whether	SCONJ
ajlm-2374	29	9	there	there	PRON
ajlm-2374	29	10	is	be	VERB
ajlm-2374	29	11	an	an	DET
ajlm-2374	29	12	association	association	NOUN
ajlm-2374	29	13	between	between	ADP
ajlm-2374	29	14	serum	serum	NOUN
ajlm-2374	29	15	lipid	lipid	NOUN
ajlm-2374	29	16	levels	level	NOUN
ajlm-2374	29	17	and	and	CCONJ
ajlm-2374	29	18	cin	cin	PROPN
ajlm-2374	29	19	among	among	ADP
ajlm-2374	29	20	women	woman	NOUN
ajlm-2374	29	21	attending	attend	VERB
ajlm-2374	29	22	the	the	DET
ajlm-2374	29	23	cervical	cervical	ADJ
ajlm-2374	29	24	cancer	cancer	NOUN
ajlm-2374	29	25	prevention	prevention	NOUN
ajlm-2374	29	26	clinic	clinic	NOUN
ajlm-2374	29	27	at	at	ADP
ajlm-2374	29	28	mbarara	mbarara	NOUN
ajlm-2374	29	29	regional	regional	ADJ
ajlm-2374	29	30	referral	referral	ADJ
ajlm-2374	29	31	hospital	hospital	NOUN
ajlm-2374	29	32	in	in	ADP
ajlm-2374	29	33	south	south	ADJ
ajlm-2374	29	34	-	-	PUNCT
ajlm-2374	29	35	western	western	ADJ
ajlm-2374	29	36	uganda	uganda	PROPN
ajlm-2374	29	37	.	.	PUNCT
ajlm-2374	30	1	methods	method	NOUN
ajlm-2374	30	2	ethical	ethical	ADJ
ajlm-2374	30	3	considerations	consideration	NOUN
ajlm-2374	30	4	ethical	ethical	ADJ
ajlm-2374	30	5	approval	approval	NOUN
ajlm-2374	30	6	for	for	ADP
ajlm-2374	30	7	this	this	DET
ajlm-2374	30	8	study	study	NOUN
ajlm-2374	30	9	was	be	AUX
ajlm-2374	30	10	granted	grant	VERB
ajlm-2374	30	11	by	by	ADP
ajlm-2374	30	12	the	the	DET
ajlm-2374	30	13	mbarara	mbarara	PROPN
ajlm-2374	30	14	university	university	PROPN
ajlm-2374	30	15	of	of	ADP
ajlm-2374	30	16	science	science	NOUN
ajlm-2374	30	17	and	and	CCONJ
ajlm-2374	30	18	technology	technology	NOUN
ajlm-2374	30	19	research	research	NOUN
ajlm-2374	30	20	ethics	ethic	NOUN
ajlm-2374	30	21	committee	committee	PROPN
ajlm-2374	30	22	(	(	PUNCT
ajlm-2374	30	23	must-2022	must-2022	NOUN
ajlm-2374	30	24	-	-	PUNCT
ajlm-2374	30	25	396	396	NUM
ajlm-2374	30	26	)	)	PUNCT
ajlm-2374	30	27	and	and	CCONJ
ajlm-2374	30	28	the	the	DET
ajlm-2374	30	29	uganda	uganda	PROPN
ajlm-2374	30	30	national	national	PROPN
ajlm-2374	30	31	council	council	PROPN
ajlm-2374	30	32	for	for	ADP
ajlm-2374	30	33	science	science	NOUN
ajlm-2374	30	34	and	and	CCONJ
ajlm-2374	30	35	technology	technology	NOUN
ajlm-2374	30	36	(	(	PUNCT
ajlm-2374	30	37	hs2395es	hs2395es	NOUN
ajlm-2374	30	38	)	)	PUNCT
ajlm-2374	30	39	.	.	PUNCT
ajlm-2374	31	1	additionally	additionally	ADV
ajlm-2374	31	2	,	,	PUNCT
ajlm-2374	31	3	administrative	administrative	ADJ
ajlm-2374	31	4	clearance	clearance	NOUN
ajlm-2374	31	5	from	from	ADP
ajlm-2374	31	6	the	the	DET
ajlm-2374	31	7	hospital	hospital	NOUN
ajlm-2374	31	8	director	director	NOUN
ajlm-2374	31	9	at	at	ADP
ajlm-2374	31	10	hospital	hospital	NOUN
ajlm-2374	31	11	director	director	NOUN
ajlm-2374	31	12	at	at	ADP
ajlm-2374	31	13	mbarara	mbarara	NOUN
ajlm-2374	31	14	regional	regional	ADJ
ajlm-2374	31	15	referral	referral	ADJ
ajlm-2374	31	16	hospital	hospital	NOUN
ajlm-2374	31	17	was	be	AUX
ajlm-2374	31	18	sought	seek	VERB
ajlm-2374	31	19	before	before	ADP
ajlm-2374	31	20	commencing	commence	VERB
ajlm-2374	31	21	the	the	DET
ajlm-2374	31	22	study	study	NOUN
ajlm-2374	31	23	.	.	PUNCT
ajlm-2374	32	1	we	we	PRON
ajlm-2374	32	2	obtained	obtain	VERB
ajlm-2374	32	3	written	write	VERB
ajlm-2374	32	4	informed	informed	ADJ
ajlm-2374	32	5	consent	consent	NOUN
ajlm-2374	32	6	from	from	ADP
ajlm-2374	32	7	each	each	DET
ajlm-2374	32	8	participant	participant	NOUN
ajlm-2374	32	9	and/or	and/or	CCONJ
ajlm-2374	32	10	their	their	PRON
ajlm-2374	32	11	legal	legal	ADJ
ajlm-2374	32	12	guardian	guardian	NOUN
ajlm-2374	32	13	prior	prior	ADV
ajlm-2374	32	14	to	to	ADP
ajlm-2374	32	15	their	their	PRON
ajlm-2374	32	16	involvement	involvement	NOUN
ajlm-2374	32	17	in	in	ADP
ajlm-2374	32	18	the	the	DET
ajlm-2374	32	19	study	study	NOUN
ajlm-2374	32	20	.	.	PUNCT
ajlm-2374	33	1	in	in	ADP
ajlm-2374	33	2	the	the	DET
ajlm-2374	33	3	case	case	NOUN
ajlm-2374	33	4	of	of	ADP
ajlm-2374	33	5	illiterate	illiterate	ADJ
ajlm-2374	33	6	participants	participant	NOUN
ajlm-2374	33	7	,	,	PUNCT
ajlm-2374	33	8	written	write	VERB
ajlm-2374	33	9	informed	informed	ADJ
ajlm-2374	33	10	consent	consent	NOUN
ajlm-2374	33	11	was	be	AUX
ajlm-2374	33	12	acquired	acquire	VERB
ajlm-2374	33	13	from	from	ADP
ajlm-2374	33	14	their	their	PRON
ajlm-2374	33	15	authorised	authorise	VERB
ajlm-2374	33	16	representatives	representative	NOUN
ajlm-2374	33	17	.	.	PUNCT
ajlm-2374	34	1	to	to	PART
ajlm-2374	34	2	maintain	maintain	VERB
ajlm-2374	34	3	confidentiality	confidentiality	NOUN
ajlm-2374	34	4	,	,	PUNCT
ajlm-2374	34	5	study	study	NOUN
ajlm-2374	34	6	numbers	number	NOUN
ajlm-2374	34	7	were	be	AUX
ajlm-2374	34	8	used	use	VERB
ajlm-2374	34	9	instead	instead	ADV
ajlm-2374	34	10	of	of	ADP
ajlm-2374	34	11	names	name	NOUN
ajlm-2374	34	12	on	on	ADP
ajlm-2374	34	13	all	all	DET
ajlm-2374	34	14	data	datum	NOUN
ajlm-2374	34	15	collection	collection	NOUN
ajlm-2374	34	16	tools	tool	NOUN
ajlm-2374	34	17	,	,	PUNCT
ajlm-2374	34	18	and	and	CCONJ
ajlm-2374	34	19	participant	participant	ADJ
ajlm-2374	34	20	identifiable	identifiable	ADJ
ajlm-2374	34	21	information	information	NOUN
ajlm-2374	34	22	was	be	AUX
ajlm-2374	34	23	separated	separate	VERB
ajlm-2374	34	24	during	during	ADP
ajlm-2374	34	25	data	datum	NOUN
ajlm-2374	34	26	analysis	analysis	NOUN
ajlm-2374	34	27	.	.	PUNCT
ajlm-2374	35	1	interactions	interaction	NOUN
ajlm-2374	35	2	between	between	ADP
ajlm-2374	35	3	participants	participant	NOUN
ajlm-2374	35	4	and	and	CCONJ
ajlm-2374	35	5	the	the	DET
ajlm-2374	35	6	research	research	NOUN
ajlm-2374	35	7	team	team	NOUN
ajlm-2374	35	8	occurred	occur	VERB
ajlm-2374	35	9	in	in	ADP
ajlm-2374	35	10	a	a	DET
ajlm-2374	35	11	private	private	ADJ
ajlm-2374	35	12	and	and	CCONJ
ajlm-2374	35	13	comfortable	comfortable	ADJ
ajlm-2374	35	14	setting	setting	NOUN
ajlm-2374	35	15	,	,	PUNCT
ajlm-2374	35	16	free	free	ADJ
ajlm-2374	35	17	from	from	ADP
ajlm-2374	35	18	disturbances	disturbance	NOUN
ajlm-2374	35	19	and	and	CCONJ
ajlm-2374	35	20	accessible	accessible	ADJ
ajlm-2374	35	21	to	to	ADP
ajlm-2374	35	22	only	only	ADV
ajlm-2374	35	23	one	one	NUM
ajlm-2374	35	24	participant	participant	NOUN
ajlm-2374	35	25	at	at	ADP
ajlm-2374	35	26	a	a	DET
ajlm-2374	35	27	time	time	NOUN
ajlm-2374	35	28	.	.	PUNCT
ajlm-2374	36	1	women	woman	NOUN
ajlm-2374	36	2	diagnosed	diagnose	VERB
ajlm-2374	36	3	with	with	ADP
ajlm-2374	36	4	cervical	cervical	ADJ
ajlm-2374	36	5	intraepithelial	intraepithelial	ADJ
ajlm-2374	36	6	lesions	lesion	NOUN
ajlm-2374	36	7	(	(	PUNCT
ajlm-2374	36	8	cases	case	NOUN
ajlm-2374	36	9	)	)	PUNCT
ajlm-2374	36	10	received	receive	VERB
ajlm-2374	36	11	the	the	DET
ajlm-2374	36	12	standard	standard	ADJ
ajlm-2374	36	13	care	care	NOUN
ajlm-2374	36	14	package	package	NOUN
ajlm-2374	36	15	at	at	ADP
ajlm-2374	36	16	the	the	DET
ajlm-2374	36	17	cervical	cervical	ADJ
ajlm-2374	36	18	cancer	cancer	NOUN
ajlm-2374	36	19	clinic	clinic	NOUN
ajlm-2374	36	20	.	.	PUNCT
ajlm-2374	37	1	the	the	DET
ajlm-2374	37	2	nurse	nurse	NOUN
ajlm-2374	37	3	at	at	ADP
ajlm-2374	37	4	the	the	DET
ajlm-2374	37	5	clinic	clinic	NOUN
ajlm-2374	37	6	provided	provide	VERB
ajlm-2374	37	7	participants	participant	NOUN
ajlm-2374	37	8	with	with	ADP
ajlm-2374	37	9	their	their	PRON
ajlm-2374	37	10	visual	visual	ADJ
ajlm-2374	37	11	inspection	inspection	NOUN
ajlm-2374	37	12	with	with	ADP
ajlm-2374	37	13	acetic	acetic	ADJ
ajlm-2374	37	14	acid	acid	NOUN
ajlm-2374	37	15	,	,	PUNCT
ajlm-2374	37	16	pap	pap	NOUN
ajlm-2374	37	17	smear	smear	NOUN
ajlm-2374	37	18	,	,	PUNCT
ajlm-2374	37	19	histology	histology	NOUN
ajlm-2374	37	20	,	,	PUNCT
ajlm-2374	37	21	and	and	CCONJ
ajlm-2374	37	22	lipid	lipid	NOUN
ajlm-2374	37	23	profile	profile	NOUN
ajlm-2374	37	24	results	result	NOUN
ajlm-2374	37	25	.	.	PUNCT
ajlm-2374	38	1	all	all	DET
ajlm-2374	38	2	methods	method	NOUN
ajlm-2374	38	3	employed	employ	VERB
ajlm-2374	38	4	in	in	ADP
ajlm-2374	38	5	this	this	DET
ajlm-2374	38	6	study	study	NOUN
ajlm-2374	38	7	adhered	adhere	VERB
ajlm-2374	38	8	to	to	ADP
ajlm-2374	38	9	relevant	relevant	ADJ
ajlm-2374	38	10	guidelines	guideline	NOUN
ajlm-2374	38	11	and	and	CCONJ
ajlm-2374	38	12	regulations	regulation	NOUN
ajlm-2374	38	13	.	.	PUNCT
ajlm-2374	39	1	study	study	NOUN
ajlm-2374	39	2	setting	set	VERB
ajlm-2374	39	3	this	this	DET
ajlm-2374	39	4	study	study	NOUN
ajlm-2374	39	5	was	be	AUX
ajlm-2374	39	6	conducted	conduct	VERB
ajlm-2374	39	7	at	at	ADP
ajlm-2374	39	8	the	the	DET
ajlm-2374	39	9	cervical	cervical	ADJ
ajlm-2374	39	10	cancer	cancer	NOUN
ajlm-2374	39	11	clinic	clinic	NOUN
ajlm-2374	39	12	of	of	ADP
ajlm-2374	39	13	mbarara	mbarara	PROPN
ajlm-2374	39	14	regional	regional	ADJ
ajlm-2374	39	15	referral	referral	ADJ
ajlm-2374	39	16	hospital	hospital	NOUN
ajlm-2374	39	17	,	,	PUNCT
ajlm-2374	39	18	between	between	ADP
ajlm-2374	39	19	01	01	NUM
ajlm-2374	39	20	december	december	PROPN
ajlm-2374	39	21	2022	2022	NUM
ajlm-2374	39	22	and	and	CCONJ
ajlm-2374	39	23	27	27	NUM
ajlm-2374	39	24	february	february	NOUN
ajlm-2374	39	25	2023	2023	NUM
ajlm-2374	39	26	.	.	PUNCT
ajlm-2374	40	1	mbarara	mbarara	PROPN
ajlm-2374	40	2	regional	regional	ADJ
ajlm-2374	40	3	referral	referral	ADJ
ajlm-2374	40	4	hospital	hospital	NOUN
ajlm-2374	40	5	is	be	AUX
ajlm-2374	40	6	a	a	DET
ajlm-2374	40	7	regional	regional	ADJ
ajlm-2374	40	8	referral	referral	ADJ
ajlm-2374	40	9	hospital	hospital	NOUN
ajlm-2374	40	10	for	for	ADP
ajlm-2374	40	11	the	the	DET
ajlm-2374	40	12	entire	entire	ADJ
ajlm-2374	40	13	south	south	ADJ
ajlm-2374	40	14	-	-	PUNCT
ajlm-2374	40	15	western	western	ADJ
ajlm-2374	40	16	uganda	uganda	PROPN
ajlm-2374	40	17	and	and	CCONJ
ajlm-2374	40	18	it	it	PRON
ajlm-2374	40	19	is	be	AUX
ajlm-2374	40	20	located	locate	VERB
ajlm-2374	40	21	in	in	ADP
ajlm-2374	40	22	mbarara	mbarara	PROPN
ajlm-2374	40	23	city	city	NOUN
ajlm-2374	40	24	,	,	PUNCT
ajlm-2374	40	25	approximately	approximately	ADV
ajlm-2374	40	26	260	260	NUM
ajlm-2374	40	27	km	km	NOUN
ajlm-2374	40	28	from	from	ADP
ajlm-2374	40	29	the	the	DET
ajlm-2374	40	30	capital	capital	NOUN
ajlm-2374	40	31	city	city	NOUN
ajlm-2374	40	32	,	,	PUNCT
ajlm-2374	40	33	kampala	kampala	PROPN
ajlm-2374	40	34	.	.	PUNCT
ajlm-2374	41	1	this	this	DET
ajlm-2374	41	2	clinic	clinic	NOUN
ajlm-2374	41	3	offers	offer	VERB
ajlm-2374	41	4	services	service	NOUN
ajlm-2374	41	5	to	to	ADP
ajlm-2374	41	6	an	an	DET
ajlm-2374	41	7	average	average	NOUN
ajlm-2374	41	8	of	of	ADP
ajlm-2374	41	9	75	75	NUM
ajlm-2374	41	10	women	woman	NOUN
ajlm-2374	41	11	per	per	ADP
ajlm-2374	41	12	week	week	NOUN
ajlm-2374	41	13	.	.	PUNCT
ajlm-2374	42	1	it	it	PRON
ajlm-2374	42	2	receives	receive	VERB
ajlm-2374	42	3	women	woman	NOUN
ajlm-2374	42	4	from	from	ADP
ajlm-2374	42	5	over	over	ADP
ajlm-2374	42	6	13	13	NUM
ajlm-2374	42	7	districts	district	NOUN
ajlm-2374	42	8	of	of	ADP
ajlm-2374	42	9	the	the	DET
ajlm-2374	42	10	entire	entire	ADJ
ajlm-2374	42	11	south	south	ADJ
ajlm-2374	42	12	-	-	PUNCT
ajlm-2374	42	13	western	western	ADJ
ajlm-2374	42	14	region	region	NOUN
ajlm-2374	42	15	of	of	ADP
ajlm-2374	42	16	uganda	uganda	PROPN
ajlm-2374	42	17	plus	plus	CCONJ
ajlm-2374	42	18	the	the	DET
ajlm-2374	42	19	neighbouring	neighbouring	ADJ
ajlm-2374	42	20	countries	country	NOUN
ajlm-2374	42	21	including	include	VERB
ajlm-2374	42	22	tanzania	tanzania	PROPN
ajlm-2374	42	23	,	,	PUNCT
ajlm-2374	42	24	rwanda	rwanda	PROPN
ajlm-2374	42	25	and	and	CCONJ
ajlm-2374	42	26	democratic	democratic	PROPN
ajlm-2374	42	27	republic	republic	PROPN
ajlm-2374	42	28	of	of	ADP
ajlm-2374	42	29	congo	congo	PROPN
ajlm-2374	42	30	.	.	PUNCT
ajlm-2374	43	1	study	study	NOUN
ajlm-2374	43	2	design	design	NOUN
ajlm-2374	43	3	we	we	PRON
ajlm-2374	43	4	conducted	conduct	VERB
ajlm-2374	43	5	this	this	DET
ajlm-2374	43	6	unmatched	unmatched	ADJ
ajlm-2374	43	7	case	case	NOUN
ajlm-2374	43	8	-	-	PUNCT
ajlm-2374	43	9	control	control	NOUN
ajlm-2374	43	10	study	study	NOUN
ajlm-2374	43	11	including	include	VERB
ajlm-2374	43	12	women	woman	NOUN
ajlm-2374	43	13	who	who	PRON
ajlm-2374	43	14	visited	visit	VERB
ajlm-2374	43	15	the	the	DET
ajlm-2374	43	16	mbarara	mbarara	NOUN
ajlm-2374	43	17	regional	regional	ADJ
ajlm-2374	43	18	referral	referral	ADJ
ajlm-2374	43	19	hospital	hospital	NOUN
ajlm-2374	43	20	cervical	cervical	ADJ
ajlm-2374	43	21	cancer	cancer	NOUN
ajlm-2374	43	22	clinic	clinic	NOUN
ajlm-2374	43	23	.	.	PUNCT
ajlm-2374	44	1	cases	case	NOUN
ajlm-2374	44	2	were	be	AUX
ajlm-2374	44	3	defined	define	VERB
ajlm-2374	44	4	as	as	ADP
ajlm-2374	44	5	women	woman	NOUN
ajlm-2374	44	6	with	with	ADP
ajlm-2374	44	7	a	a	DET
ajlm-2374	44	8	positive	positive	ADJ
ajlm-2374	44	9	visual	visual	ADJ
ajlm-2374	44	10	inspection	inspection	NOUN
ajlm-2374	44	11	with	with	ADP
ajlm-2374	44	12	acetic	acetic	ADJ
ajlm-2374	44	13	acid	acid	NOUN
ajlm-2374	44	14	result	result	NOUN
ajlm-2374	44	15	who	who	PRON
ajlm-2374	44	16	underwent	undergo	VERB
ajlm-2374	44	17	pap	pap	NOUN
ajlm-2374	44	18	smears	smear	NOUN
ajlm-2374	44	19	and	and	CCONJ
ajlm-2374	44	20	histology	histology	NOUN
ajlm-2374	44	21	,	,	PUNCT
ajlm-2374	44	22	subsequently	subsequently	ADV
ajlm-2374	44	23	confirmed	confirm	VERB
ajlm-2374	44	24	to	to	PART
ajlm-2374	44	25	have	have	VERB
ajlm-2374	44	26	cin	cin	PROPN
ajlm-2374	44	27	in	in	ADP
ajlm-2374	44	28	accordance	accordance	NOUN
ajlm-2374	44	29	with	with	ADP
ajlm-2374	44	30	the	the	DET
ajlm-2374	44	31	clinic	clinic	NOUN
ajlm-2374	44	32	’s	’s	PART
ajlm-2374	44	33	standard	standard	ADJ
ajlm-2374	44	34	care	care	NOUN
ajlm-2374	44	35	.	.	PUNCT
ajlm-2374	45	1	controls	control	NOUN
ajlm-2374	45	2	consisted	consist	VERB
ajlm-2374	45	3	of	of	ADP
ajlm-2374	45	4	women	woman	NOUN
ajlm-2374	45	5	with	with	ADP
ajlm-2374	45	6	a	a	DET
ajlm-2374	45	7	negative	negative	ADJ
ajlm-2374	45	8	visual	visual	ADJ
ajlm-2374	45	9	inspection	inspection	NOUN
ajlm-2374	45	10	with	with	ADP
ajlm-2374	45	11	acetic	acetic	ADJ
ajlm-2374	45	12	acid	acid	NOUN
ajlm-2374	45	13	result	result	NOUN
ajlm-2374	45	14	and	and	CCONJ
ajlm-2374	45	15	those	those	PRON
ajlm-2374	45	16	confirmed	confirm	VERB
ajlm-2374	45	17	to	to	PART
ajlm-2374	45	18	be	be	AUX
ajlm-2374	45	19	devoid	devoid	ADJ
ajlm-2374	45	20	of	of	ADP
ajlm-2374	45	21	cervical	cervical	ADJ
ajlm-2374	45	22	lesions	lesion	NOUN
ajlm-2374	45	23	based	base	VERB
ajlm-2374	45	24	on	on	ADP
ajlm-2374	45	25	cytology	cytology	NOUN
ajlm-2374	45	26	and	and	CCONJ
ajlm-2374	45	27	histology	histology	NOUN
ajlm-2374	45	28	.	.	PUNCT
ajlm-2374	46	1	sample	sample	NOUN
ajlm-2374	46	2	size	size	NOUN
ajlm-2374	46	3	determination	determination	NOUN
ajlm-2374	46	4	we	we	PRON
ajlm-2374	46	5	calculated	calculate	VERB
ajlm-2374	46	6	our	our	PRON
ajlm-2374	46	7	sample	sample	NOUN
ajlm-2374	46	8	size	size	NOUN
ajlm-2374	46	9	using	use	VERB
ajlm-2374	46	10	the	the	DET
ajlm-2374	46	11	online	online	ADJ
ajlm-2374	46	12	openepi	openepi	NOUN
ajlm-2374	46	13	,	,	PUNCT
ajlm-2374	46	14	version	version	NOUN
ajlm-2374	46	15	3	3	NUM
ajlm-2374	46	16	,	,	PUNCT
ajlm-2374	46	17	open	open	ADJ
ajlm-2374	46	18	-	-	PUNCT
ajlm-2374	46	19	source	source	NOUN
ajlm-2374	46	20	calculator	calculator	NOUN
ajlm-2374	46	21	-	-	PUNCT
ajlm-2374	46	22	sscc	sscc	NOUN
ajlm-2374	46	23	(	(	PUNCT
ajlm-2374	46	24	openepi	openepi	PROPN
ajlm-2374	46	25	–	–	PUNCT
ajlm-2374	46	26	sample	sample	NOUN
ajlm-2374	46	27	size	size	NOUN
ajlm-2374	46	28	for	for	ADP
ajlm-2374	46	29	unmatched	unmatched	ADJ
ajlm-2374	46	30	case	case	NOUN
ajlm-2374	46	31	-	-	PUNCT
ajlm-2374	46	32	control	control	NOUN
ajlm-2374	46	33	studies	study	NOUN
ajlm-2374	46	34	)	)	PUNCT
ajlm-2374	46	35	.	.	PUNCT
ajlm-2374	47	1	for	for	ADP
ajlm-2374	47	2	this	this	DET
ajlm-2374	47	3	calculation	calculation	NOUN
ajlm-2374	47	4	,	,	PUNCT
ajlm-2374	47	5	we	we	PRON
ajlm-2374	47	6	considered	consider	VERB
ajlm-2374	47	7	a	a	DET
ajlm-2374	47	8	two	two	NUM
ajlm-2374	47	9	-	-	PUNCT
ajlm-2374	47	10	sided	sided	ADJ
ajlm-2374	47	11	confidence	confidence	NOUN
ajlm-2374	47	12	level	level	NOUN
ajlm-2374	47	13	of	of	ADP
ajlm-2374	47	14	95	95	NUM
ajlm-2374	47	15	,	,	PUNCT
ajlm-2374	47	16	a	a	DET
ajlm-2374	47	17	study	study	NOUN
ajlm-2374	47	18	power	power	NOUN
ajlm-2374	47	19	of	of	ADP
ajlm-2374	47	20	80	80	NUM
ajlm-2374	47	21	%	%	NOUN
ajlm-2374	47	22	and	and	CCONJ
ajlm-2374	47	23	a	a	DET
ajlm-2374	47	24	case	case	NOUN
ajlm-2374	47	25	-	-	PUNCT
ajlm-2374	47	26	to	to	ADP
ajlm-2374	47	27	-	-	PUNCT
ajlm-2374	47	28	control	control	NOUN
ajlm-2374	47	29	ratio	ratio	NOUN
ajlm-2374	47	30	of	of	ADP
ajlm-2374	47	31	1	1	NUM
ajlm-2374	47	32	.	.	PUNCT
ajlm-2374	48	1	we	we	PRON
ajlm-2374	48	2	took	take	VERB
ajlm-2374	48	3	into	into	ADP
ajlm-2374	48	4	account	account	NOUN
ajlm-2374	48	5	a	a	DET
ajlm-2374	48	6	proportion	proportion	NOUN
ajlm-2374	48	7	of	of	ADP
ajlm-2374	48	8	cases	case	NOUN
ajlm-2374	48	9	with	with	ADP
ajlm-2374	48	10	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	48	11	of	of	ADP
ajlm-2374	48	12	40.99%,25	40.99%,25	NUM
ajlm-2374	48	13	along	along	ADP
ajlm-2374	48	14	with	with	ADP
ajlm-2374	48	15	a	a	DET
ajlm-2374	48	16	proportion	proportion	NOUN
ajlm-2374	48	17	of	of	ADP
ajlm-2374	48	18	controls	control	NOUN
ajlm-2374	48	19	with	with	ADP
ajlm-2374	48	20	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	48	21	of	of	ADP
ajlm-2374	48	22	18.8%,26	18.8%,26	NUM
ajlm-2374	48	23	together	together	ADV
ajlm-2374	48	24	with	with	ADP
ajlm-2374	48	25	a	a	DET
ajlm-2374	48	26	least	least	ADV
ajlm-2374	48	27	extreme	extreme	ADJ
ajlm-2374	48	28	odds	odd	NOUN
ajlm-2374	48	29	ratio	ratio	NOUN
ajlm-2374	48	30	of	of	ADP
ajlm-2374	48	31	3.0	3.0	NUM
ajlm-2374	48	32	.	.	PUNCT
ajlm-2374	49	1	this	this	PRON
ajlm-2374	49	2	is	be	AUX
ajlm-2374	49	3	based	base	VERB
ajlm-2374	49	4	on	on	ADP
ajlm-2374	49	5	previous	previous	ADJ
ajlm-2374	49	6	studies	study	NOUN
ajlm-2374	49	7	which	which	PRON
ajlm-2374	49	8	have	have	AUX
ajlm-2374	49	9	demonstrated	demonstrate	VERB
ajlm-2374	49	10	a	a	DET
ajlm-2374	49	11	high	high	ADJ
ajlm-2374	49	12	variability	variability	NOUN
ajlm-2374	49	13	in	in	ADP
ajlm-2374	49	14	prevalence	prevalence	NOUN
ajlm-2374	49	15	of	of	ADP
ajlm-2374	49	16	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	49	17	in	in	ADP
ajlm-2374	49	18	africa	africa	PROPN
ajlm-2374	49	19	,	,	PUNCT
ajlm-2374	49	20	ranging	range	VERB
ajlm-2374	49	21	from	from	ADP
ajlm-2374	49	22	5.2	5.2	NUM
ajlm-2374	49	23	%	%	NOUN
ajlm-2374	49	24	to	to	ADP
ajlm-2374	49	25	89%.27	89%.27	NUM
ajlm-2374	49	26	these	these	DET
ajlm-2374	49	27	studies	study	NOUN
ajlm-2374	49	28	offer	offer	VERB
ajlm-2374	49	29	the	the	DET
ajlm-2374	49	30	most	most	ADV
ajlm-2374	49	31	accurate	accurate	ADJ
ajlm-2374	49	32	depiction	depiction	NOUN
ajlm-2374	49	33	of	of	ADP
ajlm-2374	49	34	the	the	DET
ajlm-2374	49	35	cervical	cervical	ADJ
ajlm-2374	49	36	cancer	cancer	NOUN
ajlm-2374	49	37	study	study	NOUN
ajlm-2374	49	38	population	population	NOUN
ajlm-2374	49	39	that	that	PRON
ajlm-2374	49	40	we	we	PRON
ajlm-2374	49	41	could	could	AUX
ajlm-2374	49	42	find.25	find.25	VERB
ajlm-2374	49	43	this	this	PRON
ajlm-2374	49	44	gave	give	VERB
ajlm-2374	49	45	a	a	DET
ajlm-2374	49	46	total	total	NOUN
ajlm-2374	49	47	of	of	ADP
ajlm-2374	49	48	75	75	NUM
ajlm-2374	49	49	cases	case	NOUN
ajlm-2374	49	50	and	and	CCONJ
ajlm-2374	49	51	75	75	NUM
ajlm-2374	49	52	controls	control	NOUN
ajlm-2374	49	53	using	use	VERB
ajlm-2374	49	54	the	the	DET
ajlm-2374	49	55	fleiss	fleiss	NOUN
ajlm-2374	49	56	module	module	NOUN
ajlm-2374	49	57	with	with	ADP
ajlm-2374	49	58	continuity	continuity	NOUN
ajlm-2374	49	59	correction.28	correction.28	NOUN
ajlm-2374	49	60	after	after	ADP
ajlm-2374	49	61	factoring	factor	VERB
ajlm-2374	49	62	in	in	ADP
ajlm-2374	49	63	the	the	DET
ajlm-2374	49	64	possible	possible	ADJ
ajlm-2374	49	65	15	15	NUM
ajlm-2374	49	66	%	%	NOUN
ajlm-2374	49	67	attrition	attrition	NOUN
ajlm-2374	49	68	rate	rate	NOUN
ajlm-2374	49	69	,	,	PUNCT
ajlm-2374	49	70	the	the	DET
ajlm-2374	49	71	resultant	resultant	NOUN
ajlm-2374	49	72	sample	sample	NOUN
ajlm-2374	49	73	size	size	NOUN
ajlm-2374	49	74	came	come	VERB
ajlm-2374	49	75	to	to	ADP
ajlm-2374	49	76	at	at	ADV
ajlm-2374	49	77	least	least	ADV
ajlm-2374	49	78	86	86	NUM
ajlm-2374	49	79	cases	case	NOUN
ajlm-2374	49	80	and	and	CCONJ
ajlm-2374	49	81	86	86	NUM
ajlm-2374	49	82	controls	control	NOUN
ajlm-2374	49	83	.	.	PUNCT
ajlm-2374	50	1	sampling	sample	VERB
ajlm-2374	50	2	procedure	procedure	NOUN
ajlm-2374	50	3	we	we	PRON
ajlm-2374	50	4	prospectively	prospectively	VERB
ajlm-2374	50	5	selected	select	VERB
ajlm-2374	50	6	cases	case	NOUN
ajlm-2374	50	7	and	and	CCONJ
ajlm-2374	50	8	controls	control	NOUN
ajlm-2374	50	9	by	by	ADP
ajlm-2374	50	10	using	use	VERB
ajlm-2374	50	11	purposive	purposive	NOUN
ajlm-2374	50	12	sampling	sampling	NOUN
ajlm-2374	50	13	to	to	ADP
ajlm-2374	50	14	recruit	recruit	NOUN
ajlm-2374	50	15	cases	case	NOUN
ajlm-2374	50	16	after	after	ADP
ajlm-2374	50	17	cytology	cytology	NOUN
ajlm-2374	50	18	or	or	CCONJ
ajlm-2374	50	19	histology	histology	NOUN
ajlm-2374	50	20	specimen	speciman	NOUN
ajlm-2374	50	21	collection	collection	NOUN
ajlm-2374	50	22	and	and	CCONJ
ajlm-2374	50	23	following	follow	VERB
ajlm-2374	50	24	a	a	DET
ajlm-2374	50	25	positive	positive	ADJ
ajlm-2374	50	26	screening	screening	NOUN
ajlm-2374	50	27	test	test	NOUN
ajlm-2374	50	28	.	.	PUNCT
ajlm-2374	51	1	then	then	ADV
ajlm-2374	51	2	we	we	PRON
ajlm-2374	51	3	recruited	recruit	VERB
ajlm-2374	51	4	a	a	DET
ajlm-2374	51	5	control	control	NOUN
ajlm-2374	51	6	each	each	DET
ajlm-2374	51	7	time	time	NOUN
ajlm-2374	51	8	a	a	DET
ajlm-2374	51	9	case	case	NOUN
ajlm-2374	51	10	was	be	AUX
ajlm-2374	51	11	identified	identify	VERB
ajlm-2374	51	12	,	,	PUNCT
ajlm-2374	51	13	that	that	ADV
ajlm-2374	51	14	is	is	ADV
ajlm-2374	51	15	,	,	PUNCT
ajlm-2374	51	16	the	the	DET
ajlm-2374	51	17	incidence	incidence	NOUN
ajlm-2374	51	18	density	density	NOUN
ajlm-2374	51	19	sampling	sample	VERB
ajlm-2374	51	20	method	method	NOUN
ajlm-2374	51	21	as	as	ADP
ajlm-2374	51	22	described	describe	VERB
ajlm-2374	51	23	previously.29	previously.29	NOUN
ajlm-2374	51	24	eligibility	eligibility	NOUN
ajlm-2374	51	25	criteria	criterion	NOUN
ajlm-2374	51	26	we	we	PRON
ajlm-2374	51	27	included	include	VERB
ajlm-2374	51	28	women	woman	NOUN
ajlm-2374	51	29	aged	age	VERB
ajlm-2374	51	30	21	21	NUM
ajlm-2374	51	31	years	year	NOUN
ajlm-2374	51	32	and	and	CCONJ
ajlm-2374	51	33	above	above	ADV
ajlm-2374	51	34	,	,	PUNCT
ajlm-2374	51	35	who	who	PRON
ajlm-2374	51	36	visited	visit	VERB
ajlm-2374	51	37	the	the	DET
ajlm-2374	51	38	study	study	NOUN
ajlm-2374	51	39	site	site	NOUN
ajlm-2374	51	40	during	during	ADP
ajlm-2374	51	41	the	the	DET
ajlm-2374	51	42	time	time	NOUN
ajlm-2374	51	43	of	of	ADP
ajlm-2374	51	44	the	the	DET
ajlm-2374	51	45	study	study	NOUN
ajlm-2374	51	46	and	and	CCONJ
ajlm-2374	51	47	who	who	PRON
ajlm-2374	51	48	consented	consent	VERB
ajlm-2374	51	49	to	to	PART
ajlm-2374	51	50	participate	participate	VERB
ajlm-2374	51	51	.	.	PUNCT
ajlm-2374	52	1	we	we	PRON
ajlm-2374	52	2	excluded	exclude	VERB
ajlm-2374	52	3	any	any	DET
ajlm-2374	52	4	woman	woman	NOUN
ajlm-2374	52	5	who	who	PRON
ajlm-2374	52	6	was	be	AUX
ajlm-2374	52	7	undergoing	undergo	VERB
ajlm-2374	52	8	any	any	DET
ajlm-2374	52	9	form	form	NOUN
ajlm-2374	52	10	of	of	ADP
ajlm-2374	52	11	treatment	treatment	NOUN
ajlm-2374	52	12	with	with	ADP
ajlm-2374	52	13	any	any	DET
ajlm-2374	52	14	lipid	lipid	NOUN
ajlm-2374	52	15	-	-	PUNCT
ajlm-2374	52	16	altering	alter	VERB
ajlm-2374	52	17	drugs	drug	NOUN
ajlm-2374	52	18	such	such	ADJ
ajlm-2374	52	19	as	as	ADP
ajlm-2374	52	20	antihypertensive	antihypertensive	ADJ
ajlm-2374	52	21	and	and	CCONJ
ajlm-2374	52	22	cholesterol	cholesterol	NOUN
ajlm-2374	52	23	-	-	PUNCT
ajlm-2374	52	24	lowering	lower	VERB
ajlm-2374	52	25	drugs	drug	NOUN
ajlm-2374	52	26	.	.	PUNCT
ajlm-2374	53	1	data	datum	NOUN
ajlm-2374	53	2	collection	collection	NOUN
ajlm-2374	53	3	demographic	demographic	ADJ
ajlm-2374	53	4	data	datum	NOUN
ajlm-2374	53	5	demographic	demographic	ADJ
ajlm-2374	53	6	information	information	NOUN
ajlm-2374	53	7	was	be	AUX
ajlm-2374	53	8	gathered	gather	VERB
ajlm-2374	53	9	by	by	ADP
ajlm-2374	53	10	use	use	NOUN
ajlm-2374	53	11	of	of	ADP
ajlm-2374	53	12	a	a	DET
ajlm-2374	53	13	pretested	preteste	VERB
ajlm-2374	53	14	enrollment	enrollment	NOUN
ajlm-2374	53	15	form	form	NOUN
ajlm-2374	53	16	administered	administer	VERB
ajlm-2374	53	17	by	by	ADP
ajlm-2374	53	18	research	research	NOUN
ajlm-2374	53	19	assistants	assistant	NOUN
ajlm-2374	53	20	,	,	PUNCT
ajlm-2374	53	21	specifically	specifically	ADV
ajlm-2374	53	22	the	the	DET
ajlm-2374	53	23	midwives	midwife	NOUN
ajlm-2374	53	24	from	from	ADP
ajlm-2374	53	25	the	the	DET
ajlm-2374	53	26	mbarara	mbarara	NOUN
ajlm-2374	53	27	regional	regional	ADJ
ajlm-2374	53	28	referral	referral	ADJ
ajlm-2374	53	29	hospital	hospital	NOUN
ajlm-2374	53	30	cervical	cervical	ADJ
ajlm-2374	53	31	cancer	cancer	NOUN
ajlm-2374	53	32	clinic	clinic	NOUN
ajlm-2374	53	33	.	.	PUNCT
ajlm-2374	54	1	upon	upon	SCONJ
ajlm-2374	54	2	obtaining	obtain	VERB
ajlm-2374	54	3	written	write	VERB
ajlm-2374	54	4	informed	informed	ADJ
ajlm-2374	54	5	consent	consent	NOUN
ajlm-2374	54	6	,	,	PUNCT
ajlm-2374	54	7	participants	participant	NOUN
ajlm-2374	54	8	received	receive	VERB
ajlm-2374	54	9	assistance	assistance	NOUN
ajlm-2374	54	10	in	in	ADP
ajlm-2374	54	11	completing	complete	VERB
ajlm-2374	54	12	the	the	DET
ajlm-2374	54	13	enrollment	enrollment	NOUN
ajlm-2374	54	14	form	form	NOUN
ajlm-2374	54	15	to	to	PART
ajlm-2374	54	16	record	record	VERB
ajlm-2374	54	17	their	their	PRON
ajlm-2374	54	18	demographic	demographic	ADJ
ajlm-2374	54	19	details	detail	NOUN
ajlm-2374	54	20	.	.	PUNCT
ajlm-2374	55	1	the	the	DET
ajlm-2374	55	2	collected	collect	VERB
ajlm-2374	55	3	data	datum	NOUN
ajlm-2374	55	4	encompassed	encompass	VERB
ajlm-2374	55	5	information	information	NOUN
ajlm-2374	55	6	such	such	ADJ
ajlm-2374	55	7	as	as	ADP
ajlm-2374	55	8	age	age	NOUN
ajlm-2374	55	9	,	,	PUNCT
ajlm-2374	55	10	district	district	NOUN
ajlm-2374	55	11	and	and	CCONJ
ajlm-2374	55	12	village	village	NOUN
ajlm-2374	55	13	of	of	ADP
ajlm-2374	55	14	residence	residence	NOUN
ajlm-2374	55	15	,	,	PUNCT
ajlm-2374	55	16	history	history	NOUN
ajlm-2374	55	17	of	of	ADP
ajlm-2374	55	18	blood	blood	NOUN
ajlm-2374	55	19	pressure	pressure	NOUN
ajlm-2374	55	20	and	and	CCONJ
ajlm-2374	55	21	diabetes	diabetes	NOUN
ajlm-2374	55	22	,	,	PUNCT
ajlm-2374	55	23	marital	marital	ADJ
ajlm-2374	55	24	status	status	NOUN
ajlm-2374	55	25	,	,	PUNCT
ajlm-2374	55	26	highest	high	ADJ
ajlm-2374	55	27	attained	attain	VERB
ajlm-2374	55	28	level	level	NOUN
ajlm-2374	55	29	of	of	ADP
ajlm-2374	55	30	education	education	NOUN
ajlm-2374	55	31	,	,	PUNCT
ajlm-2374	55	32	hiv	hiv	PROPN
ajlm-2374	55	33	status	status	NOUN
ajlm-2374	55	34	,	,	PUNCT
ajlm-2374	55	35	smoking	smoking	NOUN
ajlm-2374	55	36	habits	habit	NOUN
ajlm-2374	55	37	,	,	PUNCT
ajlm-2374	55	38	oral	oral	ADJ
ajlm-2374	55	39	contraceptive	contraceptive	ADJ
ajlm-2374	55	40	use	use	NOUN
ajlm-2374	55	41	,	,	PUNCT
ajlm-2374	55	42	family	family	NOUN
ajlm-2374	55	43	history	history	NOUN
ajlm-2374	55	44	of	of	ADP
ajlm-2374	55	45	cervical	cervical	ADJ
ajlm-2374	55	46	cancer	cancer	NOUN
ajlm-2374	55	47	,	,	PUNCT
ajlm-2374	55	48	age	age	NOUN
ajlm-2374	55	49	at	at	ADP
ajlm-2374	55	50	sexual	sexual	ADJ
ajlm-2374	55	51	debut	debut	NOUN
ajlm-2374	55	52	,	,	PUNCT
ajlm-2374	55	53	number	number	NOUN
ajlm-2374	55	54	of	of	ADP
ajlm-2374	55	55	lifetime	lifetime	NOUN
ajlm-2374	55	56	sexual	sexual	ADJ
ajlm-2374	55	57	partners	partner	NOUN
ajlm-2374	55	58	,	,	PUNCT
ajlm-2374	55	59	and	and	CCONJ
ajlm-2374	55	60	the	the	DET
ajlm-2374	55	61	number	number	NOUN
ajlm-2374	55	62	of	of	ADP
ajlm-2374	55	63	full	full	ADJ
ajlm-2374	55	64	-	-	PUNCT
ajlm-2374	55	65	term	term	NOUN
ajlm-2374	55	66	births	birth	NOUN
ajlm-2374	55	67	.	.	PUNCT
ajlm-2374	56	1	blood	blood	NOUN
ajlm-2374	56	2	collection	collection	NOUN
ajlm-2374	56	3	and	and	CCONJ
ajlm-2374	56	4	lipid	lipid	NOUN
ajlm-2374	56	5	measurements	measurement	NOUN
ajlm-2374	56	6	four	four	NUM
ajlm-2374	56	7	millilitres	millilitre	NOUN
ajlm-2374	56	8	(	(	PUNCT
ajlm-2374	56	9	4	4	NUM
ajlm-2374	56	10	ml	ml	NOUN
ajlm-2374	56	11	)	)	PUNCT
ajlm-2374	56	12	of	of	ADP
ajlm-2374	56	13	venous	venous	ADJ
ajlm-2374	56	14	blood	blood	NOUN
ajlm-2374	56	15	was	be	AUX
ajlm-2374	56	16	drawn	draw	VERB
ajlm-2374	56	17	aseptically	aseptically	ADV
ajlm-2374	56	18	by	by	ADP
ajlm-2374	56	19	venipuncture	venipuncture	NOUN
ajlm-2374	56	20	from	from	ADP
ajlm-2374	56	21	the	the	DET
ajlm-2374	56	22	mid	mid	ADJ
ajlm-2374	56	23	-	-	ADJ
ajlm-2374	56	24	cubital	cubital	ADJ
ajlm-2374	56	25	vein	vein	NOUN
ajlm-2374	56	26	,	,	PUNCT
ajlm-2374	56	27	into	into	ADP
ajlm-2374	56	28	plain	plain	ADJ
ajlm-2374	56	29	vacutainers	vacutainer	NOUN
ajlm-2374	56	30	following	follow	VERB
ajlm-2374	56	31	consent	consent	NOUN
ajlm-2374	56	32	and	and	CCONJ
ajlm-2374	56	33	completion	completion	NOUN
ajlm-2374	56	34	of	of	ADP
ajlm-2374	56	35	the	the	DET
ajlm-2374	56	36	enrollment	enrollment	NOUN
ajlm-2374	56	37	form	form	NOUN
ajlm-2374	56	38	.	.	PUNCT
ajlm-2374	57	1	specimens	specimen	NOUN
ajlm-2374	57	2	were	be	AUX
ajlm-2374	57	3	given	give	VERB
ajlm-2374	57	4	identification	identification	NOUN
ajlm-2374	57	5	numbers	number	NOUN
ajlm-2374	57	6	(	(	PUNCT
ajlm-2374	57	7	codes	code	NOUN
ajlm-2374	57	8	)	)	PUNCT
ajlm-2374	57	9	and	and	CCONJ
ajlm-2374	57	10	allowed	allow	VERB
ajlm-2374	57	11	to	to	PART
ajlm-2374	57	12	clot	clot	VERB
ajlm-2374	57	13	at	at	ADP
ajlm-2374	57	14	room	room	NOUN
ajlm-2374	57	15	temperature	temperature	NOUN
ajlm-2374	57	16	,	,	PUNCT
ajlm-2374	57	17	after	after	ADP
ajlm-2374	57	18	which	which	PRON
ajlm-2374	57	19	they	they	PRON
ajlm-2374	57	20	were	be	AUX
ajlm-2374	57	21	transferred	transfer	VERB
ajlm-2374	57	22	to	to	ADP
ajlm-2374	57	23	the	the	DET
ajlm-2374	57	24	laboratory	laboratory	NOUN
ajlm-2374	57	25	for	for	ADP
ajlm-2374	57	26	centrifugation	centrifugation	NOUN
ajlm-2374	57	27	(	(	PUNCT
ajlm-2374	57	28	3000	3000	NUM
ajlm-2374	57	29	revolutions	revolution	NOUN
ajlm-2374	57	30	per	per	ADP
ajlm-2374	57	31	minute	minute	NOUN
ajlm-2374	57	32	for	for	ADP
ajlm-2374	57	33	5	5	NUM
ajlm-2374	57	34	min	min	NOUN
ajlm-2374	57	35	)	)	PUNCT
ajlm-2374	57	36	with	with	ADP
ajlm-2374	57	37	the	the	DET
ajlm-2374	57	38	aim	aim	NOUN
ajlm-2374	57	39	of	of	ADP
ajlm-2374	57	40	separating	separate	VERB
ajlm-2374	57	41	serum	serum	NOUN
ajlm-2374	57	42	from	from	ADP
ajlm-2374	57	43	blood	blood	NOUN
ajlm-2374	57	44	cells	cell	NOUN
ajlm-2374	57	45	.	.	PUNCT
ajlm-2374	58	1	the	the	DET
ajlm-2374	58	2	serum	serum	NOUN
ajlm-2374	58	3	was	be	AUX
ajlm-2374	58	4	then	then	ADV
ajlm-2374	58	5	transferred	transfer	VERB
ajlm-2374	58	6	into	into	ADP
ajlm-2374	58	7	cryovial	cryovial	ADJ
ajlm-2374	58	8	tubes	tube	NOUN
ajlm-2374	58	9	using	use	VERB
ajlm-2374	58	10	a	a	DET
ajlm-2374	58	11	micropipette	micropipette	NOUN
ajlm-2374	58	12	.	.	PUNCT
ajlm-2374	59	1	lipid	lipid	PROPN
ajlm-2374	59	2	concentrations	concentration	NOUN
ajlm-2374	59	3	were	be	AUX
ajlm-2374	59	4	measured	measure	VERB
ajlm-2374	59	5	using	use	VERB
ajlm-2374	59	6	a	a	DET
ajlm-2374	59	7	fully	fully	ADV
ajlm-2374	59	8	automated	automate	VERB
ajlm-2374	59	9	analyser	analyser	NOUN
ajlm-2374	59	10	,	,	PUNCT
ajlm-2374	59	11	cobas	cobas	NUM
ajlm-2374	59	12	6000	6000	NUM
ajlm-2374	59	13	clinical	clinical	ADJ
ajlm-2374	59	14	chemistry	chemistry	NOUN
ajlm-2374	59	15	analyzer	analyzer	NOUN
ajlm-2374	59	16	(	(	PUNCT
ajlm-2374	59	17	roche	roche	NOUN
ajlm-2374	59	18	diagnostics	diagnostic	NOUN
ajlm-2374	59	19	,	,	PUNCT
ajlm-2374	59	20	indianapolis	indianapolis	PROPN
ajlm-2374	59	21	,	,	PUNCT
ajlm-2374	59	22	indiana	indiana	PROPN
ajlm-2374	59	23	,	,	PUNCT
ajlm-2374	59	24	united	united	PROPN
ajlm-2374	59	25	states	states	PROPN
ajlm-2374	59	26	)	)	PUNCT
ajlm-2374	59	27	following	follow	VERB
ajlm-2374	59	28	standard	standard	ADJ
ajlm-2374	59	29	operating	operating	NOUN
ajlm-2374	59	30	procedures	procedure	NOUN
ajlm-2374	59	31	.	.	PUNCT
ajlm-2374	60	1	interpretation	interpretation	NOUN
ajlm-2374	60	2	of	of	ADP
ajlm-2374	60	3	lipid	lipid	PROPN
ajlm-2374	60	4	profile	profile	PROPN
ajlm-2374	60	5	serum	serum	NOUN
ajlm-2374	60	6	lipid	lipid	NOUN
ajlm-2374	60	7	measurements	measurement	NOUN
ajlm-2374	60	8	were	be	AUX
ajlm-2374	60	9	interpreted	interpret	VERB
ajlm-2374	60	10	as	as	SCONJ
ajlm-2374	60	11	follows	follow	VERB
ajlm-2374	60	12	using	use	VERB
ajlm-2374	60	13	adult	adult	NOUN
ajlm-2374	60	14	reference	reference	NOUN
ajlm-2374	60	15	ranges	range	VERB
ajlm-2374	60	16	according	accord	VERB
ajlm-2374	60	17	to	to	ADP
ajlm-2374	60	18	the	the	DET
ajlm-2374	60	19	national	national	ADJ
ajlm-2374	60	20	cholesterol	cholesterol	PROPN
ajlm-2374	60	21	education	education	NOUN
ajlm-2374	60	22	program.30	program.30	NOUN
ajlm-2374	60	23	we	we	PRON
ajlm-2374	60	24	defined	define	VERB
ajlm-2374	60	25	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	60	26	as	as	ADP
ajlm-2374	60	27	total	total	ADJ
ajlm-2374	60	28	cholesterol	cholesterol	NOUN
ajlm-2374	60	29	concentration	concentration	NOUN
ajlm-2374	60	30	above	above	ADP
ajlm-2374	60	31	200	200	NUM
ajlm-2374	60	32	mg	mg	PROPN
ajlm-2374	60	33	/	/	SYM
ajlm-2374	60	34	dl	dl	PROPN
ajlm-2374	60	35	,	,	PUNCT
ajlm-2374	60	36	low	low	ADJ
ajlm-2374	60	37	-	-	PUNCT
ajlm-2374	60	38	density	density	NOUN
ajlm-2374	60	39	lipoprotein	lipoprotein	ADJ
ajlm-2374	60	40	(	(	PUNCT
ajlm-2374	60	41	ldl	ldl	NOUN
ajlm-2374	60	42	)	)	PUNCT
ajlm-2374	60	43	concentration	concentration	NOUN
ajlm-2374	60	44	above	above	ADP
ajlm-2374	60	45	160	160	NUM
ajlm-2374	60	46	mg	mg	PROPN
ajlm-2374	60	47	/	/	SYM
ajlm-2374	60	48	dl	dl	PROPN
ajlm-2374	60	49	,	,	PUNCT
ajlm-2374	60	50	triglyceride	triglyceride	ADP
ajlm-2374	60	51	concentration	concentration	NOUN
ajlm-2374	60	52	of	of	ADP
ajlm-2374	60	53	more	more	ADJ
ajlm-2374	60	54	than	than	ADP
ajlm-2374	60	55	150	150	NUM
ajlm-2374	60	56	mg	mg	NUM
ajlm-2374	60	57	/	/	SYM
ajlm-2374	60	58	dl	dl	PROPN
ajlm-2374	60	59	,	,	PUNCT
ajlm-2374	60	60	or	or	CCONJ
ajlm-2374	60	61	high	high	ADJ
ajlm-2374	60	62	-	-	PUNCT
ajlm-2374	60	63	density	density	NOUN
ajlm-2374	60	64	lipoprotein	lipoprotein	ADJ
ajlm-2374	60	65	(	(	PUNCT
ajlm-2374	60	66	hdl	hdl	NOUN
ajlm-2374	60	67	)	)	PUNCT
ajlm-2374	60	68	concentration	concentration	NOUN
ajlm-2374	60	69	below	below	ADP
ajlm-2374	60	70	40	40	NUM
ajlm-2374	60	71	mg	mg	PROPN
ajlm-2374	60	72	/	/	SYM
ajlm-2374	60	73	dl	dl	PROPN
ajlm-2374	60	74	.	.	PROPN
ajlm-2374	60	75	histology	histology	PROPN
ajlm-2374	60	76	and	and	CCONJ
ajlm-2374	60	77	cytology	cytology	NOUN
ajlm-2374	60	78	using	use	VERB
ajlm-2374	60	79	a	a	DET
ajlm-2374	60	80	cytobrush	cytobrush	NOUN
ajlm-2374	60	81	,	,	PUNCT
ajlm-2374	60	82	cytological	cytological	ADJ
ajlm-2374	60	83	specimens	specimen	NOUN
ajlm-2374	60	84	were	be	AUX
ajlm-2374	60	85	taken	take	VERB
ajlm-2374	60	86	from	from	ADP
ajlm-2374	60	87	the	the	DET
ajlm-2374	60	88	ectocervical	ectocervical	ADJ
ajlm-2374	60	89	and	and	CCONJ
ajlm-2374	60	90	endocervical	endocervical	ADJ
ajlm-2374	60	91	regions	region	NOUN
ajlm-2374	60	92	,	,	PUNCT
ajlm-2374	60	93	smears	smear	NOUN
ajlm-2374	60	94	made	make	VERB
ajlm-2374	60	95	on	on	ADP
ajlm-2374	60	96	spotless	spotless	ADJ
ajlm-2374	60	97	,	,	PUNCT
ajlm-2374	60	98	marked	mark	VERB
ajlm-2374	60	99	glass	glass	NOUN
ajlm-2374	60	100	slides	slide	NOUN
ajlm-2374	60	101	and	and	CCONJ
ajlm-2374	60	102	quickly	quickly	ADV
ajlm-2374	60	103	fixed	fix	VERB
ajlm-2374	60	104	with	with	ADP
ajlm-2374	60	105	95	95	NUM
ajlm-2374	60	106	%	%	NOUN
ajlm-2374	60	107	alcohol	alcohol	NOUN
ajlm-2374	60	108	.	.	PUNCT
ajlm-2374	61	1	for	for	ADP
ajlm-2374	61	2	staining	stain	VERB
ajlm-2374	61	3	and	and	CCONJ
ajlm-2374	61	4	analysis	analysis	NOUN
ajlm-2374	61	5	,	,	PUNCT
ajlm-2374	61	6	fixed	fix	VERB
ajlm-2374	61	7	pap	pap	NOUN
ajlm-2374	61	8	smears	smear	NOUN
ajlm-2374	61	9	were	be	AUX
ajlm-2374	61	10	brought	bring	VERB
ajlm-2374	61	11	to	to	ADP
ajlm-2374	61	12	the	the	DET
ajlm-2374	61	13	mbarara	mbarara	NOUN
ajlm-2374	61	14	university	university	PROPN
ajlm-2374	61	15	of	of	ADP
ajlm-2374	61	16	science	science	NOUN
ajlm-2374	61	17	and	and	CCONJ
ajlm-2374	61	18	technology	technology	NOUN
ajlm-2374	61	19	histopathology	histopathology	NOUN
ajlm-2374	61	20	lab	lab	NOUN
ajlm-2374	61	21	.	.	PUNCT
ajlm-2374	62	1	using	use	VERB
ajlm-2374	62	2	the	the	DET
ajlm-2374	62	3	papanicolaou	papanicolaou	NOUN
ajlm-2374	62	4	stains	stain	NOUN
ajlm-2374	62	5	,	,	PUNCT
ajlm-2374	62	6	all	all	PRON
ajlm-2374	62	7	of	of	ADP
ajlm-2374	62	8	the	the	DET
ajlm-2374	62	9	pap	pap	NOUN
ajlm-2374	62	10	smears	smear	NOUN
ajlm-2374	62	11	were	be	AUX
ajlm-2374	62	12	stained	stain	VERB
ajlm-2374	62	13	following	follow	VERB
ajlm-2374	62	14	standard	standard	ADJ
ajlm-2374	62	15	operating	operating	NOUN
ajlm-2374	62	16	procedures	procedure	NOUN
ajlm-2374	62	17	.	.	PUNCT
ajlm-2374	63	1	the	the	DET
ajlm-2374	63	2	principal	principal	ADJ
ajlm-2374	63	3	investigator	investigator	NOUN
ajlm-2374	63	4	and	and	CCONJ
ajlm-2374	63	5	a	a	DET
ajlm-2374	63	6	pathologist	pathologist	NOUN
ajlm-2374	63	7	performed	perform	VERB
ajlm-2374	63	8	the	the	DET
ajlm-2374	63	9	examination	examination	NOUN
ajlm-2374	63	10	,	,	PUNCT
ajlm-2374	63	11	and	and	CCONJ
ajlm-2374	63	12	the	the	DET
ajlm-2374	63	13	bethesda	bethesda	NOUN
ajlm-2374	63	14	system	system	NOUN
ajlm-2374	63	15	for	for	ADP
ajlm-2374	63	16	reporting	report	VERB
ajlm-2374	63	17	cervical	cervical	ADJ
ajlm-2374	63	18	cytology31	cytology31	NOUN
ajlm-2374	63	19	was	be	AUX
ajlm-2374	63	20	followed	follow	VERB
ajlm-2374	63	21	throughout	throughout	ADP
ajlm-2374	63	22	the	the	DET
ajlm-2374	63	23	reporting	reporting	NOUN
ajlm-2374	63	24	process	process	NOUN
ajlm-2374	63	25	.	.	PUNCT
ajlm-2374	64	1	cone	cone	NOUN
ajlm-2374	64	2	/	/	SYM
ajlm-2374	64	3	punch	punch	VERB
ajlm-2374	64	4	biopsy	biopsy	NOUN
ajlm-2374	64	5	samples	sample	NOUN
ajlm-2374	64	6	were	be	AUX
ajlm-2374	64	7	taken	take	VERB
ajlm-2374	64	8	for	for	ADP
ajlm-2374	64	9	histological	histological	ADJ
ajlm-2374	64	10	analysis	analysis	NOUN
ajlm-2374	64	11	.	.	PUNCT
ajlm-2374	65	1	after	after	ADP
ajlm-2374	65	2	being	be	AUX
ajlm-2374	65	3	fixed	fix	VERB
ajlm-2374	65	4	in	in	ADP
ajlm-2374	65	5	10	10	NUM
ajlm-2374	65	6	%	%	NOUN
ajlm-2374	65	7	formaldehyde	formaldehyde	NOUN
ajlm-2374	65	8	for	for	ADP
ajlm-2374	65	9	48	48	NUM
ajlm-2374	65	10	h	h	NOUN
ajlm-2374	65	11	,	,	PUNCT
ajlm-2374	65	12	the	the	DET
ajlm-2374	65	13	samples	sample	NOUN
ajlm-2374	65	14	were	be	AUX
ajlm-2374	65	15	processed	process	VERB
ajlm-2374	65	16	in	in	ADP
ajlm-2374	65	17	an	an	DET
ajlm-2374	65	18	open	open	ADJ
ajlm-2374	65	19	system	system	NOUN
ajlm-2374	65	20	tissue	tissue	NOUN
ajlm-2374	65	21	processor	processor	NOUN
ajlm-2374	65	22	for	for	ADP
ajlm-2374	65	23	14	14	NUM
ajlm-2374	65	24	h	h	NOUN
ajlm-2374	65	25	,	,	PUNCT
ajlm-2374	65	26	following	follow	VERB
ajlm-2374	65	27	a	a	DET
ajlm-2374	65	28	standard	standard	ADJ
ajlm-2374	65	29	operating	operating	NOUN
ajlm-2374	65	30	procedure	procedure	NOUN
ajlm-2374	65	31	.	.	PUNCT
ajlm-2374	66	1	after	after	ADP
ajlm-2374	66	2	sectioning	section	VERB
ajlm-2374	66	3	,	,	PUNCT
ajlm-2374	66	4	haematoxylin	haematoxylin	NOUN
ajlm-2374	66	5	and	and	CCONJ
ajlm-2374	66	6	eosin	eosin	NOUN
ajlm-2374	66	7	staining	stain	VERB
ajlm-2374	66	8	was	be	AUX
ajlm-2374	66	9	applied	apply	VERB
ajlm-2374	66	10	to	to	ADP
ajlm-2374	66	11	the	the	DET
ajlm-2374	66	12	tissues	tissue	NOUN
ajlm-2374	66	13	.	.	PUNCT
ajlm-2374	67	1	stained	stain	VERB
ajlm-2374	67	2	slides	slide	NOUN
ajlm-2374	67	3	were	be	AUX
ajlm-2374	67	4	examined	examine	VERB
ajlm-2374	67	5	by	by	ADP
ajlm-2374	67	6	the	the	DET
ajlm-2374	67	7	principal	principal	ADJ
ajlm-2374	67	8	investigator	investigator	NOUN
ajlm-2374	67	9	together	together	ADV
ajlm-2374	67	10	with	with	ADP
ajlm-2374	67	11	a	a	DET
ajlm-2374	67	12	pathologist	pathologist	NOUN
ajlm-2374	67	13	and	and	CCONJ
ajlm-2374	67	14	reported	report	VERB
ajlm-2374	67	15	as	as	ADP
ajlm-2374	67	16	either	either	CCONJ
ajlm-2374	67	17	cin1	cin1	NOUN
ajlm-2374	67	18	,	,	PUNCT
ajlm-2374	67	19	cin2	cin2	NOUN
ajlm-2374	67	20	or	or	CCONJ
ajlm-2374	67	21	cin3	cin3	PROPN
ajlm-2374	67	22	.	.	PUNCT
ajlm-2374	68	1	cin1	cin1	PROPN
ajlm-2374	68	2	is	be	AUX
ajlm-2374	68	3	considered	consider	VERB
ajlm-2374	68	4	‘	'	PUNCT
ajlm-2374	68	5	low	low	ADJ
ajlm-2374	68	6	grade	grade	NOUN
ajlm-2374	68	7	’	'	PUNCT
ajlm-2374	68	8	and	and	CCONJ
ajlm-2374	68	9	represents	represent	VERB
ajlm-2374	68	10	abnormal	abnormal	ADJ
ajlm-2374	68	11	changes	change	NOUN
ajlm-2374	68	12	observed	observe	VERB
ajlm-2374	68	13	in	in	ADP
ajlm-2374	68	14	less	less	ADJ
ajlm-2374	68	15	than	than	ADP
ajlm-2374	68	16	one	one	NUM
ajlm-2374	68	17	-	-	PUNCT
ajlm-2374	68	18	third	third	NOUN
ajlm-2374	68	19	of	of	ADP
ajlm-2374	68	20	the	the	DET
ajlm-2374	68	21	thickness	thickness	NOUN
ajlm-2374	68	22	of	of	ADP
ajlm-2374	68	23	the	the	DET
ajlm-2374	68	24	cervical	cervical	ADJ
ajlm-2374	68	25	epithelium	epithelium	NOUN
ajlm-2374	68	26	.	.	PUNCT
ajlm-2374	69	1	cin2	cin2	NOUN
ajlm-2374	69	2	represents	represent	VERB
ajlm-2374	69	3	abnormal	abnormal	ADJ
ajlm-2374	69	4	changes	change	NOUN
ajlm-2374	69	5	observed	observe	VERB
ajlm-2374	69	6	in	in	ADP
ajlm-2374	69	7	between	between	ADP
ajlm-2374	69	8	one	one	NUM
ajlm-2374	69	9	-	-	PUNCT
ajlm-2374	69	10	third	third	NOUN
ajlm-2374	69	11	and	and	CCONJ
ajlm-2374	69	12	two	two	NUM
ajlm-2374	69	13	-	-	PUNCT
ajlm-2374	69	14	thirds	third	NOUN
ajlm-2374	69	15	of	of	ADP
ajlm-2374	69	16	the	the	DET
ajlm-2374	69	17	thickness	thickness	NOUN
ajlm-2374	69	18	of	of	ADP
ajlm-2374	69	19	the	the	DET
ajlm-2374	69	20	cervical	cervical	ADJ
ajlm-2374	69	21	epithelium	epithelium	NOUN
ajlm-2374	69	22	,	,	PUNCT
ajlm-2374	69	23	while	while	SCONJ
ajlm-2374	69	24	cin3	cin3	PROPN
ajlm-2374	69	25	represents	represent	VERB
ajlm-2374	69	26	abnormal	abnormal	ADJ
ajlm-2374	69	27	changes	change	NOUN
ajlm-2374	69	28	affecting	affect	VERB
ajlm-2374	69	29	more	more	ADJ
ajlm-2374	69	30	than	than	ADP
ajlm-2374	69	31	two	two	NUM
ajlm-2374	69	32	-	-	PUNCT
ajlm-2374	69	33	thirds	third	NOUN
ajlm-2374	69	34	of	of	ADP
ajlm-2374	69	35	the	the	DET
ajlm-2374	69	36	cervical	cervical	ADJ
ajlm-2374	69	37	epithelium	epithelium	NOUN
ajlm-2374	69	38	.	.	PUNCT
ajlm-2374	70	1	cin2	cin2	NOUN
ajlm-2374	70	2	and	and	CCONJ
ajlm-2374	70	3	cin3	cin3	PROPN
ajlm-2374	70	4	are	be	AUX
ajlm-2374	70	5	considered	consider	VERB
ajlm-2374	70	6	‘	'	PUNCT
ajlm-2374	70	7	high	high	ADJ
ajlm-2374	70	8	grade	grade	NOUN
ajlm-2374	70	9	’	'	PUNCT
ajlm-2374	70	10	.	.	PUNCT
ajlm-2374	71	1	data	datum	NOUN
ajlm-2374	71	2	management	management	NOUN
ajlm-2374	71	3	and	and	CCONJ
ajlm-2374	71	4	analysis	analysis	NOUN
ajlm-2374	71	5	after	after	ADP
ajlm-2374	71	6	collection	collection	NOUN
ajlm-2374	71	7	by	by	ADP
ajlm-2374	71	8	research	research	NOUN
ajlm-2374	71	9	assistants	assistant	NOUN
ajlm-2374	71	10	and	and	CCONJ
ajlm-2374	71	11	the	the	DET
ajlm-2374	71	12	principal	principal	ADJ
ajlm-2374	71	13	investigator	investigator	NOUN
ajlm-2374	71	14	,	,	PUNCT
ajlm-2374	71	15	data	datum	NOUN
ajlm-2374	71	16	were	be	AUX
ajlm-2374	71	17	entered	enter	VERB
ajlm-2374	71	18	into	into	ADP
ajlm-2374	71	19	an	an	DET
ajlm-2374	71	20	excel	excel	NOUN
ajlm-2374	71	21	spreadsheet	spreadsheet	NOUN
ajlm-2374	71	22	(	(	PUNCT
ajlm-2374	71	23	microsoft	microsoft	PROPN
ajlm-2374	71	24	office	office	PROPN
ajlm-2374	71	25	professional	professional	PROPN
ajlm-2374	71	26	plus	plus	CCONJ
ajlm-2374	71	27	2013	2013	NUM
ajlm-2374	71	28	,	,	PUNCT
ajlm-2374	71	29	version	version	NOUN
ajlm-2374	71	30	15.0.4675.1003	15.0.4675.1003	PROPN
ajlm-2374	71	31	,	,	PUNCT
ajlm-2374	71	32	microsoft	microsoft	PROPN
ajlm-2374	71	33	inc	inc	PROPN
ajlm-2374	71	34	.	.	PROPN
ajlm-2374	71	35	,	,	PUNCT
ajlm-2374	71	36	redmond	redmond	PROPN
ajlm-2374	71	37	,	,	PUNCT
ajlm-2374	71	38	washington	washington	PROPN
ajlm-2374	71	39	,	,	PUNCT
ajlm-2374	71	40	united	united	PROPN
ajlm-2374	71	41	states	states	PROPN
ajlm-2374	71	42	)	)	PUNCT
ajlm-2374	71	43	and	and	CCONJ
ajlm-2374	71	44	then	then	ADV
ajlm-2374	71	45	imported	import	VERB
ajlm-2374	71	46	into	into	ADP
ajlm-2374	71	47	stata	stata	NOUN
ajlm-2374	71	48	13	13	NUM
ajlm-2374	71	49	(	(	PUNCT
ajlm-2374	71	50	statacorp	statacorp	PROPN
ajlm-2374	71	51	llc	llc	PROPN
ajlm-2374	71	52	,	,	PUNCT
ajlm-2374	71	53	college	college	NOUN
ajlm-2374	71	54	station	station	NOUN
ajlm-2374	71	55	,	,	PUNCT
ajlm-2374	71	56	lakeway	lakeway	PROPN
ajlm-2374	71	57	,	,	PUNCT
ajlm-2374	71	58	texas	texas	PROPN
ajlm-2374	71	59	,	,	PUNCT
ajlm-2374	71	60	united	united	PROPN
ajlm-2374	71	61	states	states	PROPN
ajlm-2374	71	62	)	)	PUNCT
ajlm-2374	71	63	software	software	NOUN
ajlm-2374	71	64	.	.	PUNCT
ajlm-2374	72	1	we	we	PRON
ajlm-2374	72	2	used	use	VERB
ajlm-2374	72	3	descriptive	descriptive	ADJ
ajlm-2374	72	4	statistics	statistic	NOUN
ajlm-2374	72	5	including	include	VERB
ajlm-2374	72	6	frequencies	frequency	NOUN
ajlm-2374	72	7	,	,	PUNCT
ajlm-2374	72	8	means	mean	VERB
ajlm-2374	72	9	±	±	NUM
ajlm-2374	72	10	standard	standard	ADJ
ajlm-2374	72	11	deviations	deviation	NOUN
ajlm-2374	72	12	,	,	PUNCT
ajlm-2374	72	13	median	median	ADJ
ajlm-2374	72	14	values	value	NOUN
ajlm-2374	72	15	and	and	CCONJ
ajlm-2374	72	16	interquartile	interquartile	NOUN
ajlm-2374	72	17	ranges	range	NOUN
ajlm-2374	72	18	to	to	PART
ajlm-2374	72	19	characterise	characterise	VERB
ajlm-2374	72	20	the	the	DET
ajlm-2374	72	21	population	population	NOUN
ajlm-2374	72	22	.	.	PUNCT
ajlm-2374	73	1	differences	difference	NOUN
ajlm-2374	73	2	between	between	ADP
ajlm-2374	73	3	respective	respective	ADJ
ajlm-2374	73	4	groups	group	NOUN
ajlm-2374	73	5	were	be	AUX
ajlm-2374	73	6	tested	test	VERB
ajlm-2374	73	7	using	use	VERB
ajlm-2374	73	8	the	the	DET
ajlm-2374	73	9	standard	standard	ADJ
ajlm-2374	73	10	t	t	PROPN
ajlm-2374	73	11	-	-	PUNCT
ajlm-2374	73	12	tests	test	NOUN
ajlm-2374	73	13	,	,	PUNCT
ajlm-2374	73	14	chi	chi	ADJ
ajlm-2374	73	15	-	-	PUNCT
ajlm-2374	73	16	square	square	ADJ
ajlm-2374	73	17	tests	test	NOUN
ajlm-2374	73	18	and	and	CCONJ
ajlm-2374	73	19	the	the	DET
ajlm-2374	73	20	fisher	fisher	NOUN
ajlm-2374	73	21	’s	’s	PART
ajlm-2374	73	22	exact	exact	ADJ
ajlm-2374	73	23	tests	test	NOUN
ajlm-2374	73	24	.	.	PUNCT
ajlm-2374	74	1	associations	association	NOUN
ajlm-2374	74	2	between	between	ADP
ajlm-2374	74	3	cin	cin	PROPN
ajlm-2374	74	4	grades	grade	NOUN
ajlm-2374	74	5	and	and	CCONJ
ajlm-2374	74	6	specific	specific	ADJ
ajlm-2374	74	7	dyslipidaemias	dyslipidaemia	NOUN
ajlm-2374	74	8	were	be	AUX
ajlm-2374	74	9	derived	derive	VERB
ajlm-2374	74	10	using	use	VERB
ajlm-2374	74	11	logistic	logistic	ADJ
ajlm-2374	74	12	regression	regression	NOUN
ajlm-2374	74	13	analysis	analysis	NOUN
ajlm-2374	74	14	.	.	PUNCT
ajlm-2374	75	1	cases	case	NOUN
ajlm-2374	75	2	with	with	ADP
ajlm-2374	75	3	cin2	cin2	NOUN
ajlm-2374	75	4	or	or	CCONJ
ajlm-2374	75	5	cin3	cin3	PROPN
ajlm-2374	75	6	were	be	AUX
ajlm-2374	75	7	combined	combine	VERB
ajlm-2374	75	8	into	into	ADP
ajlm-2374	75	9	a	a	DET
ajlm-2374	75	10	single	single	ADJ
ajlm-2374	75	11	group	group	NOUN
ajlm-2374	75	12	called	call	VERB
ajlm-2374	75	13	‘	'	PUNCT
ajlm-2374	75	14	cin2	cin2	NOUN
ajlm-2374	75	15	+	+	NOUN
ajlm-2374	75	16	’	'	PUNCT
ajlm-2374	75	17	,	,	PUNCT
ajlm-2374	75	18	because	because	SCONJ
ajlm-2374	75	19	of	of	ADP
ajlm-2374	75	20	the	the	DET
ajlm-2374	75	21	small	small	ADJ
ajlm-2374	75	22	number	number	NOUN
ajlm-2374	75	23	of	of	ADP
ajlm-2374	75	24	cases	case	NOUN
ajlm-2374	75	25	in	in	ADP
ajlm-2374	75	26	each	each	DET
ajlm-2374	75	27	group	group	NOUN
ajlm-2374	75	28	.	.	PUNCT
ajlm-2374	76	1	all	all	DET
ajlm-2374	76	2	statistical	statistical	ADJ
ajlm-2374	76	3	outcomes	outcome	NOUN
ajlm-2374	76	4	were	be	AUX
ajlm-2374	76	5	reported	report	VERB
ajlm-2374	76	6	with	with	ADP
ajlm-2374	76	7	95	95	NUM
ajlm-2374	76	8	%	%	NOUN
ajlm-2374	76	9	confidence	confidence	NOUN
ajlm-2374	76	10	intervals	interval	NOUN
ajlm-2374	76	11	and	and	CCONJ
ajlm-2374	76	12	p	p	NOUN
ajlm-2374	76	13	-	-	PUNCT
ajlm-2374	76	14	values	value	NOUN
ajlm-2374	76	15	of	of	ADP
ajlm-2374	76	16	<	<	X
ajlm-2374	76	17	0.05	0.05	NUM
ajlm-2374	76	18	were	be	AUX
ajlm-2374	76	19	considered	consider	VERB
ajlm-2374	76	20	significant	significant	ADJ
ajlm-2374	76	21	.	.	PUNCT
ajlm-2374	77	1	we	we	PRON
ajlm-2374	77	2	performed	perform	VERB
ajlm-2374	77	3	both	both	CCONJ
ajlm-2374	77	4	bivariate	bivariate	ADJ
ajlm-2374	77	5	and	and	CCONJ
ajlm-2374	77	6	multivariate	multivariate	VERB
ajlm-2374	77	7	logistic	logistic	ADJ
ajlm-2374	77	8	regression	regression	NOUN
ajlm-2374	77	9	analysis	analysis	NOUN
ajlm-2374	77	10	.	.	PUNCT
ajlm-2374	78	1	factors	factor	NOUN
ajlm-2374	78	2	which	which	PRON
ajlm-2374	78	3	were	be	AUX
ajlm-2374	78	4	biologically	biologically	ADV
ajlm-2374	78	5	plausible	plausible	ADJ
ajlm-2374	78	6	in	in	ADP
ajlm-2374	78	7	cervical	cervical	ADJ
ajlm-2374	78	8	cancer	cancer	NOUN
ajlm-2374	78	9	and	and	CCONJ
ajlm-2374	78	10	those	those	PRON
ajlm-2374	78	11	whose	whose	DET
ajlm-2374	78	12	p	p	NOUN
ajlm-2374	78	13	-	-	PUNCT
ajlm-2374	78	14	values	value	NOUN
ajlm-2374	78	15	were	be	AUX
ajlm-2374	78	16	≤	≤	NUM
ajlm-2374	78	17	0.2	0.2	NUM
ajlm-2374	78	18	at	at	ADP
ajlm-2374	78	19	bivariate	bivariate	ADJ
ajlm-2374	78	20	analysis	analysis	NOUN
ajlm-2374	78	21	were	be	AUX
ajlm-2374	78	22	considered	consider	VERB
ajlm-2374	78	23	for	for	ADP
ajlm-2374	78	24	multivariate	multivariate	NOUN
ajlm-2374	78	25	logistic	logistic	ADJ
ajlm-2374	78	26	regression	regression	NOUN
ajlm-2374	78	27	analysis	analysis	NOUN
ajlm-2374	78	28	.	.	PUNCT
ajlm-2374	79	1	these	these	DET
ajlm-2374	79	2	factors	factor	NOUN
ajlm-2374	79	3	included	include	VERB
ajlm-2374	79	4	age	age	NOUN
ajlm-2374	79	5	,	,	PUNCT
ajlm-2374	79	6	smoking	smoking	NOUN
ajlm-2374	79	7	,	,	PUNCT
ajlm-2374	79	8	contraceptive	contraceptive	ADJ
ajlm-2374	79	9	use	use	NOUN
ajlm-2374	79	10	,	,	PUNCT
ajlm-2374	79	11	level	level	NOUN
ajlm-2374	79	12	of	of	ADP
ajlm-2374	79	13	education	education	NOUN
ajlm-2374	79	14	,	,	PUNCT
ajlm-2374	79	15	history	history	NOUN
ajlm-2374	79	16	of	of	ADP
ajlm-2374	79	17	high	high	ADJ
ajlm-2374	79	18	blood	blood	NOUN
ajlm-2374	79	19	pressure	pressure	NOUN
ajlm-2374	79	20	and	and	CCONJ
ajlm-2374	79	21	history	history	NOUN
ajlm-2374	79	22	of	of	ADP
ajlm-2374	79	23	diabetes	diabetes	NOUN
ajlm-2374	79	24	.	.	PUNCT
ajlm-2374	80	1	results	result	NOUN
ajlm-2374	80	2	study	study	VERB
ajlm-2374	80	3	participants	participant	NOUN
ajlm-2374	80	4	’	'	PUNCT
ajlm-2374	80	5	characteristics	characteristic	NOUN
ajlm-2374	80	6	in	in	ADP
ajlm-2374	80	7	this	this	DET
ajlm-2374	80	8	case	case	NOUN
ajlm-2374	80	9	-	-	PUNCT
ajlm-2374	80	10	control	control	NOUN
ajlm-2374	80	11	study	study	NOUN
ajlm-2374	81	1	,	,	PUNCT
ajlm-2374	81	2	we	we	PRON
ajlm-2374	81	3	enrolled	enrol	VERB
ajlm-2374	81	4	93	93	NUM
ajlm-2374	81	5	cases	case	NOUN
ajlm-2374	81	6	and	and	CCONJ
ajlm-2374	81	7	93	93	NUM
ajlm-2374	81	8	controls	control	NOUN
ajlm-2374	81	9	(	(	PUNCT
ajlm-2374	81	10	table	table	NOUN
ajlm-2374	81	11	1	1	NUM
ajlm-2374	81	12	)	)	PUNCT
ajlm-2374	81	13	.	.	PUNCT
ajlm-2374	82	1	there	there	PRON
ajlm-2374	82	2	was	be	VERB
ajlm-2374	82	3	a	a	DET
ajlm-2374	82	4	statistically	statistically	ADV
ajlm-2374	82	5	significant	significant	ADJ
ajlm-2374	82	6	variation	variation	NOUN
ajlm-2374	82	7	in	in	ADP
ajlm-2374	82	8	age	age	NOUN
ajlm-2374	82	9	between	between	ADP
ajlm-2374	82	10	the	the	DET
ajlm-2374	82	11	two	two	NUM
ajlm-2374	82	12	groups	group	NOUN
ajlm-2374	82	13	(	(	PUNCT
ajlm-2374	82	14	p	p	X
ajlm-2374	82	15	<	<	X
ajlm-2374	82	16	0.001	0.001	NUM
ajlm-2374	82	17	)	)	PUNCT
ajlm-2374	82	18	;	;	PUNCT
ajlm-2374	82	19	the	the	DET
ajlm-2374	82	20	mean	mean	ADJ
ajlm-2374	82	21	age	age	NOUN
ajlm-2374	82	22	of	of	ADP
ajlm-2374	82	23	participants	participant	NOUN
ajlm-2374	82	24	control	control	PROPN
ajlm-2374	82	25	group	group	PROPN
ajlm-2374	82	26	was	be	AUX
ajlm-2374	82	27	38.87	38.87	NUM
ajlm-2374	82	28	years	year	NOUN
ajlm-2374	82	29	and	and	CCONJ
ajlm-2374	82	30	in	in	ADP
ajlm-2374	82	31	the	the	DET
ajlm-2374	82	32	case	case	NOUN
ajlm-2374	82	33	group	group	NOUN
ajlm-2374	82	34	was	be	AUX
ajlm-2374	82	35	34.57	34.57	NUM
ajlm-2374	82	36	years	year	NOUN
ajlm-2374	82	37	.	.	PUNCT
ajlm-2374	83	1	additionally	additionally	ADV
ajlm-2374	83	2	,	,	PUNCT
ajlm-2374	83	3	more	more	ADJ
ajlm-2374	83	4	than	than	ADP
ajlm-2374	83	5	half	half	NOUN
ajlm-2374	83	6	of	of	ADP
ajlm-2374	83	7	the	the	DET
ajlm-2374	83	8	participants	participant	NOUN
ajlm-2374	83	9	fell	fall	VERB
ajlm-2374	83	10	within	within	ADP
ajlm-2374	83	11	the	the	DET
ajlm-2374	83	12	age	age	NOUN
ajlm-2374	83	13	group	group	NOUN
ajlm-2374	83	14	of	of	ADP
ajlm-2374	83	15	30	30	NUM
ajlm-2374	83	16	years	year	NOUN
ajlm-2374	83	17	–	–	PUNCT
ajlm-2374	83	18	49	49	NUM
ajlm-2374	83	19	years	year	NOUN
ajlm-2374	83	20	and	and	CCONJ
ajlm-2374	83	21	this	this	DET
ajlm-2374	83	22	observation	observation	NOUN
ajlm-2374	83	23	was	be	AUX
ajlm-2374	83	24	statistically	statistically	ADV
ajlm-2374	83	25	significant	significant	ADJ
ajlm-2374	83	26	(	(	PUNCT
ajlm-2374	83	27	p	p	X
ajlm-2374	83	28	=	=	NOUN
ajlm-2374	83	29	0.044	0.044	NUM
ajlm-2374	83	30	)	)	PUNCT
ajlm-2374	83	31	.	.	PUNCT
ajlm-2374	84	1	there	there	PRON
ajlm-2374	84	2	were	be	VERB
ajlm-2374	84	3	notable	notable	ADJ
ajlm-2374	84	4	statistically	statistically	ADV
ajlm-2374	84	5	significant	significant	ADJ
ajlm-2374	84	6	differences	difference	NOUN
ajlm-2374	84	7	in	in	ADP
ajlm-2374	84	8	the	the	DET
ajlm-2374	84	9	highest	high	ADJ
ajlm-2374	84	10	level	level	NOUN
ajlm-2374	84	11	of	of	ADP
ajlm-2374	84	12	education	education	NOUN
ajlm-2374	84	13	attained	attain	VERB
ajlm-2374	84	14	among	among	ADP
ajlm-2374	84	15	study	study	NOUN
ajlm-2374	84	16	groups	group	NOUN
ajlm-2374	84	17	,	,	PUNCT
ajlm-2374	84	18	with	with	ADP
ajlm-2374	84	19	13	13	NUM
ajlm-2374	84	20	out	out	ADP
ajlm-2374	84	21	of	of	ADP
ajlm-2374	84	22	93	93	NUM
ajlm-2374	84	23	(	(	PUNCT
ajlm-2374	84	24	13.9	13.9	NUM
ajlm-2374	84	25	%	%	NOUN
ajlm-2374	84	26	)	)	PUNCT
ajlm-2374	84	27	controls	control	NOUN
ajlm-2374	84	28	and	and	CCONJ
ajlm-2374	84	29	3	3	NUM
ajlm-2374	84	30	out	out	ADP
ajlm-2374	84	31	of	of	ADP
ajlm-2374	84	32	93	93	NUM
ajlm-2374	84	33	cases	case	NOUN
ajlm-2374	84	34	(	(	PUNCT
ajlm-2374	84	35	3.2	3.2	NUM
ajlm-2374	84	36	%	%	NOUN
ajlm-2374	84	37	)	)	PUNCT
ajlm-2374	84	38	reporting	report	VERB
ajlm-2374	84	39	never	never	ADV
ajlm-2374	84	40	having	having	AUX
ajlm-2374	84	41	studied	study	VERB
ajlm-2374	84	42	.	.	PUNCT
ajlm-2374	85	1	contraceptive	contraceptive	ADJ
ajlm-2374	85	2	use	use	NOUN
ajlm-2374	85	3	was	be	AUX
ajlm-2374	85	4	reported	report	VERB
ajlm-2374	85	5	by	by	ADP
ajlm-2374	85	6	38	38	NUM
ajlm-2374	85	7	out	out	ADP
ajlm-2374	85	8	of	of	ADP
ajlm-2374	85	9	93	93	NUM
ajlm-2374	85	10	(	(	PUNCT
ajlm-2374	85	11	40.9	40.9	NUM
ajlm-2374	85	12	%	%	NOUN
ajlm-2374	85	13	)	)	PUNCT
ajlm-2374	85	14	controls	control	NOUN
ajlm-2374	85	15	and	and	CCONJ
ajlm-2374	85	16	56	56	NUM
ajlm-2374	85	17	out	out	ADP
ajlm-2374	85	18	of	of	ADP
ajlm-2374	85	19	93	93	NUM
ajlm-2374	85	20	(	(	PUNCT
ajlm-2374	85	21	60.2	60.2	NUM
ajlm-2374	85	22	%	%	NOUN
ajlm-2374	85	23	)	)	PUNCT
ajlm-2374	85	24	cases	case	NOUN
ajlm-2374	85	25	.	.	PUNCT
ajlm-2374	86	1	among	among	ADP
ajlm-2374	86	2	the	the	DET
ajlm-2374	86	3	cases	case	NOUN
ajlm-2374	86	4	,	,	PUNCT
ajlm-2374	86	5	7	7	NUM
ajlm-2374	86	6	out	out	ADP
ajlm-2374	86	7	of	of	ADP
ajlm-2374	86	8	93	93	NUM
ajlm-2374	86	9	reported	report	VERB
ajlm-2374	86	10	being	be	AUX
ajlm-2374	86	11	smokers	smoker	NOUN
ajlm-2374	86	12	,	,	PUNCT
ajlm-2374	86	13	resulting	result	VERB
ajlm-2374	86	14	in	in	ADP
ajlm-2374	86	15	a	a	DET
ajlm-2374	86	16	smoking	smoking	NOUN
ajlm-2374	86	17	prevalence	prevalence	NOUN
ajlm-2374	86	18	of	of	ADP
ajlm-2374	86	19	7.6	7.6	NUM
ajlm-2374	86	20	%	%	NOUN
ajlm-2374	86	21	among	among	ADP
ajlm-2374	86	22	cases	case	NOUN
ajlm-2374	86	23	.	.	PUNCT
ajlm-2374	87	1	table	table	NOUN
ajlm-2374	87	2	1	1	NUM
ajlm-2374	87	3	:	:	PUNCT
ajlm-2374	87	4	 	 	SPACE
ajlm-2374	87	5	demographic	demographic	ADJ
ajlm-2374	87	6	characteristics	characteristic	NOUN
ajlm-2374	87	7	of	of	ADP
ajlm-2374	87	8	study	study	NOUN
ajlm-2374	87	9	participants	participant	NOUN
ajlm-2374	87	10	at	at	ADP
ajlm-2374	87	11	mbarara	mbarara	NOUN
ajlm-2374	87	12	regional	regional	ADJ
ajlm-2374	87	13	referral	referral	ADJ
ajlm-2374	87	14	hospital	hospital	NOUN
ajlm-2374	87	15	between	between	ADP
ajlm-2374	87	16	december	december	PROPN
ajlm-2374	87	17	2022	2022	NUM
ajlm-2374	87	18	and	and	CCONJ
ajlm-2374	87	19	february	february	PROPN
ajlm-2374	87	20	2023	2023	NUM
ajlm-2374	87	21	.	.	PUNCT
ajlm-2374	88	1	distribution	distribution	NOUN
ajlm-2374	88	2	of	of	ADP
ajlm-2374	88	3	dyslipidaemias	dyslipidaemia	NOUN
ajlm-2374	88	4	across	across	ADP
ajlm-2374	88	5	cervical	cervical	ADJ
ajlm-2374	88	6	intraepithelial	intraepithelial	ADJ
ajlm-2374	88	7	neoplasia	neoplasia	NOUN
ajlm-2374	88	8	grades	grade	NOUN
ajlm-2374	88	9	out	out	ADP
ajlm-2374	88	10	of	of	ADP
ajlm-2374	88	11	the	the	DET
ajlm-2374	88	12	93	93	NUM
ajlm-2374	88	13	cases	case	NOUN
ajlm-2374	88	14	,	,	PUNCT
ajlm-2374	88	15	81	81	NUM
ajlm-2374	88	16	had	have	VERB
ajlm-2374	88	17	cin1	cin1	ADJ
ajlm-2374	88	18	while	while	SCONJ
ajlm-2374	88	19	12	12	NUM
ajlm-2374	88	20	had	have	VERB
ajlm-2374	88	21	cin2	cin2	NOUN
ajlm-2374	88	22	+	+	PROPN
ajlm-2374	88	23	.	.	PUNCT
ajlm-2374	89	1	the	the	DET
ajlm-2374	89	2	mean	mean	ADJ
ajlm-2374	89	3	triglyceride	triglyceride	ADJ
ajlm-2374	89	4	levels	level	NOUN
ajlm-2374	89	5	among	among	ADP
ajlm-2374	89	6	cases	case	NOUN
ajlm-2374	89	7	was	be	AUX
ajlm-2374	89	8	95.9	95.9	NUM
ajlm-2374	89	9	mg	mg	PROPN
ajlm-2374	89	10	/	/	SYM
ajlm-2374	89	11	dl	dl	PROPN
ajlm-2374	89	12	and	and	CCONJ
ajlm-2374	89	13	among	among	ADP
ajlm-2374	89	14	controls	control	NOUN
ajlm-2374	89	15	was	be	AUX
ajlm-2374	89	16	123.7	123.7	NUM
ajlm-2374	89	17	mg	mg	PROPN
ajlm-2374	89	18	/	/	SYM
ajlm-2374	89	19	dl	dl	PROPN
ajlm-2374	89	20	,	,	PUNCT
ajlm-2374	89	21	demonstrating	demonstrate	VERB
ajlm-2374	89	22	a	a	DET
ajlm-2374	89	23	statistically	statistically	ADV
ajlm-2374	89	24	significant	significant	ADJ
ajlm-2374	89	25	difference	difference	NOUN
ajlm-2374	89	26	(	(	PUNCT
ajlm-2374	89	27	p	p	NOUN
ajlm-2374	89	28	=	=	NOUN
ajlm-2374	89	29	0.001	0.001	NUM
ajlm-2374	89	30	)	)	PUNCT
ajlm-2374	89	31	.	.	PUNCT
ajlm-2374	90	1	high	high	ADJ
ajlm-2374	90	2	triglycerides	triglyceride	NOUN
ajlm-2374	90	3	showed	show	VERB
ajlm-2374	90	4	a	a	DET
ajlm-2374	90	5	prevalence	prevalence	NOUN
ajlm-2374	90	6	of	of	ADP
ajlm-2374	90	7	13.9	13.9	NUM
ajlm-2374	90	8	%	%	NOUN
ajlm-2374	90	9	(	(	PUNCT
ajlm-2374	90	10	12/93	12/93	NUM
ajlm-2374	90	11	)	)	PUNCT
ajlm-2374	90	12	among	among	ADP
ajlm-2374	90	13	the	the	DET
ajlm-2374	90	14	controls	control	NOUN
ajlm-2374	90	15	and	and	CCONJ
ajlm-2374	90	16	a	a	DET
ajlm-2374	90	17	lower	low	ADJ
ajlm-2374	90	18	prevalence	prevalence	NOUN
ajlm-2374	90	19	of	of	ADP
ajlm-2374	90	20	3.7	3.7	NUM
ajlm-2374	90	21	%	%	NOUN
ajlm-2374	90	22	(	(	PUNCT
ajlm-2374	90	23	3/81	3/81	NUM
ajlm-2374	90	24	)	)	PUNCT
ajlm-2374	90	25	among	among	ADP
ajlm-2374	90	26	cases	case	NOUN
ajlm-2374	90	27	,	,	PUNCT
ajlm-2374	90	28	though	though	SCONJ
ajlm-2374	90	29	this	this	DET
ajlm-2374	90	30	difference	difference	NOUN
ajlm-2374	90	31	in	in	ADP
ajlm-2374	90	32	distribution	distribution	NOUN
ajlm-2374	90	33	was	be	AUX
ajlm-2374	90	34	not	not	PART
ajlm-2374	90	35	statistically	statistically	ADV
ajlm-2374	90	36	significant	significant	ADJ
ajlm-2374	90	37	(	(	PUNCT
ajlm-2374	90	38	p	p	X
ajlm-2374	90	39	=	=	NOUN
ajlm-2374	90	40	0.08	0.08	NUM
ajlm-2374	90	41	)	)	PUNCT
ajlm-2374	90	42	.	.	PUNCT
ajlm-2374	91	1	high	high	ADJ
ajlm-2374	91	2	ldl	ldl	NOUN
ajlm-2374	91	3	showed	show	VERB
ajlm-2374	91	4	a	a	DET
ajlm-2374	91	5	prevalence	prevalence	NOUN
ajlm-2374	91	6	of	of	ADP
ajlm-2374	91	7	12.9	12.9	NUM
ajlm-2374	91	8	%	%	NOUN
ajlm-2374	91	9	(	(	PUNCT
ajlm-2374	91	10	12/93	12/93	NUM
ajlm-2374	91	11	)	)	PUNCT
ajlm-2374	91	12	among	among	ADP
ajlm-2374	91	13	controls	control	NOUN
ajlm-2374	91	14	and	and	CCONJ
ajlm-2374	91	15	a	a	DET
ajlm-2374	91	16	prevalence	prevalence	NOUN
ajlm-2374	91	17	of	of	ADP
ajlm-2374	91	18	3.7	3.7	NUM
ajlm-2374	91	19	%	%	NOUN
ajlm-2374	91	20	(	(	PUNCT
ajlm-2374	91	21	3/81	3/81	NUM
ajlm-2374	91	22	)	)	PUNCT
ajlm-2374	91	23	among	among	ADP
ajlm-2374	91	24	cases	case	NOUN
ajlm-2374	91	25	,	,	PUNCT
ajlm-2374	91	26	and	and	CCONJ
ajlm-2374	91	27	this	this	DET
ajlm-2374	91	28	distribution	distribution	NOUN
ajlm-2374	91	29	was	be	AUX
ajlm-2374	91	30	also	also	ADV
ajlm-2374	91	31	not	not	PART
ajlm-2374	91	32	statistically	statistically	ADV
ajlm-2374	91	33	significant	significant	ADJ
ajlm-2374	91	34	(	(	PUNCT
ajlm-2374	91	35	p	p	X
ajlm-2374	91	36	=	=	NOUN
ajlm-2374	91	37	0.08	0.08	NUM
ajlm-2374	91	38	)	)	PUNCT
ajlm-2374	91	39	.	.	PUNCT
ajlm-2374	92	1	the	the	DET
ajlm-2374	92	2	prevalence	prevalence	NOUN
ajlm-2374	92	3	of	of	ADP
ajlm-2374	92	4	low	low	ADJ
ajlm-2374	92	5	hdl	hdl	PROPN
ajlm-2374	92	6	was	be	AUX
ajlm-2374	92	7	higher	high	ADJ
ajlm-2374	92	8	in	in	ADP
ajlm-2374	92	9	cin2	cin2	NOUN
ajlm-2374	92	10	+	+	CCONJ
ajlm-2374	92	11	cases	case	NOUN
ajlm-2374	92	12	(	(	PUNCT
ajlm-2374	92	13	66.7	66.7	NUM
ajlm-2374	92	14	%	%	NOUN
ajlm-2374	92	15	;	;	PUNCT
ajlm-2374	92	16	8/12	8/12	NUM
ajlm-2374	92	17	)	)	PUNCT
ajlm-2374	92	18	although	although	SCONJ
ajlm-2374	92	19	not	not	PART
ajlm-2374	92	20	statistically	statistically	ADV
ajlm-2374	92	21	significant	significant	ADJ
ajlm-2374	92	22	when	when	SCONJ
ajlm-2374	92	23	compared	compare	VERB
ajlm-2374	92	24	to	to	ADP
ajlm-2374	92	25	controls	control	NOUN
ajlm-2374	92	26	(	(	PUNCT
ajlm-2374	92	27	p	p	X
ajlm-2374	92	28	=	=	NOUN
ajlm-2374	92	29	0.086	0.086	NUM
ajlm-2374	92	30	)	)	PUNCT
ajlm-2374	92	31	(	(	PUNCT
ajlm-2374	92	32	table	table	NOUN
ajlm-2374	92	33	2	2	NUM
ajlm-2374	92	34	)	)	PUNCT
ajlm-2374	92	35	.	.	PUNCT
ajlm-2374	93	1	table	table	NOUN
ajlm-2374	93	2	2	2	NUM
ajlm-2374	93	3	:	:	PUNCT
ajlm-2374	93	4	 	 	SPACE
ajlm-2374	93	5	distribution	distribution	NOUN
ajlm-2374	93	6	of	of	ADP
ajlm-2374	93	7	dyslipidaemias	dyslipidaemia	NOUN
ajlm-2374	93	8	across	across	ADP
ajlm-2374	93	9	cytology	cytology	NOUN
ajlm-2374	93	10	/	/	SYM
ajlm-2374	93	11	histology	histology	NOUN
ajlm-2374	93	12	results	result	NOUN
ajlm-2374	93	13	of	of	ADP
ajlm-2374	93	14	study	study	NOUN
ajlm-2374	93	15	participants	participant	NOUN
ajlm-2374	93	16	at	at	ADP
ajlm-2374	93	17	mbarara	mbarara	NOUN
ajlm-2374	93	18	regional	regional	ADJ
ajlm-2374	93	19	referral	referral	ADJ
ajlm-2374	93	20	hospital	hospital	NOUN
ajlm-2374	93	21	between	between	ADP
ajlm-2374	93	22	december	december	PROPN
ajlm-2374	93	23	2022	2022	NUM
ajlm-2374	93	24	and	and	CCONJ
ajlm-2374	93	25	february	february	PROPN
ajlm-2374	93	26	2023	2023	NUM
ajlm-2374	93	27	.	.	PUNCT
ajlm-2374	94	1	association	association	NOUN
ajlm-2374	94	2	between	between	ADP
ajlm-2374	94	3	dyslipidaemias	dyslipidaemia	NOUN
ajlm-2374	94	4	and	and	CCONJ
ajlm-2374	94	5	cervical	cervical	ADJ
ajlm-2374	94	6	intraepithelial	intraepithelial	ADJ
ajlm-2374	94	7	neoplasia	neoplasia	NOUN
ajlm-2374	94	8	from	from	ADP
ajlm-2374	94	9	univariate	univariate	ADJ
ajlm-2374	94	10	logistic	logistic	ADJ
ajlm-2374	94	11	regression	regression	NOUN
ajlm-2374	94	12	analysis	analysis	NOUN
ajlm-2374	94	13	,	,	PUNCT
ajlm-2374	94	14	both	both	PRON
ajlm-2374	94	15	high	high	ADJ
ajlm-2374	94	16	serum	serum	NOUN
ajlm-2374	94	17	triglycerides	triglyceride	NOUN
ajlm-2374	94	18	and	and	CCONJ
ajlm-2374	94	19	high	high	ADJ
ajlm-2374	94	20	serum	serum	NOUN
ajlm-2374	94	21	ldl	ldl	NOUN
ajlm-2374	94	22	were	be	AUX
ajlm-2374	94	23	found	find	VERB
ajlm-2374	94	24	to	to	PART
ajlm-2374	94	25	be	be	AUX
ajlm-2374	94	26	associated	associate	VERB
ajlm-2374	94	27	with	with	ADP
ajlm-2374	94	28	cin	cin	PROPN
ajlm-2374	94	29	(	(	PUNCT
ajlm-2374	94	30	table	table	NOUN
ajlm-2374	94	31	3	3	NUM
ajlm-2374	94	32	)	)	PUNCT
ajlm-2374	94	33	.	.	PUNCT
ajlm-2374	95	1	however	however	ADV
ajlm-2374	95	2	,	,	PUNCT
ajlm-2374	95	3	in	in	ADP
ajlm-2374	95	4	multivariate	multivariate	NOUN
ajlm-2374	95	5	logistic	logistic	ADJ
ajlm-2374	95	6	regression	regression	NOUN
ajlm-2374	95	7	analysis	analysis	NOUN
ajlm-2374	95	8	,	,	PUNCT
ajlm-2374	95	9	with	with	ADP
ajlm-2374	95	10	adjustments	adjustment	NOUN
ajlm-2374	95	11	made	make	VERB
ajlm-2374	95	12	for	for	ADP
ajlm-2374	95	13	age	age	NOUN
ajlm-2374	95	14	,	,	PUNCT
ajlm-2374	95	15	smoking	smoking	NOUN
ajlm-2374	95	16	,	,	PUNCT
ajlm-2374	95	17	contraceptive	contraceptive	ADJ
ajlm-2374	95	18	use	use	NOUN
ajlm-2374	95	19	,	,	PUNCT
ajlm-2374	95	20	level	level	NOUN
ajlm-2374	95	21	of	of	ADP
ajlm-2374	95	22	education	education	NOUN
ajlm-2374	95	23	,	,	PUNCT
ajlm-2374	95	24	history	history	NOUN
ajlm-2374	95	25	of	of	ADP
ajlm-2374	95	26	high	high	ADJ
ajlm-2374	95	27	blood	blood	NOUN
ajlm-2374	95	28	pressure	pressure	NOUN
ajlm-2374	95	29	and	and	CCONJ
ajlm-2374	95	30	diabetes	diabetes	NOUN
ajlm-2374	95	31	,	,	PUNCT
ajlm-2374	95	32	only	only	ADV
ajlm-2374	95	33	high	high	ADJ
ajlm-2374	95	34	serum	serum	NOUN
ajlm-2374	95	35	triglycerides	triglyceride	NOUN
ajlm-2374	95	36	was	be	AUX
ajlm-2374	95	37	significantly	significantly	ADV
ajlm-2374	95	38	associated	associate	VERB
ajlm-2374	95	39	with	with	ADP
ajlm-2374	95	40	cin	cin	PROPN
ajlm-2374	95	41	(	(	PUNCT
ajlm-2374	95	42	odds	odd	NOUN
ajlm-2374	95	43	ratio	ratio	NOUN
ajlm-2374	95	44	:	:	PUNCT
ajlm-2374	95	45	1.395	1.395	NUM
ajlm-2374	95	46	,	,	PUNCT
ajlm-2374	95	47	95	95	NUM
ajlm-2374	95	48	%	%	NOUN
ajlm-2374	95	49	confidence	confidence	NOUN
ajlm-2374	95	50	interval	interval	NOUN
ajlm-2374	95	51	:	:	PUNCT
ajlm-2374	95	52	0.084–1.851	0.084–1.851	NOUN
ajlm-2374	95	53	,	,	PUNCT
ajlm-2374	95	54	p	p	X
ajlm-2374	95	55	=	=	NOUN
ajlm-2374	95	56	0.007	0.007	NUM
ajlm-2374	95	57	)	)	PUNCT
ajlm-2374	95	58	.	.	PUNCT
ajlm-2374	96	1	on	on	ADP
ajlm-2374	96	2	the	the	DET
ajlm-2374	96	3	other	other	ADJ
ajlm-2374	96	4	hand	hand	NOUN
ajlm-2374	96	5	,	,	PUNCT
ajlm-2374	96	6	high	high	ADJ
ajlm-2374	96	7	serum	serum	NOUN
ajlm-2374	96	8	ldl	ldl	NOUN
ajlm-2374	96	9	showed	show	VERB
ajlm-2374	96	10	borderline	borderline	NOUN
ajlm-2374	96	11	association	association	NOUN
ajlm-2374	96	12	with	with	ADP
ajlm-2374	96	13	cin	cin	PROPN
ajlm-2374	96	14	(	(	PUNCT
ajlm-2374	96	15	odds	odd	NOUN
ajlm-2374	96	16	ratio	ratio	NOUN
ajlm-2374	96	17	:	:	PUNCT
ajlm-2374	96	18	0.251	0.251	NUM
ajlm-2374	96	19	,	,	PUNCT
ajlm-2374	96	20	95	95	NUM
ajlm-2374	96	21	%	%	NOUN
ajlm-2374	96	22	confidence	confidence	NOUN
ajlm-2374	96	23	interval	interval	NOUN
ajlm-2374	96	24	:	:	PUNCT
ajlm-2374	96	25	0.061–1.047	0.061–1.047	NUM
ajlm-2374	96	26	,	,	PUNCT
ajlm-2374	96	27	p	p	X
ajlm-2374	96	28	=	=	NOUN
ajlm-2374	96	29	0.058	0.058	NUM
ajlm-2374	96	30	)	)	PUNCT
ajlm-2374	96	31	.	.	PUNCT
ajlm-2374	97	1	table	table	NOUN
ajlm-2374	97	2	3	3	NUM
ajlm-2374	97	3	:	:	PUNCT
ajlm-2374	97	4	 	 	SPACE
ajlm-2374	97	5	logistic	logistic	ADJ
ajlm-2374	97	6	regression	regression	NOUN
ajlm-2374	97	7	analysis	analysis	NOUN
ajlm-2374	97	8	showing	show	VERB
ajlm-2374	97	9	association	association	NOUN
ajlm-2374	97	10	between	between	ADP
ajlm-2374	97	11	dyslipidaemias	dyslipidaemia	NOUN
ajlm-2374	97	12	and	and	CCONJ
ajlm-2374	97	13	cervical	cervical	ADJ
ajlm-2374	97	14	intraepithelial	intraepithelial	ADJ
ajlm-2374	97	15	neoplasia	neoplasia	NOUN
ajlm-2374	97	16	among	among	ADP
ajlm-2374	97	17	study	study	NOUN
ajlm-2374	97	18	participants	participant	NOUN
ajlm-2374	97	19	at	at	ADP
ajlm-2374	97	20	mbarara	mbarara	NOUN
ajlm-2374	97	21	regional	regional	ADJ
ajlm-2374	97	22	referral	referral	ADJ
ajlm-2374	97	23	hospital	hospital	NOUN
ajlm-2374	97	24	between	between	ADP
ajlm-2374	97	25	december	december	PROPN
ajlm-2374	97	26	2022	2022	NUM
ajlm-2374	97	27	and	and	CCONJ
ajlm-2374	97	28	february	february	PROPN
ajlm-2374	97	29	2023	2023	NUM
ajlm-2374	97	30	.	.	PUNCT
ajlm-2374	98	1	discussion	discussion	NOUN
ajlm-2374	98	2	we	we	PRON
ajlm-2374	98	3	present	present	VERB
ajlm-2374	98	4	a	a	DET
ajlm-2374	98	5	high	high	ADJ
ajlm-2374	98	6	prevalence	prevalence	NOUN
ajlm-2374	98	7	of	of	ADP
ajlm-2374	98	8	reduced	reduce	VERB
ajlm-2374	98	9	hdl	hdl	PROPN
ajlm-2374	98	10	in	in	ADP
ajlm-2374	98	11	cin	cin	PROPN
ajlm-2374	98	12	(	(	PUNCT
ajlm-2374	98	13	40.9	40.9	NUM
ajlm-2374	98	14	%	%	NOUN
ajlm-2374	98	15	)	)	PUNCT
ajlm-2374	98	16	,	,	PUNCT
ajlm-2374	98	17	especially	especially	ADV
ajlm-2374	98	18	those	those	PRON
ajlm-2374	98	19	with	with	ADP
ajlm-2374	98	20	cin2	cin2	NOUN
ajlm-2374	98	21	+	+	CCONJ
ajlm-2374	98	22	(	(	PUNCT
ajlm-2374	98	23	66.7	66.7	NUM
ajlm-2374	98	24	%	%	NOUN
ajlm-2374	98	25	)	)	PUNCT
ajlm-2374	98	26	.	.	PUNCT
ajlm-2374	99	1	we	we	PRON
ajlm-2374	99	2	also	also	ADV
ajlm-2374	99	3	present	present	VERB
ajlm-2374	99	4	the	the	DET
ajlm-2374	99	5	overall	overall	ADJ
ajlm-2374	99	6	prevalence	prevalence	NOUN
ajlm-2374	99	7	of	of	ADP
ajlm-2374	99	8	increased	increase	VERB
ajlm-2374	99	9	serum	serum	NOUN
ajlm-2374	99	10	triglycerides	triglyceride	NOUN
ajlm-2374	99	11	as	as	ADP
ajlm-2374	99	12	3.2	3.2	NUM
ajlm-2374	99	13	%	%	NOUN
ajlm-2374	99	14	in	in	ADP
ajlm-2374	99	15	cin	cin	PROPN
ajlm-2374	99	16	and	and	CCONJ
ajlm-2374	99	17	3.7	3.7	NUM
ajlm-2374	99	18	%	%	NOUN
ajlm-2374	99	19	specifically	specifically	ADV
ajlm-2374	99	20	for	for	ADP
ajlm-2374	99	21	cin1	cin1	PROPN
ajlm-2374	99	22	.	.	PUNCT
ajlm-2374	100	1	high	high	ADJ
ajlm-2374	100	2	serum	serum	NOUN
ajlm-2374	100	3	triglycerides	triglyceride	NOUN
ajlm-2374	100	4	was	be	AUX
ajlm-2374	100	5	also	also	ADV
ajlm-2374	100	6	significantly	significantly	ADV
ajlm-2374	100	7	associated	associate	VERB
ajlm-2374	100	8	with	with	ADP
ajlm-2374	100	9	cin	cin	PROPN
ajlm-2374	100	10	in	in	ADP
ajlm-2374	100	11	our	our	PRON
ajlm-2374	100	12	study	study	NOUN
ajlm-2374	100	13	population	population	NOUN
ajlm-2374	100	14	.	.	PUNCT
ajlm-2374	101	1	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	101	2	entails	entail	VERB
ajlm-2374	101	3	a	a	DET
ajlm-2374	101	4	variety	variety	NOUN
ajlm-2374	101	5	of	of	ADP
ajlm-2374	101	6	lipid	lipid	ADJ
ajlm-2374	101	7	abnormalities	abnormality	NOUN
ajlm-2374	101	8	and	and	CCONJ
ajlm-2374	101	9	may	may	AUX
ajlm-2374	101	10	involve	involve	VERB
ajlm-2374	101	11	a	a	DET
ajlm-2374	101	12	combination	combination	NOUN
ajlm-2374	101	13	of	of	ADP
ajlm-2374	101	14	:	:	PUNCT
ajlm-2374	101	15	extremely	extremely	ADV
ajlm-2374	101	16	high	high	ADJ
ajlm-2374	101	17	cholesterol	cholesterol	NOUN
ajlm-2374	101	18	level	level	NOUN
ajlm-2374	101	19	of	of	ADP
ajlm-2374	101	20	above	above	ADP
ajlm-2374	101	21	200	200	NUM
ajlm-2374	101	22	mg	mg	PROPN
ajlm-2374	101	23	/	/	SYM
ajlm-2374	101	24	dl	dl	PROPN
ajlm-2374	101	25	,	,	PUNCT
ajlm-2374	101	26	ldl	ldl	VERB
ajlm-2374	101	27	cholesterol	cholesterol	NOUN
ajlm-2374	101	28	greater	great	ADJ
ajlm-2374	101	29	than	than	ADP
ajlm-2374	101	30	160	160	NUM
ajlm-2374	101	31	mg	mg	PROPN
ajlm-2374	101	32	/	/	SYM
ajlm-2374	101	33	dl	dl	PROPN
ajlm-2374	101	34	,	,	PUNCT
ajlm-2374	101	35	hypertriglyceridaemia	hypertriglyceridaemia	NOUN
ajlm-2374	101	36	of	of	ADP
ajlm-2374	101	37	more	more	ADJ
ajlm-2374	101	38	than	than	ADP
ajlm-2374	101	39	150	150	NUM
ajlm-2374	101	40	mg	mg	NUM
ajlm-2374	101	41	/	/	SYM
ajlm-2374	101	42	dl	dl	PROPN
ajlm-2374	101	43	or	or	CCONJ
ajlm-2374	101	44	significantly	significantly	ADV
ajlm-2374	101	45	reduced	reduce	VERB
ajlm-2374	101	46	hdl	hdl	PROPN
ajlm-2374	101	47	cholesterol	cholesterol	NOUN
ajlm-2374	101	48	of	of	ADP
ajlm-2374	101	49	≤	≤	NUM
ajlm-2374	101	50	40	40	NUM
ajlm-2374	101	51	mg	mg	NUM
ajlm-2374	101	52	/	/	SYM
ajlm-2374	101	53	dl.32	dl.32	PROPN
ajlm-2374	101	54	it	it	PRON
ajlm-2374	101	55	is	be	AUX
ajlm-2374	101	56	one	one	NUM
ajlm-2374	101	57	of	of	ADP
ajlm-2374	101	58	the	the	DET
ajlm-2374	101	59	five	five	NUM
ajlm-2374	101	60	metabolic	metabolic	NOUN
ajlm-2374	101	61	syndrome	syndrome	NOUN
ajlm-2374	101	62	components33	components33	NOUN
ajlm-2374	101	63	and	and	CCONJ
ajlm-2374	101	64	it	it	PRON
ajlm-2374	101	65	increases	increase	VERB
ajlm-2374	101	66	one	one	NUM
ajlm-2374	101	67	’s	’s	PART
ajlm-2374	101	68	risk	risk	NOUN
ajlm-2374	101	69	of	of	ADP
ajlm-2374	101	70	developing	develop	VERB
ajlm-2374	101	71	cardiovascular	cardiovascular	ADJ
ajlm-2374	101	72	and	and	CCONJ
ajlm-2374	101	73	other	other	ADJ
ajlm-2374	101	74	non	non	ADJ
ajlm-2374	101	75	-	-	ADJ
ajlm-2374	101	76	communicable	communicable	ADJ
ajlm-2374	101	77	diseases	disease	NOUN
ajlm-2374	101	78	,	,	PUNCT
ajlm-2374	101	79	including	include	VERB
ajlm-2374	101	80	cancer	cancer	NOUN
ajlm-2374	101	81	of	of	ADP
ajlm-2374	101	82	the	the	DET
ajlm-2374	101	83	cervix.34	cervix.34	NOUN
ajlm-2374	101	84	it	it	PRON
ajlm-2374	101	85	is	be	AUX
ajlm-2374	101	86	therefore	therefore	ADV
ajlm-2374	101	87	important	important	ADJ
ajlm-2374	101	88	to	to	PART
ajlm-2374	101	89	detect	detect	VERB
ajlm-2374	101	90	metabolic	metabolic	NOUN
ajlm-2374	101	91	syndrome	syndrome	NOUN
ajlm-2374	101	92	components	component	NOUN
ajlm-2374	101	93	in	in	ADP
ajlm-2374	101	94	cin	cin	PROPN
ajlm-2374	101	95	in	in	ADP
ajlm-2374	101	96	order	order	NOUN
ajlm-2374	101	97	to	to	PART
ajlm-2374	101	98	prevent	prevent	VERB
ajlm-2374	101	99	heart	heart	NOUN
ajlm-2374	101	100	and	and	CCONJ
ajlm-2374	101	101	other	other	ADJ
ajlm-2374	101	102	cardiovascular	cardiovascular	ADJ
ajlm-2374	101	103	diseases	disease	NOUN
ajlm-2374	101	104	.	.	PUNCT
ajlm-2374	102	1	from	from	ADP
ajlm-2374	102	2	our	our	PRON
ajlm-2374	102	3	study	study	NOUN
ajlm-2374	102	4	,	,	PUNCT
ajlm-2374	102	5	we	we	PRON
ajlm-2374	102	6	observed	observe	VERB
ajlm-2374	102	7	that	that	SCONJ
ajlm-2374	102	8	reduced	reduce	VERB
ajlm-2374	102	9	hdl	hdl	PROPN
ajlm-2374	102	10	cholesterol	cholesterol	PROPN
ajlm-2374	102	11	was	be	AUX
ajlm-2374	102	12	the	the	DET
ajlm-2374	102	13	most	most	ADV
ajlm-2374	102	14	prevalent	prevalent	ADJ
ajlm-2374	102	15	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	102	16	,	,	PUNCT
ajlm-2374	102	17	an	an	DET
ajlm-2374	102	18	observation	observation	NOUN
ajlm-2374	102	19	that	that	PRON
ajlm-2374	102	20	has	have	AUX
ajlm-2374	102	21	been	be	AUX
ajlm-2374	102	22	reported	report	VERB
ajlm-2374	102	23	in	in	ADP
ajlm-2374	102	24	many	many	ADJ
ajlm-2374	102	25	previous	previous	ADJ
ajlm-2374	102	26	studies.35,36	studies.35,36	NOUN
ajlm-2374	102	27	a	a	DET
ajlm-2374	102	28	study	study	NOUN
ajlm-2374	102	29	among	among	ADP
ajlm-2374	102	30	south	south	PROPN
ajlm-2374	102	31	africans	africans	PROPN
ajlm-2374	102	32	in	in	ADP
ajlm-2374	102	33	the	the	DET
ajlm-2374	102	34	vaal	vaal	NOUN
ajlm-2374	102	35	region	region	NOUN
ajlm-2374	102	36	,	,	PUNCT
ajlm-2374	102	37	between	between	ADP
ajlm-2374	102	38	2008	2008	NUM
ajlm-2374	102	39	and	and	CCONJ
ajlm-2374	102	40	2011	2011	NUM
ajlm-2374	102	41	,	,	PUNCT
ajlm-2374	102	42	reported	report	VERB
ajlm-2374	102	43	similar	similar	ADJ
ajlm-2374	102	44	findings	finding	NOUN
ajlm-2374	102	45	on	on	ADP
ajlm-2374	102	46	reduced	reduce	VERB
ajlm-2374	102	47	hdl	hdl	PROPN
ajlm-2374	102	48	and	and	CCONJ
ajlm-2374	102	49	increased	increase	VERB
ajlm-2374	102	50	triglycerides.37	triglycerides.37	PROPN
ajlm-2374	102	51	a	a	DET
ajlm-2374	102	52	systematic	systematic	ADJ
ajlm-2374	102	53	review	review	NOUN
ajlm-2374	102	54	in	in	ADP
ajlm-2374	102	55	2018	2018	NUM
ajlm-2374	102	56	revealed	reveal	VERB
ajlm-2374	102	57	a	a	DET
ajlm-2374	102	58	reduced	reduce	VERB
ajlm-2374	102	59	hdl	hdl	NOUN
ajlm-2374	102	60	prevalence	prevalence	NOUN
ajlm-2374	102	61	of	of	ADP
ajlm-2374	102	62	41.4	41.4	NUM
ajlm-2374	102	63	%	%	NOUN
ajlm-2374	102	64	and	and	CCONJ
ajlm-2374	102	65	a	a	DET
ajlm-2374	102	66	prevalence	prevalence	NOUN
ajlm-2374	102	67	of	of	ADP
ajlm-2374	102	68	increased	increase	VERB
ajlm-2374	102	69	triglycerides	triglyceride	NOUN
ajlm-2374	102	70	of	of	ADP
ajlm-2374	102	71	16.5	16.5	NUM
ajlm-2374	102	72	%	%	NOUN
ajlm-2374	102	73	in	in	ADP
ajlm-2374	102	74	the	the	DET
ajlm-2374	102	75	general	general	ADJ
ajlm-2374	102	76	african	african	ADJ
ajlm-2374	102	77	adult	adult	NOUN
ajlm-2374	102	78	population	population	NOUN
ajlm-2374	102	79	which	which	PRON
ajlm-2374	102	80	is	be	AUX
ajlm-2374	102	81	consistent	consistent	ADJ
ajlm-2374	102	82	with	with	ADP
ajlm-2374	102	83	our	our	PRON
ajlm-2374	102	84	findings.38	findings.38	NOUN
ajlm-2374	102	85	this	this	PRON
ajlm-2374	102	86	shows	show	VERB
ajlm-2374	102	87	an	an	DET
ajlm-2374	102	88	increased	increased	ADJ
ajlm-2374	102	89	risk	risk	NOUN
ajlm-2374	102	90	of	of	ADP
ajlm-2374	102	91	cardiovascular	cardiovascular	ADJ
ajlm-2374	102	92	diseases	disease	NOUN
ajlm-2374	102	93	among	among	ADP
ajlm-2374	102	94	the	the	DET
ajlm-2374	102	95	study	study	NOUN
ajlm-2374	102	96	population	population	NOUN
ajlm-2374	102	97	.	.	PUNCT
ajlm-2374	103	1	we	we	PRON
ajlm-2374	103	2	did	do	AUX
ajlm-2374	103	3	not	not	PART
ajlm-2374	103	4	observe	observe	VERB
ajlm-2374	103	5	any	any	DET
ajlm-2374	103	6	significant	significant	ADJ
ajlm-2374	103	7	association	association	NOUN
ajlm-2374	103	8	between	between	ADP
ajlm-2374	103	9	reduced	reduce	VERB
ajlm-2374	103	10	hdl	hdl	PROPN
ajlm-2374	103	11	cholesterol	cholesterol	PROPN
ajlm-2374	103	12	and	and	CCONJ
ajlm-2374	103	13	cin	cin	PROPN
ajlm-2374	103	14	.	.	PUNCT
ajlm-2374	104	1	this	this	PRON
ajlm-2374	104	2	is	be	AUX
ajlm-2374	104	3	contrary	contrary	ADJ
ajlm-2374	104	4	to	to	ADP
ajlm-2374	104	5	previous	previous	ADJ
ajlm-2374	104	6	findings	finding	NOUN
ajlm-2374	104	7	.	.	PUNCT
ajlm-2374	105	1	for	for	ADP
ajlm-2374	105	2	instance	instance	NOUN
ajlm-2374	105	3	,	,	PUNCT
ajlm-2374	105	4	frontela	frontela	PROPN
ajlm-2374	105	5	-	-	PUNCT
ajlm-2374	105	6	noda	noda	PROPN
ajlm-2374	105	7	et	et	PROPN
ajlm-2374	105	8	al	al	PROPN
ajlm-2374	105	9	.	.	PROPN
ajlm-2374	105	10	,	,	PUNCT
ajlm-2374	105	11	through	through	ADP
ajlm-2374	105	12	their	their	PRON
ajlm-2374	105	13	study	study	NOUN
ajlm-2374	105	14	at	at	ADP
ajlm-2374	105	15	cuba	cuba	PROPN
ajlm-2374	105	16	’s	’s	PART
ajlm-2374	105	17	national	national	PROPN
ajlm-2374	105	18	institute	institute	PROPN
ajlm-2374	105	19	of	of	ADP
ajlm-2374	105	20	oncology	oncology	NOUN
ajlm-2374	105	21	and	and	CCONJ
ajlm-2374	105	22	radiobiology	radiobiology	NOUN
ajlm-2374	105	23	,	,	PUNCT
ajlm-2374	105	24	among	among	ADP
ajlm-2374	105	25	adult	adult	NOUN
ajlm-2374	105	26	women	woman	NOUN
ajlm-2374	105	27	from	from	ADP
ajlm-2374	105	28	2018	2018	NUM
ajlm-2374	105	29	to	to	ADP
ajlm-2374	105	30	2020	2020	NUM
ajlm-2374	105	31	,	,	PUNCT
ajlm-2374	105	32	reported	report	VERB
ajlm-2374	105	33	a	a	DET
ajlm-2374	105	34	significant	significant	ADJ
ajlm-2374	105	35	association	association	NOUN
ajlm-2374	105	36	between	between	ADP
ajlm-2374	105	37	high	high	ADJ
ajlm-2374	105	38	grade	grade	NOUN
ajlm-2374	105	39	squamous	squamous	ADJ
ajlm-2374	105	40	intraepithelial	intraepithelial	ADJ
ajlm-2374	105	41	lesion	lesion	NOUN
ajlm-2374	105	42	and	and	CCONJ
ajlm-2374	105	43	low	low	ADJ
ajlm-2374	105	44	hdl	hdl	PROPN
ajlm-2374	105	45	cholesterol.39	cholesterol.39	PROPN
ajlm-2374	105	46	however	however	ADV
ajlm-2374	105	47	,	,	PUNCT
ajlm-2374	105	48	from	from	ADP
ajlm-2374	105	49	a	a	DET
ajlm-2374	105	50	survey	survey	NOUN
ajlm-2374	105	51	conducted	conduct	VERB
ajlm-2374	105	52	from	from	ADP
ajlm-2374	105	53	1999	1999	NUM
ajlm-2374	105	54	to	to	ADP
ajlm-2374	105	55	2010	2010	NUM
ajlm-2374	105	56	,	,	PUNCT
ajlm-2374	105	57	a	a	DET
ajlm-2374	105	58	reduced	reduce	VERB
ajlm-2374	105	59	serum	serum	NOUN
ajlm-2374	105	60	hdl	hdl	PROPN
ajlm-2374	105	61	concentration	concentration	NOUN
ajlm-2374	105	62	was	be	AUX
ajlm-2374	105	63	reported	report	VERB
ajlm-2374	105	64	to	to	PART
ajlm-2374	105	65	be	be	AUX
ajlm-2374	105	66	positively	positively	ADV
ajlm-2374	105	67	correlated	correlate	VERB
ajlm-2374	105	68	with	with	ADP
ajlm-2374	105	69	cervical	cervical	ADJ
ajlm-2374	105	70	cancer	cancer	NOUN
ajlm-2374	105	71	among	among	ADP
ajlm-2374	105	72	united	united	PROPN
ajlm-2374	105	73	states	states	PROPN
ajlm-2374	105	74	citizens.40	citizens.40	PROPN
ajlm-2374	105	75	this	this	PRON
ajlm-2374	105	76	also	also	ADV
ajlm-2374	105	77	indicated	indicate	VERB
ajlm-2374	105	78	an	an	DET
ajlm-2374	105	79	increased	increase	VERB
ajlm-2374	105	80	likelihood	likelihood	NOUN
ajlm-2374	105	81	of	of	ADP
ajlm-2374	105	82	development	development	NOUN
ajlm-2374	105	83	of	of	ADP
ajlm-2374	105	84	cardiovascular	cardiovascular	ADJ
ajlm-2374	105	85	diseases	disease	NOUN
ajlm-2374	105	86	among	among	ADP
ajlm-2374	105	87	the	the	DET
ajlm-2374	105	88	study	study	NOUN
ajlm-2374	105	89	population	population	NOUN
ajlm-2374	105	90	.	.	PUNCT
ajlm-2374	106	1	this	this	DET
ajlm-2374	106	2	study	study	NOUN
ajlm-2374	106	3	found	find	VERB
ajlm-2374	106	4	a	a	DET
ajlm-2374	106	5	statistically	statistically	ADV
ajlm-2374	106	6	significant	significant	ADJ
ajlm-2374	106	7	association	association	NOUN
ajlm-2374	106	8	between	between	ADP
ajlm-2374	106	9	increased	increase	VERB
ajlm-2374	106	10	serum	serum	NOUN
ajlm-2374	106	11	triglycerides	triglyceride	NOUN
ajlm-2374	106	12	and	and	CCONJ
ajlm-2374	106	13	cin	cin	PROPN
ajlm-2374	106	14	.	.	PUNCT
ajlm-2374	107	1	this	this	DET
ajlm-2374	107	2	observation	observation	NOUN
ajlm-2374	107	3	is	be	AUX
ajlm-2374	107	4	consistent	consistent	ADJ
ajlm-2374	107	5	with	with	ADP
ajlm-2374	107	6	previous	previous	ADJ
ajlm-2374	107	7	reports	report	NOUN
ajlm-2374	107	8	on	on	ADP
ajlm-2374	107	9	the	the	DET
ajlm-2374	107	10	link	link	NOUN
ajlm-2374	107	11	between	between	ADP
ajlm-2374	107	12	triglycerides	triglyceride	NOUN
ajlm-2374	107	13	and	and	CCONJ
ajlm-2374	107	14	cin	cin	PROPN
ajlm-2374	107	15	.	.	PUNCT
ajlm-2374	108	1	though	though	SCONJ
ajlm-2374	108	2	we	we	PRON
ajlm-2374	108	3	studied	study	VERB
ajlm-2374	108	4	cin	cin	PROPN
ajlm-2374	108	5	,	,	PUNCT
ajlm-2374	108	6	a	a	DET
ajlm-2374	108	7	precursor	precursor	NOUN
ajlm-2374	108	8	stage	stage	NOUN
ajlm-2374	108	9	for	for	ADP
ajlm-2374	108	10	cervical	cervical	ADJ
ajlm-2374	108	11	cancer	cancer	NOUN
ajlm-2374	108	12	,	,	PUNCT
ajlm-2374	108	13	previous	previous	ADJ
ajlm-2374	108	14	cohort	cohort	NOUN
ajlm-2374	108	15	studies	study	NOUN
ajlm-2374	108	16	among	among	ADP
ajlm-2374	108	17	icelanders	icelanders	PROPN
ajlm-2374	108	18	and	and	CCONJ
ajlm-2374	108	19	austrians	austrians	PROPN
ajlm-2374	108	20	showed	show	VERB
ajlm-2374	108	21	that	that	SCONJ
ajlm-2374	108	22	increased	increase	VERB
ajlm-2374	108	23	serum	serum	NOUN
ajlm-2374	108	24	triglyceride	triglyceride	ADP
ajlm-2374	108	25	concentration	concentration	NOUN
ajlm-2374	108	26	is	be	AUX
ajlm-2374	108	27	associated	associate	VERB
ajlm-2374	108	28	with	with	ADP
ajlm-2374	108	29	an	an	DET
ajlm-2374	108	30	increased	increase	VERB
ajlm-2374	108	31	cervical	cervical	ADJ
ajlm-2374	108	32	cancer	cancer	NOUN
ajlm-2374	108	33	prevalence.41,42	prevalence.41,42	NOUN
ajlm-2374	108	34	it	it	PRON
ajlm-2374	108	35	is	be	AUX
ajlm-2374	108	36	important	important	ADJ
ajlm-2374	108	37	,	,	PUNCT
ajlm-2374	108	38	however	however	ADV
ajlm-2374	108	39	,	,	PUNCT
ajlm-2374	108	40	to	to	PART
ajlm-2374	108	41	note	note	VERB
ajlm-2374	108	42	that	that	SCONJ
ajlm-2374	108	43	observations	observation	NOUN
ajlm-2374	108	44	in	in	ADP
ajlm-2374	108	45	cin	cin	PROPN
ajlm-2374	108	46	can	can	AUX
ajlm-2374	108	47	not	not	PART
ajlm-2374	108	48	just	just	ADV
ajlm-2374	108	49	be	be	AUX
ajlm-2374	108	50	extrapolated	extrapolate	VERB
ajlm-2374	108	51	to	to	ADP
ajlm-2374	108	52	cervical	cervical	ADJ
ajlm-2374	108	53	cancer	cancer	NOUN
ajlm-2374	108	54	,	,	PUNCT
ajlm-2374	108	55	even	even	ADV
ajlm-2374	108	56	if	if	SCONJ
ajlm-2374	108	57	one	one	PRON
ajlm-2374	108	58	leads	lead	VERB
ajlm-2374	108	59	to	to	ADP
ajlm-2374	108	60	the	the	DET
ajlm-2374	108	61	other	other	ADJ
ajlm-2374	108	62	.	.	PUNCT
ajlm-2374	109	1	another	another	DET
ajlm-2374	109	2	case	case	NOUN
ajlm-2374	109	3	-	-	PUNCT
ajlm-2374	109	4	control	control	NOUN
ajlm-2374	109	5	study	study	NOUN
ajlm-2374	109	6	among	among	ADP
ajlm-2374	109	7	united	united	PROPN
ajlm-2374	109	8	states	states	PROPN
ajlm-2374	109	9	adult	adult	PROPN
ajlm-2374	109	10	women	woman	NOUN
ajlm-2374	109	11	revealed	reveal	VERB
ajlm-2374	109	12	that	that	SCONJ
ajlm-2374	109	13	serum	serum	NOUN
ajlm-2374	109	14	triglyceride	triglyceride	ADP
ajlm-2374	109	15	concentrations	concentration	NOUN
ajlm-2374	109	16	are	be	AUX
ajlm-2374	109	17	correlated	correlate	VERB
ajlm-2374	109	18	with	with	ADP
ajlm-2374	109	19	increased	increase	VERB
ajlm-2374	109	20	risk	risk	NOUN
ajlm-2374	109	21	of	of	ADP
ajlm-2374	109	22	cancer	cancer	NOUN
ajlm-2374	109	23	of	of	ADP
ajlm-2374	109	24	the	the	DET
ajlm-2374	109	25	cervix.40	cervix.40	PROPN
ajlm-2374	109	26	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	109	27	is	be	AUX
ajlm-2374	109	28	said	say	VERB
ajlm-2374	109	29	to	to	PART
ajlm-2374	109	30	go	go	VERB
ajlm-2374	109	31	hand	hand	NOUN
ajlm-2374	109	32	in	in	ADP
ajlm-2374	109	33	hand	hand	NOUN
ajlm-2374	109	34	with	with	ADP
ajlm-2374	109	35	other	other	ADJ
ajlm-2374	109	36	components	component	NOUN
ajlm-2374	109	37	of	of	ADP
ajlm-2374	109	38	metabolic	metabolic	NOUN
ajlm-2374	109	39	syndrome	syndrome	NOUN
ajlm-2374	109	40	,	,	PUNCT
ajlm-2374	109	41	including	include	VERB
ajlm-2374	109	42	obesity	obesity	NOUN
ajlm-2374	109	43	,	,	PUNCT
ajlm-2374	109	44	whose	whose	DET
ajlm-2374	109	45	contribution	contribution	NOUN
ajlm-2374	109	46	to	to	ADP
ajlm-2374	109	47	cervical	cervical	ADJ
ajlm-2374	109	48	cancer	cancer	NOUN
ajlm-2374	109	49	risk	risk	NOUN
ajlm-2374	109	50	is	be	AUX
ajlm-2374	109	51	not	not	PART
ajlm-2374	109	52	only	only	ADV
ajlm-2374	109	53	reflected	reflect	VERB
ajlm-2374	109	54	in	in	ADP
ajlm-2374	109	55	elevated	elevated	ADJ
ajlm-2374	109	56	oestrogen	oestrogen	NOUN
ajlm-2374	109	57	levels43	levels43	NOUN
ajlm-2374	109	58	but	but	CCONJ
ajlm-2374	109	59	also	also	ADV
ajlm-2374	109	60	in	in	ADP
ajlm-2374	109	61	increased	increase	VERB
ajlm-2374	109	62	risk	risk	NOUN
ajlm-2374	109	63	of	of	ADP
ajlm-2374	109	64	hpv	hpv	PROPN
ajlm-2374	109	65	infection.44,45	infection.44,45	PROPN
ajlm-2374	109	66	metabolic	metabolic	PROPN
ajlm-2374	109	67	syndrome	syndrome	PROPN
ajlm-2374	109	68	components	component	NOUN
ajlm-2374	109	69	are	be	AUX
ajlm-2374	109	70	said	say	VERB
ajlm-2374	109	71	to	to	PART
ajlm-2374	109	72	act	act	VERB
ajlm-2374	109	73	as	as	SCONJ
ajlm-2374	109	74	cofactors	cofactor	NOUN
ajlm-2374	109	75	in	in	ADP
ajlm-2374	109	76	cervical	cervical	ADJ
ajlm-2374	109	77	carcinogenesis	carcinogenesis	NOUN
ajlm-2374	109	78	,	,	PUNCT
ajlm-2374	109	79	which	which	PRON
ajlm-2374	109	80	is	be	AUX
ajlm-2374	109	81	based	base	VERB
ajlm-2374	109	82	on	on	ADP
ajlm-2374	109	83	the	the	DET
ajlm-2374	109	84	positive	positive	ADJ
ajlm-2374	109	85	correlation	correlation	NOUN
ajlm-2374	109	86	of	of	ADP
ajlm-2374	109	87	oestrogen	oestrogen	NOUN
ajlm-2374	109	88	and	and	CCONJ
ajlm-2374	109	89	adipokine	adipokine	ADJ
ajlm-2374	109	90	levels	level	NOUN
ajlm-2374	109	91	with	with	ADP
ajlm-2374	109	92	cervical	cervical	ADJ
ajlm-2374	109	93	cancer.46,47	cancer.46,47	NOUN
ajlm-2374	109	94	increased	increase	VERB
ajlm-2374	109	95	serum	serum	NOUN
ajlm-2374	109	96	triglycerides	triglyceride	NOUN
ajlm-2374	109	97	and	and	CCONJ
ajlm-2374	109	98	low	low	ADJ
ajlm-2374	109	99	hdl	hdl	PROPN
ajlm-2374	109	100	are	be	AUX
ajlm-2374	109	101	said	say	VERB
ajlm-2374	109	102	to	to	PART
ajlm-2374	109	103	be	be	AUX
ajlm-2374	109	104	risk	risk	NOUN
ajlm-2374	109	105	factors	factor	NOUN
ajlm-2374	109	106	for	for	ADP
ajlm-2374	109	107	cervical	cervical	ADJ
ajlm-2374	109	108	cancer.48	cancer.48	NOUN
ajlm-2374	109	109	they	they	PRON
ajlm-2374	109	110	are	be	AUX
ajlm-2374	109	111	known	know	VERB
ajlm-2374	109	112	to	to	PART
ajlm-2374	109	113	stimulate	stimulate	VERB
ajlm-2374	109	114	proliferation	proliferation	NOUN
ajlm-2374	109	115	of	of	ADP
ajlm-2374	109	116	cancer	cancer	NOUN
ajlm-2374	109	117	cells	cell	NOUN
ajlm-2374	109	118	and	and	CCONJ
ajlm-2374	109	119	induce	induce	VERB
ajlm-2374	109	120	anti	anti	ADJ
ajlm-2374	109	121	apoptotic	apoptotic	ADJ
ajlm-2374	109	122	capacity	capacity	NOUN
ajlm-2374	109	123	by	by	ADP
ajlm-2374	109	124	activation	activation	NOUN
ajlm-2374	109	125	of	of	ADP
ajlm-2374	109	126	reactive	reactive	ADJ
ajlm-2374	109	127	oxygen	oxygen	NOUN
ajlm-2374	109	128	species.49	species.49	NOUN
ajlm-2374	109	129	it	it	PRON
ajlm-2374	109	130	is	be	AUX
ajlm-2374	109	131	worth	worth	ADJ
ajlm-2374	109	132	noting	note	VERB
ajlm-2374	109	133	that	that	SCONJ
ajlm-2374	109	134	a	a	DET
ajlm-2374	109	135	good	good	ADJ
ajlm-2374	109	136	fraction	fraction	NOUN
ajlm-2374	109	137	of	of	ADP
ajlm-2374	109	138	our	our	PRON
ajlm-2374	109	139	participants	participant	NOUN
ajlm-2374	109	140	in	in	ADP
ajlm-2374	109	141	both	both	DET
ajlm-2374	109	142	case	case	NOUN
ajlm-2374	109	143	and	and	CCONJ
ajlm-2374	109	144	control	control	NOUN
ajlm-2374	109	145	groups	group	NOUN
ajlm-2374	109	146	reported	report	VERB
ajlm-2374	109	147	a	a	DET
ajlm-2374	109	148	history	history	NOUN
ajlm-2374	109	149	of	of	ADP
ajlm-2374	109	150	diabetes	diabetes	NOUN
ajlm-2374	109	151	and	and	CCONJ
ajlm-2374	109	152	hypertension	hypertension	NOUN
ajlm-2374	109	153	.	.	PUNCT
ajlm-2374	110	1	previous	previous	ADJ
ajlm-2374	110	2	studies	study	NOUN
ajlm-2374	110	3	have	have	AUX
ajlm-2374	110	4	demonstrated	demonstrate	VERB
ajlm-2374	110	5	that	that	SCONJ
ajlm-2374	110	6	hypertension	hypertension	NOUN
ajlm-2374	110	7	results	result	NOUN
ajlm-2374	110	8	in	in	ADP
ajlm-2374	110	9	hypoxia	hypoxia	NOUN
ajlm-2374	110	10	,	,	PUNCT
ajlm-2374	110	11	which	which	PRON
ajlm-2374	110	12	results	result	VERB
ajlm-2374	110	13	in	in	ADP
ajlm-2374	110	14	synthesis	synthesis	NOUN
ajlm-2374	110	15	of	of	ADP
ajlm-2374	110	16	hypoxia	hypoxia	NOUN
ajlm-2374	110	17	-	-	PUNCT
ajlm-2374	110	18	induced	induce	VERB
ajlm-2374	110	19	factor-1	factor-1	PROPN
ajlm-2374	110	20	,	,	PUNCT
ajlm-2374	110	21	which	which	PRON
ajlm-2374	110	22	in	in	ADP
ajlm-2374	110	23	turn	turn	NOUN
ajlm-2374	110	24	promotes	promote	VERB
ajlm-2374	110	25	angiogenesis.50	angiogenesis.50	PROPN
ajlm-2374	110	26	it	it	PRON
ajlm-2374	110	27	is	be	AUX
ajlm-2374	110	28	hypoxia	hypoxia	NOUN
ajlm-2374	110	29	-	-	PUNCT
ajlm-2374	110	30	induced	induced	ADJ
ajlm-2374	110	31	factor-1	factor-1	NUM
ajlm-2374	111	1	that	that	PRON
ajlm-2374	111	2	is	be	AUX
ajlm-2374	111	3	said	say	VERB
ajlm-2374	111	4	to	to	PART
ajlm-2374	111	5	support	support	VERB
ajlm-2374	111	6	development	development	NOUN
ajlm-2374	111	7	of	of	ADP
ajlm-2374	111	8	hpv	hpv	NOUN
ajlm-2374	111	9	-	-	PUNCT
ajlm-2374	111	10	induced	induce	VERB
ajlm-2374	111	11	lesions.51	lesions.51	NOUN
ajlm-2374	111	12	the	the	DET
ajlm-2374	111	13	fact	fact	NOUN
ajlm-2374	111	14	that	that	SCONJ
ajlm-2374	111	15	controls	control	NOUN
ajlm-2374	111	16	also	also	ADV
ajlm-2374	111	17	had	have	AUX
ajlm-2374	111	18	a	a	DET
ajlm-2374	111	19	history	history	NOUN
ajlm-2374	111	20	of	of	ADP
ajlm-2374	111	21	hypertension	hypertension	NOUN
ajlm-2374	111	22	and	and	CCONJ
ajlm-2374	111	23	diabetes	diabetes	NOUN
ajlm-2374	111	24	,	,	PUNCT
ajlm-2374	111	25	therefore	therefore	ADV
ajlm-2374	111	26	,	,	PUNCT
ajlm-2374	111	27	emphasises	emphasise	VERB
ajlm-2374	111	28	the	the	DET
ajlm-2374	111	29	multifactorial	multifactorial	ADJ
ajlm-2374	111	30	requirement	requirement	NOUN
ajlm-2374	111	31	for	for	ADP
ajlm-2374	111	32	development	development	NOUN
ajlm-2374	111	33	of	of	ADP
ajlm-2374	111	34	cervical	cervical	ADJ
ajlm-2374	111	35	cancer	cancer	NOUN
ajlm-2374	111	36	other	other	ADJ
ajlm-2374	111	37	than	than	ADP
ajlm-2374	111	38	hpv	hpv	ADJ
ajlm-2374	111	39	infection	infection	NOUN
ajlm-2374	111	40	.	.	PUNCT
ajlm-2374	112	1	this	this	DET
ajlm-2374	112	2	case	case	NOUN
ajlm-2374	112	3	-	-	PUNCT
ajlm-2374	112	4	control	control	NOUN
ajlm-2374	112	5	study	study	NOUN
ajlm-2374	112	6	was	be	AUX
ajlm-2374	112	7	designed	design	VERB
ajlm-2374	112	8	with	with	ADP
ajlm-2374	112	9	adequate	adequate	ADJ
ajlm-2374	112	10	power	power	NOUN
ajlm-2374	112	11	to	to	PART
ajlm-2374	112	12	derive	derive	VERB
ajlm-2374	112	13	associations	association	NOUN
ajlm-2374	112	14	.	.	PUNCT
ajlm-2374	113	1	the	the	DET
ajlm-2374	113	2	other	other	ADJ
ajlm-2374	113	3	strength	strength	NOUN
ajlm-2374	113	4	of	of	ADP
ajlm-2374	113	5	this	this	DET
ajlm-2374	113	6	study	study	NOUN
ajlm-2374	113	7	was	be	AUX
ajlm-2374	113	8	that	that	SCONJ
ajlm-2374	113	9	we	we	PRON
ajlm-2374	113	10	used	use	VERB
ajlm-2374	113	11	internationally	internationally	ADV
ajlm-2374	113	12	acceptable	acceptable	ADJ
ajlm-2374	113	13	cut	cut	VERB
ajlm-2374	113	14	-	-	PUNCT
ajlm-2374	113	15	off	off	ADP
ajlm-2374	113	16	values	value	NOUN
ajlm-2374	113	17	for	for	ADP
ajlm-2374	113	18	categorising	categorise	VERB
ajlm-2374	113	19	dyslipidaemias	dyslipidaemia	NOUN
ajlm-2374	113	20	.	.	PUNCT
ajlm-2374	114	1	also	also	ADV
ajlm-2374	114	2	,	,	PUNCT
ajlm-2374	114	3	the	the	DET
ajlm-2374	114	4	presence	presence	NOUN
ajlm-2374	114	5	of	of	ADP
ajlm-2374	114	6	cin	cin	PROPN
ajlm-2374	114	7	was	be	AUX
ajlm-2374	114	8	confirmed	confirm	VERB
ajlm-2374	114	9	with	with	ADP
ajlm-2374	114	10	either	either	PRON
ajlm-2374	114	11	pap	pap	NOUN
ajlm-2374	114	12	smear	smear	NOUN
ajlm-2374	114	13	or	or	CCONJ
ajlm-2374	114	14	histology	histology	NOUN
ajlm-2374	114	15	,	,	PUNCT
ajlm-2374	114	16	the	the	DET
ajlm-2374	114	17	gold	gold	NOUN
ajlm-2374	114	18	standard	standard	NOUN
ajlm-2374	114	19	,	,	PUNCT
ajlm-2374	114	20	following	follow	VERB
ajlm-2374	114	21	national	national	ADJ
ajlm-2374	114	22	guidelines	guideline	NOUN
ajlm-2374	114	23	.	.	PUNCT
ajlm-2374	115	1	for	for	ADP
ajlm-2374	115	2	controls	control	NOUN
ajlm-2374	115	3	,	,	PUNCT
ajlm-2374	115	4	absence	absence	NOUN
ajlm-2374	115	5	of	of	ADP
ajlm-2374	115	6	lesions	lesion	NOUN
ajlm-2374	115	7	was	be	AUX
ajlm-2374	115	8	ascertained	ascertain	VERB
ajlm-2374	115	9	by	by	ADP
ajlm-2374	115	10	a	a	DET
ajlm-2374	115	11	negative	negative	ADJ
ajlm-2374	115	12	visual	visual	ADJ
ajlm-2374	115	13	inspection	inspection	NOUN
ajlm-2374	115	14	with	with	ADP
ajlm-2374	115	15	acetic	acetic	ADJ
ajlm-2374	115	16	acid	acid	NOUN
ajlm-2374	115	17	test	test	NOUN
ajlm-2374	115	18	result	result	NOUN
ajlm-2374	115	19	,	,	PUNCT
ajlm-2374	115	20	the	the	DET
ajlm-2374	115	21	routine	routine	ADJ
ajlm-2374	115	22	screening	screening	NOUN
ajlm-2374	115	23	test	test	NOUN
ajlm-2374	115	24	as	as	SCONJ
ajlm-2374	115	25	recommended	recommend	VERB
ajlm-2374	115	26	by	by	ADP
ajlm-2374	115	27	national	national	ADJ
ajlm-2374	115	28	guidelines	guideline	NOUN
ajlm-2374	115	29	.	.	PUNCT
ajlm-2374	116	1	implications	implication	NOUN
ajlm-2374	116	2	for	for	ADP
ajlm-2374	116	3	clinical	clinical	ADJ
ajlm-2374	116	4	practice	practice	NOUN
ajlm-2374	116	5	this	this	DET
ajlm-2374	116	6	study	study	NOUN
ajlm-2374	116	7	demonstrates	demonstrate	VERB
ajlm-2374	116	8	the	the	DET
ajlm-2374	116	9	association	association	NOUN
ajlm-2374	116	10	between	between	ADP
ajlm-2374	116	11	triglyceride	triglyceride	ADP
ajlm-2374	116	12	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	116	13	and	and	CCONJ
ajlm-2374	116	14	cin	cin	PROPN
ajlm-2374	116	15	.	.	PUNCT
ajlm-2374	117	1	with	with	ADP
ajlm-2374	117	2	increasing	increase	VERB
ajlm-2374	117	3	prevalence	prevalence	NOUN
ajlm-2374	117	4	of	of	ADP
ajlm-2374	117	5	non	non	ADJ
ajlm-2374	117	6	-	-	ADJ
ajlm-2374	117	7	communicable	communicable	ADJ
ajlm-2374	117	8	diseases	disease	NOUN
ajlm-2374	117	9	,	,	PUNCT
ajlm-2374	117	10	patients	patient	NOUN
ajlm-2374	117	11	would	would	AUX
ajlm-2374	117	12	benefit	benefit	VERB
ajlm-2374	117	13	from	from	ADP
ajlm-2374	117	14	combined	combine	VERB
ajlm-2374	117	15	screening	screening	NOUN
ajlm-2374	117	16	for	for	ADP
ajlm-2374	117	17	cervical	cervical	ADJ
ajlm-2374	117	18	cancer	cancer	NOUN
ajlm-2374	117	19	as	as	ADV
ajlm-2374	117	20	well	well	ADV
ajlm-2374	117	21	as	as	ADP
ajlm-2374	117	22	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	117	23	,	,	PUNCT
ajlm-2374	117	24	preferably	preferably	ADV
ajlm-2374	117	25	on	on	ADP
ajlm-2374	117	26	a	a	DET
ajlm-2374	117	27	single	single	ADJ
ajlm-2374	117	28	visit	visit	NOUN
ajlm-2374	117	29	.	.	PUNCT
ajlm-2374	118	1	just	just	ADV
ajlm-2374	118	2	as	as	ADP
ajlm-2374	118	3	for	for	ADP
ajlm-2374	118	4	cervical	cervical	ADJ
ajlm-2374	118	5	cancer	cancer	NOUN
ajlm-2374	118	6	screening	screening	NOUN
ajlm-2374	118	7	,	,	PUNCT
ajlm-2374	118	8	a	a	DET
ajlm-2374	118	9	test	test	NOUN
ajlm-2374	118	10	and	and	CCONJ
ajlm-2374	118	11	treat	treat	VERB
ajlm-2374	118	12	approach	approach	NOUN
ajlm-2374	118	13	would	would	AUX
ajlm-2374	118	14	be	be	AUX
ajlm-2374	118	15	more	more	ADV
ajlm-2374	118	16	impactful	impactful	ADJ
ajlm-2374	118	17	if	if	SCONJ
ajlm-2374	118	18	coupled	couple	VERB
ajlm-2374	118	19	with	with	ADP
ajlm-2374	118	20	screening	screen	VERB
ajlm-2374	118	21	for	for	ADP
ajlm-2374	118	22	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	118	23	.	.	PUNCT
ajlm-2374	119	1	limitations	limitation	NOUN
ajlm-2374	119	2	a	a	DET
ajlm-2374	119	3	major	major	ADJ
ajlm-2374	119	4	limitation	limitation	NOUN
ajlm-2374	119	5	of	of	ADP
ajlm-2374	119	6	this	this	DET
ajlm-2374	119	7	study	study	NOUN
ajlm-2374	119	8	was	be	AUX
ajlm-2374	119	9	the	the	DET
ajlm-2374	119	10	fact	fact	NOUN
ajlm-2374	119	11	that	that	SCONJ
ajlm-2374	119	12	controls	control	NOUN
ajlm-2374	119	13	were	be	AUX
ajlm-2374	119	14	not	not	PART
ajlm-2374	119	15	matched	match	VERB
ajlm-2374	119	16	with	with	ADP
ajlm-2374	119	17	cases	case	NOUN
ajlm-2374	119	18	.	.	PUNCT
ajlm-2374	120	1	some	some	DET
ajlm-2374	120	2	confounders	confounder	NOUN
ajlm-2374	120	3	may	may	AUX
ajlm-2374	120	4	still	still	ADV
ajlm-2374	120	5	have	have	AUX
ajlm-2374	120	6	had	have	VERB
ajlm-2374	120	7	an	an	DET
ajlm-2374	120	8	effect	effect	NOUN
ajlm-2374	120	9	on	on	ADP
ajlm-2374	120	10	statistics	statistic	NOUN
ajlm-2374	120	11	.	.	PUNCT
ajlm-2374	121	1	this	this	PRON
ajlm-2374	121	2	further	further	ADJ
ajlm-2374	121	3	presents	present	VERB
ajlm-2374	121	4	a	a	DET
ajlm-2374	121	5	shortcoming	shortcoming	NOUN
ajlm-2374	121	6	for	for	ADP
ajlm-2374	121	7	case	case	NOUN
ajlm-2374	121	8	-	-	PUNCT
ajlm-2374	121	9	control	control	NOUN
ajlm-2374	121	10	studies	study	NOUN
ajlm-2374	121	11	,	,	PUNCT
ajlm-2374	121	12	in	in	ADP
ajlm-2374	121	13	addition	addition	NOUN
ajlm-2374	121	14	to	to	ADP
ajlm-2374	121	15	their	their	PRON
ajlm-2374	121	16	inability	inability	NOUN
ajlm-2374	121	17	to	to	PART
ajlm-2374	121	18	ascertain	ascertain	VERB
ajlm-2374	121	19	causation	causation	NOUN
ajlm-2374	121	20	.	.	PUNCT
ajlm-2374	122	1	however	however	ADV
ajlm-2374	122	2	,	,	PUNCT
ajlm-2374	122	3	to	to	ADP
ajlm-2374	122	4	the	the	DET
ajlm-2374	122	5	best	good	ADJ
ajlm-2374	122	6	of	of	ADP
ajlm-2374	122	7	our	our	PRON
ajlm-2374	122	8	knowledge	knowledge	NOUN
ajlm-2374	122	9	,	,	PUNCT
ajlm-2374	122	10	we	we	PRON
ajlm-2374	122	11	gathered	gather	VERB
ajlm-2374	122	12	information	information	NOUN
ajlm-2374	122	13	on	on	ADP
ajlm-2374	122	14	all	all	DET
ajlm-2374	122	15	factors	factor	NOUN
ajlm-2374	122	16	known	know	VERB
ajlm-2374	122	17	to	to	PART
ajlm-2374	122	18	be	be	AUX
ajlm-2374	122	19	associated	associate	VERB
ajlm-2374	122	20	with	with	ADP
ajlm-2374	122	21	cervical	cervical	ADJ
ajlm-2374	122	22	lesions	lesion	NOUN
ajlm-2374	122	23	and	and	CCONJ
ajlm-2374	122	24	performed	perform	VERB
ajlm-2374	122	25	logistic	logistic	ADJ
ajlm-2374	122	26	regression	regression	NOUN
ajlm-2374	122	27	analysis	analysis	NOUN
ajlm-2374	122	28	which	which	PRON
ajlm-2374	122	29	generated	generate	VERB
ajlm-2374	122	30	a	a	DET
ajlm-2374	122	31	logistic	logistic	ADJ
ajlm-2374	122	32	regression	regression	NOUN
ajlm-2374	122	33	model	model	NOUN
ajlm-2374	122	34	with	with	ADP
ajlm-2374	122	35	all	all	DET
ajlm-2374	122	36	the	the	DET
ajlm-2374	122	37	factors	factor	NOUN
ajlm-2374	122	38	included	include	VERB
ajlm-2374	122	39	.	.	PUNCT
ajlm-2374	123	1	we	we	PRON
ajlm-2374	123	2	also	also	ADV
ajlm-2374	123	3	expect	expect	VERB
ajlm-2374	123	4	our	our	PRON
ajlm-2374	123	5	study	study	NOUN
ajlm-2374	123	6	to	to	PART
ajlm-2374	123	7	have	have	AUX
ajlm-2374	123	8	suffered	suffer	VERB
ajlm-2374	123	9	from	from	ADP
ajlm-2374	123	10	selection	selection	NOUN
ajlm-2374	123	11	bias	bias	NOUN
ajlm-2374	123	12	as	as	ADV
ajlm-2374	123	13	well	well	ADV
ajlm-2374	123	14	as	as	ADP
ajlm-2374	123	15	recall	recall	NOUN
ajlm-2374	123	16	bias	bias	NOUN
ajlm-2374	123	17	during	during	ADP
ajlm-2374	123	18	participant	participant	ADJ
ajlm-2374	123	19	enrollment	enrollment	NOUN
ajlm-2374	123	20	.	.	PUNCT
ajlm-2374	124	1	during	during	ADP
ajlm-2374	124	2	collection	collection	NOUN
ajlm-2374	124	3	of	of	ADP
ajlm-2374	124	4	data	datum	NOUN
ajlm-2374	124	5	,	,	PUNCT
ajlm-2374	124	6	participants	participant	NOUN
ajlm-2374	124	7	were	be	AUX
ajlm-2374	124	8	required	require	VERB
ajlm-2374	124	9	to	to	PART
ajlm-2374	124	10	remember	remember	VERB
ajlm-2374	124	11	information	information	NOUN
ajlm-2374	124	12	on	on	ADP
ajlm-2374	124	13	a	a	DET
ajlm-2374	124	14	number	number	NOUN
ajlm-2374	124	15	of	of	ADP
ajlm-2374	124	16	variables	variable	NOUN
ajlm-2374	124	17	including	include	VERB
ajlm-2374	124	18	history	history	NOUN
ajlm-2374	124	19	of	of	ADP
ajlm-2374	124	20	diabetes	diabetes	NOUN
ajlm-2374	124	21	and	and	CCONJ
ajlm-2374	124	22	hypertension	hypertension	NOUN
ajlm-2374	124	23	.	.	PUNCT
ajlm-2374	125	1	these	these	PRON
ajlm-2374	125	2	could	could	AUX
ajlm-2374	125	3	have	have	AUX
ajlm-2374	125	4	led	lead	VERB
ajlm-2374	125	5	to	to	ADP
ajlm-2374	125	6	false	false	ADJ
ajlm-2374	125	7	conclusions	conclusion	NOUN
ajlm-2374	125	8	about	about	ADP
ajlm-2374	125	9	the	the	DET
ajlm-2374	125	10	study	study	NOUN
ajlm-2374	125	11	population	population	NOUN
ajlm-2374	125	12	since	since	SCONJ
ajlm-2374	125	13	a	a	DET
ajlm-2374	125	14	lot	lot	NOUN
ajlm-2374	125	15	of	of	ADP
ajlm-2374	125	16	data	datum	NOUN
ajlm-2374	125	17	may	may	AUX
ajlm-2374	125	18	have	have	AUX
ajlm-2374	125	19	been	be	AUX
ajlm-2374	125	20	left	leave	VERB
ajlm-2374	125	21	out	out	ADP
ajlm-2374	125	22	or	or	CCONJ
ajlm-2374	125	23	improperly	improperly	ADV
ajlm-2374	125	24	reported	report	VERB
ajlm-2374	125	25	during	during	ADP
ajlm-2374	125	26	data	datum	NOUN
ajlm-2374	125	27	collection	collection	NOUN
ajlm-2374	125	28	.	.	PUNCT
ajlm-2374	126	1	however	however	ADV
ajlm-2374	126	2	,	,	PUNCT
ajlm-2374	126	3	for	for	ADP
ajlm-2374	126	4	most	most	ADJ
ajlm-2374	126	5	of	of	ADP
ajlm-2374	126	6	the	the	DET
ajlm-2374	126	7	variables	variable	NOUN
ajlm-2374	126	8	that	that	PRON
ajlm-2374	126	9	required	require	VERB
ajlm-2374	126	10	participants	participant	NOUN
ajlm-2374	126	11	to	to	PART
ajlm-2374	126	12	recall	recall	VERB
ajlm-2374	126	13	,	,	PUNCT
ajlm-2374	126	14	we	we	PRON
ajlm-2374	126	15	did	do	VERB
ajlm-2374	126	16	our	our	PRON
ajlm-2374	126	17	best	good	ADJ
ajlm-2374	126	18	to	to	PART
ajlm-2374	126	19	compare	compare	VERB
ajlm-2374	126	20	the	the	DET
ajlm-2374	126	21	provided	provide	VERB
ajlm-2374	126	22	information	information	NOUN
ajlm-2374	126	23	with	with	ADP
ajlm-2374	126	24	participants	participant	NOUN
ajlm-2374	126	25	’	'	PUNCT
ajlm-2374	126	26	charts	chart	NOUN
ajlm-2374	126	27	.	.	PUNCT
ajlm-2374	127	1	we	we	PRON
ajlm-2374	127	2	also	also	ADV
ajlm-2374	127	3	observe	observe	VERB
ajlm-2374	127	4	that	that	SCONJ
ajlm-2374	127	5	the	the	DET
ajlm-2374	127	6	sample	sample	NOUN
ajlm-2374	127	7	size	size	NOUN
ajlm-2374	127	8	used	use	VERB
ajlm-2374	127	9	for	for	ADP
ajlm-2374	127	10	this	this	DET
ajlm-2374	127	11	study	study	NOUN
ajlm-2374	127	12	was	be	AUX
ajlm-2374	127	13	smaller	small	ADJ
ajlm-2374	127	14	than	than	ADP
ajlm-2374	127	15	what	what	PRON
ajlm-2374	127	16	is	be	AUX
ajlm-2374	127	17	observed	observe	VERB
ajlm-2374	127	18	in	in	ADP
ajlm-2374	127	19	other	other	ADJ
ajlm-2374	127	20	studies	study	NOUN
ajlm-2374	127	21	,	,	PUNCT
ajlm-2374	127	22	despite	despite	SCONJ
ajlm-2374	127	23	the	the	DET
ajlm-2374	127	24	adequate	adequate	ADJ
ajlm-2374	127	25	power	power	NOUN
ajlm-2374	127	26	.	.	PUNCT
ajlm-2374	128	1	this	this	PRON
ajlm-2374	128	2	therefore	therefore	ADV
ajlm-2374	128	3	might	might	AUX
ajlm-2374	128	4	have	have	VERB
ajlm-2374	128	5	a	a	DET
ajlm-2374	128	6	negative	negative	ADJ
ajlm-2374	128	7	impact	impact	NOUN
ajlm-2374	128	8	on	on	ADP
ajlm-2374	128	9	the	the	DET
ajlm-2374	128	10	generalisability	generalisability	NOUN
ajlm-2374	128	11	of	of	ADP
ajlm-2374	128	12	results	result	NOUN
ajlm-2374	128	13	to	to	ADP
ajlm-2374	128	14	the	the	DET
ajlm-2374	128	15	general	general	ADJ
ajlm-2374	128	16	population	population	NOUN
ajlm-2374	128	17	.	.	PUNCT
ajlm-2374	129	1	conclusion	conclusion	NOUN
ajlm-2374	129	2	we	we	PRON
ajlm-2374	129	3	observed	observe	VERB
ajlm-2374	129	4	a	a	DET
ajlm-2374	129	5	significant	significant	ADJ
ajlm-2374	129	6	association	association	NOUN
ajlm-2374	129	7	between	between	ADP
ajlm-2374	129	8	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	129	9	,	,	PUNCT
ajlm-2374	129	10	especially	especially	ADV
ajlm-2374	129	11	triglyceride	triglyceride	ADP
ajlm-2374	129	12	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	129	13	,	,	PUNCT
ajlm-2374	129	14	and	and	CCONJ
ajlm-2374	129	15	cin	cin	PROPN
ajlm-2374	129	16	.	.	PUNCT
ajlm-2374	130	1	this	this	PRON
ajlm-2374	130	2	underscores	underscore	VERB
ajlm-2374	130	3	the	the	DET
ajlm-2374	130	4	importance	importance	NOUN
ajlm-2374	130	5	of	of	ADP
ajlm-2374	130	6	expanding	expand	VERB
ajlm-2374	130	7	screening	screen	VERB
ajlm-2374	130	8	efforts	effort	NOUN
ajlm-2374	130	9	for	for	ADP
ajlm-2374	130	10	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	130	11	to	to	PART
ajlm-2374	130	12	effectively	effectively	ADV
ajlm-2374	130	13	manage	manage	VERB
ajlm-2374	130	14	potential	potential	ADJ
ajlm-2374	130	15	complications	complication	NOUN
ajlm-2374	130	16	and	and	CCONJ
ajlm-2374	130	17	other	other	ADJ
ajlm-2374	130	18	non	non	ADJ
ajlm-2374	130	19	-	-	ADJ
ajlm-2374	130	20	communicable	communicable	ADJ
ajlm-2374	130	21	diseases	disease	NOUN
ajlm-2374	130	22	associated	associate	VERB
ajlm-2374	130	23	with	with	ADP
ajlm-2374	130	24	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	130	25	.	.	PUNCT
ajlm-2374	131	1	furthermore	furthermore	ADV
ajlm-2374	131	2	,	,	PUNCT
ajlm-2374	131	3	we	we	PRON
ajlm-2374	131	4	advocate	advocate	VERB
ajlm-2374	131	5	for	for	ADP
ajlm-2374	131	6	prospective	prospective	ADJ
ajlm-2374	131	7	cohort	cohort	NOUN
ajlm-2374	131	8	studies	study	NOUN
ajlm-2374	131	9	,	,	PUNCT
ajlm-2374	131	10	with	with	ADP
ajlm-2374	131	11	larger	large	ADJ
ajlm-2374	131	12	sample	sample	NOUN
ajlm-2374	131	13	sizes	size	NOUN
ajlm-2374	131	14	,	,	PUNCT
ajlm-2374	131	15	to	to	PART
ajlm-2374	131	16	deepen	deepen	VERB
ajlm-2374	131	17	our	our	PRON
ajlm-2374	131	18	understanding	understanding	NOUN
ajlm-2374	131	19	of	of	ADP
ajlm-2374	131	20	the	the	DET
ajlm-2374	131	21	relationship	relationship	NOUN
ajlm-2374	131	22	between	between	ADP
ajlm-2374	131	23	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	131	24	and	and	CCONJ
ajlm-2374	131	25	cin	cin	PROPN
ajlm-2374	131	26	,	,	PUNCT
ajlm-2374	131	27	as	as	ADV
ajlm-2374	131	28	well	well	ADV
ajlm-2374	131	29	as	as	ADP
ajlm-2374	131	30	its	its	PRON
ajlm-2374	131	31	broader	broad	ADJ
ajlm-2374	131	32	implications	implication	NOUN
ajlm-2374	131	33	for	for	ADP
ajlm-2374	131	34	cervical	cervical	ADJ
ajlm-2374	131	35	cancer	cancer	NOUN
ajlm-2374	131	36	.	.	PUNCT
ajlm-2374	132	1	adequate	adequate	ADJ
ajlm-2374	132	2	management	management	NOUN
ajlm-2374	132	3	of	of	ADP
ajlm-2374	132	4	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	132	5	could	could	AUX
ajlm-2374	132	6	stop	stop	VERB
ajlm-2374	132	7	progression	progression	NOUN
ajlm-2374	132	8	of	of	ADP
ajlm-2374	132	9	cin	cin	PROPN
ajlm-2374	132	10	to	to	ADP
ajlm-2374	132	11	cervical	cervical	ADJ
ajlm-2374	132	12	cancer	cancer	NOUN
ajlm-2374	132	13	.	.	PUNCT
ajlm-2374	133	1	molecular	molecular	ADJ
ajlm-2374	133	2	studies	study	NOUN
ajlm-2374	133	3	could	could	AUX
ajlm-2374	133	4	be	be	AUX
ajlm-2374	133	5	carried	carry	VERB
ajlm-2374	133	6	out	out	ADP
ajlm-2374	133	7	to	to	PART
ajlm-2374	133	8	understand	understand	VERB
ajlm-2374	133	9	the	the	DET
ajlm-2374	133	10	biochemical	biochemical	ADJ
ajlm-2374	133	11	processes	process	NOUN
ajlm-2374	133	12	and	and	CCONJ
ajlm-2374	133	13	interactions	interaction	NOUN
ajlm-2374	133	14	behind	behind	ADP
ajlm-2374	133	15	lipids	lipids	ADJ
ajlm-2374	133	16	and	and	CCONJ
ajlm-2374	133	17	cervical	cervical	ADJ
ajlm-2374	133	18	carcinogenesis	carcinogenesis	NOUN
ajlm-2374	133	19	.	.	PUNCT
ajlm-2374	134	1	acknowledgements	acknowledgement	NOUN
ajlm-2374	134	2	we	we	PRON
ajlm-2374	134	3	acknowledge	acknowledge	VERB
ajlm-2374	134	4	the	the	DET
ajlm-2374	134	5	nurses	nurse	NOUN
ajlm-2374	134	6	,	,	PUNCT
ajlm-2374	134	7	midwives	midwife	NOUN
ajlm-2374	134	8	and	and	CCONJ
ajlm-2374	134	9	clinicians	clinician	NOUN
ajlm-2374	134	10	of	of	ADP
ajlm-2374	134	11	mbarara	mbarara	NOUN
ajlm-2374	134	12	regional	regional	ADJ
ajlm-2374	134	13	referral	referral	ADJ
ajlm-2374	134	14	hospital	hospital	NOUN
ajlm-2374	134	15	,	,	PUNCT
ajlm-2374	134	16	especially	especially	ADV
ajlm-2374	134	17	the	the	DET
ajlm-2374	134	18	cervical	cervical	ADJ
ajlm-2374	134	19	cancer	cancer	NOUN
ajlm-2374	134	20	clinic	clinic	NOUN
ajlm-2374	134	21	.	.	PUNCT
ajlm-2374	135	1	we	we	PRON
ajlm-2374	135	2	also	also	ADV
ajlm-2374	135	3	acknowledge	acknowledge	VERB
ajlm-2374	135	4	the	the	DET
ajlm-2374	135	5	research	research	NOUN
ajlm-2374	135	6	assistants	assistant	NOUN
ajlm-2374	135	7	who	who	PRON
ajlm-2374	135	8	participated	participate	VERB
ajlm-2374	135	9	in	in	ADP
ajlm-2374	135	10	data	datum	NOUN
ajlm-2374	135	11	collection	collection	NOUN
ajlm-2374	135	12	.	.	PUNCT
ajlm-2374	136	1	special	special	ADJ
ajlm-2374	136	2	acknowledgement	acknowledgement	NOUN
ajlm-2374	136	3	goes	go	VERB
ajlm-2374	136	4	to	to	ADP
ajlm-2374	136	5	expert	expert	NOUN
ajlm-2374	136	6	laboratories	laboratory	NOUN
ajlm-2374	136	7	and	and	CCONJ
ajlm-2374	136	8	the	the	DET
ajlm-2374	136	9	mbarara	mbarara	NOUN
ajlm-2374	136	10	university	university	PROPN
ajlm-2374	136	11	of	of	ADP
ajlm-2374	136	12	science	science	NOUN
ajlm-2374	136	13	and	and	CCONJ
ajlm-2374	136	14	technology	technology	NOUN
ajlm-2374	136	15	histopathology	histopathology	NOUN
ajlm-2374	136	16	laboratory	laboratory	NOUN
ajlm-2374	136	17	where	where	SCONJ
ajlm-2374	136	18	lipid	lipid	NOUN
ajlm-2374	136	19	estimation	estimation	NOUN
ajlm-2374	136	20	and	and	CCONJ
ajlm-2374	136	21	histopathology	histopathology	NOUN
ajlm-2374	136	22	analysis	analysis	NOUN
ajlm-2374	136	23	were	be	AUX
ajlm-2374	136	24	done	do	VERB
ajlm-2374	136	25	,	,	PUNCT
ajlm-2374	136	26	respectively	respectively	ADV
ajlm-2374	136	27	.	.	PUNCT
ajlm-2374	137	1	competing	compete	VERB
ajlm-2374	137	2	interests	interest	NOUN
ajlm-2374	137	3	the	the	DET
ajlm-2374	137	4	authors	author	NOUN
ajlm-2374	137	5	declare	declare	VERB
ajlm-2374	137	6	that	that	SCONJ
ajlm-2374	137	7	they	they	PRON
ajlm-2374	137	8	have	have	VERB
ajlm-2374	137	9	no	no	DET
ajlm-2374	137	10	financial	financial	ADJ
ajlm-2374	137	11	or	or	CCONJ
ajlm-2374	137	12	personal	personal	ADJ
ajlm-2374	137	13	relationships	relationship	NOUN
ajlm-2374	137	14	that	that	PRON
ajlm-2374	137	15	may	may	AUX
ajlm-2374	137	16	have	have	AUX
ajlm-2374	137	17	inappropriately	inappropriately	ADV
ajlm-2374	137	18	influenced	influence	VERB
ajlm-2374	137	19	them	they	PRON
ajlm-2374	137	20	in	in	ADP
ajlm-2374	137	21	writing	write	VERB
ajlm-2374	137	22	this	this	DET
ajlm-2374	137	23	article	article	NOUN
ajlm-2374	137	24	.	.	PUNCT
ajlm-2374	138	1	authors	author	NOUN
ajlm-2374	138	2	’	’	PART
ajlm-2374	138	3	contributions	contribution	NOUN
ajlm-2374	138	4	f.s	f.s	PROPN
ajlm-2374	138	5	.	.	PROPN
ajlm-2374	138	6	conceived	conceive	VERB
ajlm-2374	138	7	the	the	DET
ajlm-2374	138	8	idea	idea	NOUN
ajlm-2374	138	9	and	and	CCONJ
ajlm-2374	138	10	developed	develop	VERB
ajlm-2374	138	11	the	the	DET
ajlm-2374	138	12	protocol	protocol	NOUN
ajlm-2374	138	13	and	and	CCONJ
ajlm-2374	138	14	the	the	DET
ajlm-2374	138	15	first	first	ADJ
ajlm-2374	138	16	draft	draft	NOUN
ajlm-2374	138	17	of	of	ADP
ajlm-2374	138	18	the	the	DET
ajlm-2374	138	19	manuscript	manuscript	NOUN
ajlm-2374	138	20	.	.	PUNCT
ajlm-2374	139	1	co	co	NOUN
ajlm-2374	139	2	-	-	NOUN
ajlm-2374	139	3	authors	author	NOUN
ajlm-2374	139	4	t.c.r	t.c.r	NOUN
ajlm-2374	139	5	.	.	PROPN
ajlm-2374	139	6	,	,	PUNCT
ajlm-2374	139	7	d.t	d.t	PROPN
ajlm-2374	139	8	.	.	PROPN
ajlm-2374	139	9	and	and	CCONJ
ajlm-2374	139	10	j.n	j.n	PROPN
ajlm-2374	139	11	.	.	PROPN
ajlm-2374	139	12	participated	participate	VERB
ajlm-2374	139	13	in	in	ADP
ajlm-2374	139	14	protocol	protocol	NOUN
ajlm-2374	139	15	writing	writing	NOUN
ajlm-2374	139	16	,	,	PUNCT
ajlm-2374	139	17	and	and	CCONJ
ajlm-2374	139	18	supervised	supervise	VERB
ajlm-2374	139	19	from	from	ADP
ajlm-2374	139	20	data	datum	NOUN
ajlm-2374	139	21	collection	collection	NOUN
ajlm-2374	139	22	to	to	ADP
ajlm-2374	139	23	analysis	analysis	NOUN
ajlm-2374	139	24	.	.	PUNCT
ajlm-2374	140	1	they	they	PRON
ajlm-2374	140	2	reviewed	review	VERB
ajlm-2374	140	3	and	and	CCONJ
ajlm-2374	140	4	provided	provide	VERB
ajlm-2374	140	5	overall	overall	ADJ
ajlm-2374	140	6	guidance	guidance	NOUN
ajlm-2374	140	7	in	in	ADP
ajlm-2374	140	8	the	the	DET
ajlm-2374	140	9	entire	entire	ADJ
ajlm-2374	140	10	write	write	NOUN
ajlm-2374	140	11	-	-	PUNCT
ajlm-2374	140	12	up	up	NOUN
ajlm-2374	140	13	and	and	CCONJ
ajlm-2374	140	14	approved	approve	VERB
ajlm-2374	140	15	the	the	DET
ajlm-2374	140	16	final	final	ADJ
ajlm-2374	140	17	version	version	NOUN
ajlm-2374	140	18	prior	prior	ADV
ajlm-2374	140	19	to	to	ADP
ajlm-2374	140	20	submission	submission	NOUN
ajlm-2374	140	21	.	.	PUNCT
ajlm-2374	141	1	j.n.n	j.n.n	PROPN
ajlm-2374	141	2	.	.	PROPN
ajlm-2374	141	3	,	,	PUNCT
ajlm-2374	141	4	r.k	r.k	PROPN
ajlm-2374	141	5	.	.	PROPN
ajlm-2374	141	6	,	,	PUNCT
ajlm-2374	141	7	a.n	a.n	PROPN
ajlm-2374	141	8	.	.	PROPN
ajlm-2374	141	9	and	and	CCONJ
ajlm-2374	141	10	j.m	j.m	PROPN
ajlm-2374	141	11	.	.	PROPN
ajlm-2374	141	12	participated	participate	VERB
ajlm-2374	141	13	in	in	ADP
ajlm-2374	141	14	data	datum	NOUN
ajlm-2374	141	15	collection	collection	NOUN
ajlm-2374	141	16	and	and	CCONJ
ajlm-2374	141	17	analysis	analysis	NOUN
ajlm-2374	141	18	,	,	PUNCT
ajlm-2374	141	19	and	and	CCONJ
ajlm-2374	141	20	reviewed	review	VERB
ajlm-2374	141	21	and	and	CCONJ
ajlm-2374	141	22	approved	approve	VERB
ajlm-2374	141	23	the	the	DET
ajlm-2374	141	24	final	final	ADJ
ajlm-2374	141	25	version	version	NOUN
ajlm-2374	141	26	of	of	ADP
ajlm-2374	141	27	the	the	DET
ajlm-2374	141	28	manuscript	manuscript	NOUN
ajlm-2374	141	29	.	.	PUNCT
ajlm-2374	142	1	all	all	DET
ajlm-2374	142	2	authors	author	NOUN
ajlm-2374	142	3	are	be	AUX
ajlm-2374	142	4	accountable	accountable	ADJ
ajlm-2374	142	5	for	for	ADP
ajlm-2374	142	6	all	all	DET
ajlm-2374	142	7	aspects	aspect	NOUN
ajlm-2374	142	8	of	of	ADP
ajlm-2374	142	9	this	this	DET
ajlm-2374	142	10	manuscript	manuscript	NOUN
ajlm-2374	142	11	.	.	PUNCT
ajlm-2374	143	1	sources	source	NOUN
ajlm-2374	143	2	of	of	ADP
ajlm-2374	143	3	support	support	NOUN
ajlm-2374	143	4	research	research	NOUN
ajlm-2374	143	5	reported	report	VERB
ajlm-2374	143	6	in	in	ADP
ajlm-2374	143	7	this	this	DET
ajlm-2374	143	8	publication	publication	NOUN
ajlm-2374	143	9	was	be	AUX
ajlm-2374	143	10	supported	support	VERB
ajlm-2374	143	11	by	by	ADP
ajlm-2374	143	12	the	the	DET
ajlm-2374	143	13	fogarty	fogarty	PROPN
ajlm-2374	143	14	international	international	PROPN
ajlm-2374	143	15	centre	centre	PROPN
ajlm-2374	143	16	of	of	ADP
ajlm-2374	143	17	the	the	DET
ajlm-2374	143	18	national	national	PROPN
ajlm-2374	143	19	institutes	institutes	PROPN
ajlm-2374	143	20	of	of	ADP
ajlm-2374	143	21	health	health	PROPN
ajlm-2374	143	22	under	under	ADP
ajlm-2374	143	23	award	award	NOUN
ajlm-2374	143	24	number	number	NOUN
ajlm-2374	143	25	d43tw011632	d43tw011632	NOUN
ajlm-2374	143	26	.	.	PUNCT
ajlm-2374	144	1	the	the	DET
ajlm-2374	144	2	content	content	NOUN
ajlm-2374	144	3	is	be	AUX
ajlm-2374	144	4	solely	solely	ADV
ajlm-2374	144	5	the	the	DET
ajlm-2374	144	6	responsibility	responsibility	NOUN
ajlm-2374	144	7	of	of	ADP
ajlm-2374	144	8	the	the	DET
ajlm-2374	144	9	authors	author	NOUN
ajlm-2374	144	10	and	and	CCONJ
ajlm-2374	144	11	does	do	AUX
ajlm-2374	144	12	not	not	PART
ajlm-2374	144	13	necessarily	necessarily	ADV
ajlm-2374	144	14	represent	represent	VERB
ajlm-2374	144	15	the	the	DET
ajlm-2374	144	16	official	official	ADJ
ajlm-2374	144	17	views	view	NOUN
ajlm-2374	144	18	of	of	ADP
ajlm-2374	144	19	the	the	DET
ajlm-2374	144	20	national	national	PROPN
ajlm-2374	144	21	institutes	institutes	PROPN
ajlm-2374	144	22	of	of	ADP
ajlm-2374	144	23	health	health	PROPN
ajlm-2374	144	24	.	.	PUNCT
ajlm-2374	145	1	data	datum	NOUN
ajlm-2374	145	2	availability	availability	NOUN
ajlm-2374	145	3	all	all	DET
ajlm-2374	145	4	the	the	DET
ajlm-2374	145	5	data	datum	NOUN
ajlm-2374	145	6	from	from	ADP
ajlm-2374	145	7	which	which	PRON
ajlm-2374	145	8	this	this	DET
ajlm-2374	145	9	article	article	NOUN
ajlm-2374	145	10	was	be	AUX
ajlm-2374	145	11	generated	generate	VERB
ajlm-2374	145	12	are	be	AUX
ajlm-2374	145	13	available	available	ADJ
ajlm-2374	145	14	from	from	ADP
ajlm-2374	145	15	the	the	DET
ajlm-2374	145	16	corresponding	corresponding	ADJ
ajlm-2374	145	17	author	author	NOUN
ajlm-2374	145	18	,	,	PUNCT
ajlm-2374	145	19	f.s	f.s	PROPN
ajlm-2374	145	20	.	.	PROPN
ajlm-2374	145	21	,	,	PUNCT
ajlm-2374	145	22	upon	upon	SCONJ
ajlm-2374	145	23	reasonable	reasonable	ADJ
ajlm-2374	145	24	request	request	NOUN
ajlm-2374	145	25	.	.	PUNCT
ajlm-2374	146	1	disclaimer	disclaimer	VERB
ajlm-2374	146	2	the	the	DET
ajlm-2374	146	3	views	view	NOUN
ajlm-2374	146	4	and	and	CCONJ
ajlm-2374	146	5	opinions	opinion	NOUN
ajlm-2374	146	6	expressed	express	VERB
ajlm-2374	146	7	in	in	ADP
ajlm-2374	146	8	this	this	DET
ajlm-2374	146	9	article	article	NOUN
ajlm-2374	146	10	are	be	AUX
ajlm-2374	146	11	those	those	PRON
ajlm-2374	146	12	of	of	ADP
ajlm-2374	146	13	the	the	DET
ajlm-2374	146	14	authors	author	NOUN
ajlm-2374	146	15	and	and	CCONJ
ajlm-2374	146	16	are	be	AUX
ajlm-2374	146	17	the	the	DET
ajlm-2374	146	18	product	product	NOUN
ajlm-2374	146	19	of	of	ADP
ajlm-2374	146	20	professional	professional	ADJ
ajlm-2374	146	21	research	research	NOUN
ajlm-2374	146	22	.	.	PUNCT
ajlm-2374	147	1	it	it	PRON
ajlm-2374	147	2	does	do	AUX
ajlm-2374	147	3	not	not	PART
ajlm-2374	147	4	necessarily	necessarily	ADV
ajlm-2374	147	5	reflect	reflect	VERB
ajlm-2374	147	6	the	the	DET
ajlm-2374	147	7	official	official	ADJ
ajlm-2374	147	8	policy	policy	NOUN
ajlm-2374	147	9	or	or	CCONJ
ajlm-2374	147	10	position	position	NOUN
ajlm-2374	147	11	of	of	ADP
ajlm-2374	147	12	any	any	DET
ajlm-2374	147	13	affiliated	affiliated	ADJ
ajlm-2374	147	14	institution	institution	NOUN
ajlm-2374	147	15	,	,	PUNCT
ajlm-2374	147	16	funder	funder	NOUN
ajlm-2374	147	17	,	,	PUNCT
ajlm-2374	147	18	agency	agency	NOUN
ajlm-2374	147	19	,	,	PUNCT
ajlm-2374	147	20	or	or	CCONJ
ajlm-2374	147	21	that	that	PRON
ajlm-2374	147	22	of	of	ADP
ajlm-2374	147	23	the	the	DET
ajlm-2374	147	24	publisher	publisher	NOUN
ajlm-2374	147	25	.	.	PUNCT
ajlm-2374	148	1	the	the	DET
ajlm-2374	148	2	authors	author	NOUN
ajlm-2374	148	3	are	be	AUX
ajlm-2374	148	4	responsible	responsible	ADJ
ajlm-2374	148	5	for	for	ADP
ajlm-2374	148	6	this	this	DET
ajlm-2374	148	7	article	article	NOUN
ajlm-2374	148	8	’s	’s	PART
ajlm-2374	148	9	results	result	NOUN
ajlm-2374	148	10	,	,	PUNCT
ajlm-2374	148	11	findings	finding	NOUN
ajlm-2374	148	12	,	,	PUNCT
ajlm-2374	148	13	and	and	CCONJ
ajlm-2374	148	14	content	content	NOUN
ajlm-2374	148	15	.	.	PUNCT
ajlm-2374	149	1	references	reference	NOUN
ajlm-2374	149	2	sung	sing	VERB
ajlm-2374	149	3	h	h	NOUN
ajlm-2374	149	4	,	,	PUNCT
ajlm-2374	149	5	ferlay	ferlay	PROPN
ajlm-2374	149	6	j	j	PROPN
ajlm-2374	149	7	,	,	PUNCT
ajlm-2374	149	8	siegel	siegel	PROPN
ajlm-2374	149	9	rl	rl	PROPN
ajlm-2374	149	10	,	,	PUNCT
ajlm-2374	149	11	et	et	PROPN
ajlm-2374	149	12	al	al	PROPN
ajlm-2374	149	13	.	.	PUNCT
ajlm-2374	150	1	global	global	ADJ
ajlm-2374	150	2	cancer	cancer	NOUN
ajlm-2374	150	3	statistics	statistic	NOUN
ajlm-2374	150	4	2020	2020	NUM
ajlm-2374	150	5	:	:	PUNCT
ajlm-2374	150	6	globocan	globocan	PROPN
ajlm-2374	150	7	estimates	estimate	NOUN
ajlm-2374	150	8	of	of	ADP
ajlm-2374	150	9	incidence	incidence	NOUN
ajlm-2374	150	10	and	and	CCONJ
ajlm-2374	150	11	mortality	mortality	NOUN
ajlm-2374	150	12	worldwide	worldwide	ADV
ajlm-2374	150	13	for	for	ADP
ajlm-2374	150	14	36	36	NUM
ajlm-2374	150	15	cancers	cancer	NOUN
ajlm-2374	150	16	in	in	ADP
ajlm-2374	150	17	185	185	NUM
ajlm-2374	150	18	countries	country	NOUN
ajlm-2374	150	19	.	.	PUNCT
ajlm-2374	151	1	ca	can	AUX
ajlm-2374	151	2	cancer	cancer	PROPN
ajlm-2374	151	3	j	j	PROPN
ajlm-2374	151	4	clin	clin	PROPN
ajlm-2374	151	5	.	.	PUNCT
ajlm-2374	152	1	2021;71(3):209–249	2021;71(3):209–249	X
ajlm-2374	152	2	.	.	PUNCT
ajlm-2374	153	1	https://doi.org/10.3322/caac.21660	https://doi.org/10.3322/caac.21660	PRON
ajlm-2374	153	2	jedy	jedy	NOUN
ajlm-2374	153	3	-	-	PUNCT
ajlm-2374	153	4	agba	agba	PROPN
ajlm-2374	153	5	e	e	NOUN
ajlm-2374	153	6	,	,	PUNCT
ajlm-2374	153	7	joko	joko	PROPN
ajlm-2374	153	8	wy	wy	PROPN
ajlm-2374	153	9	,	,	PUNCT
ajlm-2374	153	10	liu	liu	PROPN
ajlm-2374	153	11	b	b	PROPN
ajlm-2374	153	12	,	,	PUNCT
ajlm-2374	153	13	et	et	PROPN
ajlm-2374	153	14	al	al	PROPN
ajlm-2374	153	15	.	.	PUNCT
ajlm-2374	153	16	trends	trend	NOUN
ajlm-2374	153	17	in	in	ADP
ajlm-2374	153	18	cervical	cervical	ADJ
ajlm-2374	153	19	cancer	cancer	NOUN
ajlm-2374	153	20	incidence	incidence	NOUN
ajlm-2374	153	21	in	in	ADP
ajlm-2374	153	22	sub	sub	ADJ
ajlm-2374	153	23	-	-	ADJ
ajlm-2374	153	24	saharan	saharan	ADJ
ajlm-2374	153	25	africa	africa	PROPN
ajlm-2374	153	26	.	.	PUNCT
ajlm-2374	154	1	br	br	PROPN
ajlm-2374	154	2	j	j	PROPN
ajlm-2374	154	3	cancer	cancer	NOUN
ajlm-2374	154	4	.	.	PUNCT
ajlm-2374	155	1	2020;123(1):148–154	2020;123(1):148–154	NUM
ajlm-2374	155	2	.	.	PUNCT
ajlm-2374	155	3	https://doi.org/10.1038/s41416-020-0831-9	https://doi.org/10.1038/s41416-020-0831-9	NUM
ajlm-2374	155	4	choi	choi	PROPN
ajlm-2374	155	5	s	s	PROPN
ajlm-2374	155	6	,	,	PUNCT
ajlm-2374	155	7	ismail	ismail	PROPN
ajlm-2374	155	8	a	a	PRON
ajlm-2374	155	9	,	,	PUNCT
ajlm-2374	155	10	pappas	pappas	PROPN
ajlm-2374	155	11	-	-	PUNCT
ajlm-2374	155	12	gogos	gogos	PROPN
ajlm-2374	155	13	g	g	NOUN
ajlm-2374	155	14	,	,	PUNCT
ajlm-2374	155	15	boussios	boussios	PROPN
ajlm-2374	155	16	s.	s.	PROPN
ajlm-2374	155	17	hpv	hpv	PROPN
ajlm-2374	155	18	and	and	CCONJ
ajlm-2374	155	19	cervical	cervical	ADJ
ajlm-2374	155	20	cancer	cancer	NOUN
ajlm-2374	155	21	:	:	PUNCT
ajlm-2374	155	22	a	a	DET
ajlm-2374	155	23	review	review	NOUN
ajlm-2374	155	24	of	of	ADP
ajlm-2374	155	25	epidemiology	epidemiology	NOUN
ajlm-2374	155	26	and	and	CCONJ
ajlm-2374	155	27	screening	screen	VERB
ajlm-2374	155	28	uptake	uptake	ADJ
ajlm-2374	155	29	in	in	ADP
ajlm-2374	155	30	the	the	DET
ajlm-2374	155	31	uk	uk	PROPN
ajlm-2374	155	32	.	.	PUNCT
ajlm-2374	155	33	pathogens	pathogen	NOUN
ajlm-2374	155	34	.	.	PUNCT
ajlm-2374	156	1	2023;12(2):298	2023;12(2):298	NUM
ajlm-2374	156	2	.	.	PUNCT
ajlm-2374	157	1	https://doi.org/10.3390/pathogens12020298	https://doi.org/10.3390/pathogens12020298	PROPN
ajlm-2374	157	2	walboomers	walboomer	NOUN
ajlm-2374	157	3	jm	jm	PROPN
ajlm-2374	157	4	,	,	PUNCT
ajlm-2374	157	5	jacobs	jacobs	PROPN
ajlm-2374	157	6	mv	mv	PROPN
ajlm-2374	157	7	,	,	PUNCT
ajlm-2374	157	8	manos	manos	PROPN
ajlm-2374	157	9	mm	mm	PROPN
ajlm-2374	157	10	,	,	PUNCT
ajlm-2374	157	11	et	et	PROPN
ajlm-2374	157	12	al	al	PROPN
ajlm-2374	157	13	.	.	PUNCT
ajlm-2374	158	1	human	human	ADJ
ajlm-2374	158	2	papillomavirus	papillomavirus	NOUN
ajlm-2374	158	3	is	be	AUX
ajlm-2374	158	4	a	a	DET
ajlm-2374	158	5	necessary	necessary	ADJ
ajlm-2374	158	6	cause	cause	NOUN
ajlm-2374	158	7	of	of	ADP
ajlm-2374	158	8	invasive	invasive	ADJ
ajlm-2374	158	9	cervical	cervical	ADJ
ajlm-2374	158	10	cancer	cancer	NOUN
ajlm-2374	158	11	worldwide	worldwide	ADV
ajlm-2374	158	12	.	.	PUNCT
ajlm-2374	159	1	j	j	PROPN
ajlm-2374	159	2	pathol	pathol	NOUN
ajlm-2374	159	3	.	.	PUNCT
ajlm-2374	160	1	1999;189(1):12–19	1999;189(1):12–19	NUM
ajlm-2374	160	2	.	.	PUNCT
ajlm-2374	161	1	https://doi.org/10.1002/(sici)1096-9896(199909)189:1<12::aid-path431>3.0.co;2-f	https://doi.org/10.1002/(sici)1096-9896(199909)189:1<12::aid-path431>3.0.co;2-f	NOUN
ajlm-2374	161	2	crosbie	crosbie	VERB
ajlm-2374	161	3	ej	ej	PROPN
ajlm-2374	161	4	,	,	PUNCT
ajlm-2374	161	5	einstein	einstein	PROPN
ajlm-2374	161	6	mh	mh	PROPN
ajlm-2374	161	7	,	,	PUNCT
ajlm-2374	161	8	franceschi	franceschi	PROPN
ajlm-2374	161	9	s	s	PROPN
ajlm-2374	161	10	,	,	PUNCT
ajlm-2374	161	11	kitchener	kitchener	PROPN
ajlm-2374	161	12	hc	hc	PROPN
ajlm-2374	161	13	.	.	PROPN
ajlm-2374	161	14	human	human	ADJ
ajlm-2374	161	15	papillomavirus	papillomavirus	NOUN
ajlm-2374	161	16	and	and	CCONJ
ajlm-2374	161	17	cervical	cervical	ADJ
ajlm-2374	161	18	cancer	cancer	NOUN
ajlm-2374	161	19	.	.	PUNCT
ajlm-2374	162	1	lancet	lancet	NOUN
ajlm-2374	162	2	.	.	PUNCT
ajlm-2374	163	1	2013;382(9895):889–899	2013;382(9895):889–899	NOUN
ajlm-2374	163	2	.	.	PUNCT
ajlm-2374	164	1	https://doi.org/10.1016/s0140-6736(13)60022-7	https://doi.org/10.1016/s0140-6736(13)60022-7	PROPN
ajlm-2374	164	2	vernieri	vernieri	PROPN
ajlm-2374	164	3	c	c	PROPN
ajlm-2374	164	4	,	,	PUNCT
ajlm-2374	164	5	casola	casola	PROPN
ajlm-2374	164	6	s	s	PROPN
ajlm-2374	164	7	,	,	PUNCT
ajlm-2374	164	8	foiani	foiani	PROPN
ajlm-2374	164	9	m	m	PROPN
ajlm-2374	164	10	,	,	PUNCT
ajlm-2374	164	11	pietrantonio	pietrantonio	PROPN
ajlm-2374	164	12	f	f	PROPN
ajlm-2374	164	13	,	,	PUNCT
ajlm-2374	164	14	de	de	X
ajlm-2374	164	15	braud	braud	VERB
ajlm-2374	164	16	f	f	PROPN
ajlm-2374	164	17	,	,	PUNCT
ajlm-2374	164	18	longo	longo	PROPN
ajlm-2374	164	19	v.	v.	ADP
ajlm-2374	164	20	targeting	target	VERB
ajlm-2374	164	21	cancer	cancer	NOUN
ajlm-2374	164	22	metabolism	metabolism	NOUN
ajlm-2374	164	23	:	:	PUNCT
ajlm-2374	164	24	dietary	dietary	ADJ
ajlm-2374	164	25	and	and	CCONJ
ajlm-2374	164	26	pharmacologic	pharmacologic	ADJ
ajlm-2374	164	27	interventions	intervention	NOUN
ajlm-2374	164	28	.	.	PUNCT
ajlm-2374	165	1	cancer	cancer	NOUN
ajlm-2374	165	2	discov	discov	NOUN
ajlm-2374	165	3	.	.	PUNCT
ajlm-2374	166	1	2016;6(12):1315–1333	2016;6(12):1315–1333	NOUN
ajlm-2374	166	2	.	.	PUNCT
ajlm-2374	167	1	https://doi.org/10.1158/2159-8290.cd-16-0615	https://doi.org/10.1158/2159-8290.cd-16-0615	NOUN
ajlm-2374	167	2	woodman	woodman	PROPN
ajlm-2374	167	3	cb	cb	PROPN
ajlm-2374	167	4	,	,	PUNCT
ajlm-2374	167	5	collins	collins	PROPN
ajlm-2374	167	6	si	si	PROPN
ajlm-2374	167	7	,	,	PUNCT
ajlm-2374	167	8	young	young	ADJ
ajlm-2374	167	9	ls	ls	PROPN
ajlm-2374	167	10	.	.	PUNCT
ajlm-2374	168	1	the	the	DET
ajlm-2374	168	2	natural	natural	ADJ
ajlm-2374	168	3	history	history	NOUN
ajlm-2374	168	4	of	of	ADP
ajlm-2374	168	5	cervical	cervical	ADJ
ajlm-2374	168	6	hpv	hpv	NOUN
ajlm-2374	168	7	infection	infection	NOUN
ajlm-2374	168	8	:	:	PUNCT
ajlm-2374	168	9	unresolved	unresolved	ADJ
ajlm-2374	168	10	issues	issue	NOUN
ajlm-2374	168	11	.	.	PUNCT
ajlm-2374	169	1	nat	nat	PROPN
ajlm-2374	169	2	rev	rev	PROPN
ajlm-2374	169	3	cancer	cancer	NOUN
ajlm-2374	169	4	.	.	PUNCT
ajlm-2374	170	1	2007;7(1):11–22	2007;7(1):11–22	NUM
ajlm-2374	170	2	.	.	PUNCT
ajlm-2374	171	1	https://doi.org/10.1038/nrc2050	https://doi.org/10.1038/nrc2050	VERB
ajlm-2374	171	2	small	small	ADJ
ajlm-2374	171	3	jr	jr	PROPN
ajlm-2374	171	4	w	w	PROPN
ajlm-2374	171	5	,	,	PUNCT
ajlm-2374	171	6	bacon	bacon	PROPN
ajlm-2374	171	7	ma	ma	PROPN
ajlm-2374	171	8	,	,	PUNCT
ajlm-2374	171	9	bajaj	bajaj	PROPN
ajlm-2374	171	10	a	a	PROPN
ajlm-2374	171	11	,	,	PUNCT
ajlm-2374	171	12	et	et	PROPN
ajlm-2374	171	13	al	al	PROPN
ajlm-2374	171	14	.	.	PUNCT
ajlm-2374	171	15	cervical	cervical	ADJ
ajlm-2374	171	16	cancer	cancer	NOUN
ajlm-2374	171	17	:	:	PUNCT
ajlm-2374	171	18	a	a	DET
ajlm-2374	171	19	global	global	ADJ
ajlm-2374	171	20	health	health	NOUN
ajlm-2374	171	21	crisis	crisis	NOUN
ajlm-2374	171	22	.	.	PUNCT
ajlm-2374	172	1	cancer	cancer	NOUN
ajlm-2374	172	2	.	.	PUNCT
ajlm-2374	173	1	2017;123(13):2404–2412	2017;123(13):2404–2412	NUM
ajlm-2374	173	2	.	.	X
ajlm-2374	173	3	https://doi.org/10.1002/cncr.30667	https://doi.org/10.1002/cncr.30667	AUX
ajlm-2374	173	4	schottenfeld	schottenfeld	PROPN
ajlm-2374	173	5	d	d	PROPN
ajlm-2374	173	6	,	,	PUNCT
ajlm-2374	173	7	fraumeni	fraumeni	PROPN
ajlm-2374	173	8	jr	jr	PROPN
ajlm-2374	173	9	,	,	PUNCT
ajlm-2374	173	10	jf	jf	PROPN
ajlm-2374	173	11	.	.	PUNCT
ajlm-2374	173	12	cancer	cancer	NOUN
ajlm-2374	173	13	epidemiology	epidemiology	NOUN
ajlm-2374	173	14	and	and	CCONJ
ajlm-2374	173	15	prevention	prevention	NOUN
ajlm-2374	173	16	.	.	PUNCT
ajlm-2374	174	1	oxford	oxford	PROPN
ajlm-2374	174	2	university	university	PROPN
ajlm-2374	174	3	press	press	NOUN
ajlm-2374	174	4	:	:	PUNCT
ajlm-2374	174	5	oxford	oxford	PROPN
ajlm-2374	174	6	,	,	PUNCT
ajlm-2374	174	7	united	united	ADJ
ajlm-2374	174	8	kingdom	kingdom	PROPN
ajlm-2374	174	9	;	;	PUNCT
ajlm-2374	174	10	2006	2006	NUM
ajlm-2374	174	11	.	.	PUNCT
ajlm-2374	175	1	https://doi.org/10.1093/acprof:oso/9780195149616.001.0001	https://doi.org/10.1093/acprof:oso/9780195149616.001.0001	NUM
ajlm-2374	175	2	thun	thun	PROPN
ajlm-2374	175	3	m	m	PROPN
ajlm-2374	175	4	,	,	PUNCT
ajlm-2374	175	5	linet	linet	PROPN
ajlm-2374	175	6	ms	ms	PROPN
ajlm-2374	175	7	,	,	PUNCT
ajlm-2374	175	8	cerhan	cerhan	PROPN
ajlm-2374	175	9	jr	jr	PROPN
ajlm-2374	175	10	,	,	PUNCT
ajlm-2374	175	11	haiman	haiman	PROPN
ajlm-2374	175	12	ca	ca	PROPN
ajlm-2374	175	13	,	,	PUNCT
ajlm-2374	175	14	schottenfeld	schottenfeld	VERB
ajlm-2374	175	15	d.	d.	PROPN
ajlm-2374	175	16	cancer	cancer	PROPN
ajlm-2374	175	17	epidemiology	epidemiology	NOUN
ajlm-2374	175	18	and	and	CCONJ
ajlm-2374	175	19	prevention	prevention	NOUN
ajlm-2374	175	20	.	.	PUNCT
ajlm-2374	176	1	oxford	oxford	PROPN
ajlm-2374	176	2	university	university	PROPN
ajlm-2374	176	3	press	press	NOUN
ajlm-2374	176	4	:	:	PUNCT
ajlm-2374	176	5	oxford	oxford	PROPN
ajlm-2374	176	6	,	,	PUNCT
ajlm-2374	176	7	united	united	ADJ
ajlm-2374	176	8	kingdom	kingdom	PROPN
ajlm-2374	176	9	;	;	PUNCT
ajlm-2374	176	10	2017	2017	NUM
ajlm-2374	176	11	.	.	PUNCT
ajlm-2374	177	1	cohen	cohen	PROPN
ajlm-2374	177	2	pa	pa	PROPN
ajlm-2374	177	3	,	,	PUNCT
ajlm-2374	177	4	jhingran	jhingran	VERB
ajlm-2374	177	5	a	a	DET
ajlm-2374	177	6	,	,	PUNCT
ajlm-2374	177	7	oaknin	oaknin	PROPN
ajlm-2374	177	8	a	a	X
ajlm-2374	177	9	,	,	PUNCT
ajlm-2374	177	10	denny	denny	PROPN
ajlm-2374	177	11	l.	l.	PROPN
ajlm-2374	177	12	cervical	cervical	ADJ
ajlm-2374	177	13	cancer	cancer	NOUN
ajlm-2374	177	14	.	.	PUNCT
ajlm-2374	178	1	lancet	lancet	NOUN
ajlm-2374	178	2	.	.	PUNCT
ajlm-2374	179	1	2019;393(10167):169–182	2019;393(10167):169–182	X
ajlm-2374	179	2	.	.	PUNCT
ajlm-2374	180	1	https://doi.org/10.1016/s0140-6736(18)32470-x	https://doi.org/10.1016/s0140-6736(18)32470-x	VERB
ajlm-2374	180	2	ssedyabane	ssedyabane	PROPN
ajlm-2374	180	3	f	f	PROPN
ajlm-2374	180	4	,	,	PUNCT
ajlm-2374	180	5	ngonzi	ngonzi	PROPN
ajlm-2374	180	6	j	j	PROPN
ajlm-2374	180	7	,	,	PUNCT
ajlm-2374	180	8	kajabwangu	kajabwangu	ADJ
ajlm-2374	180	9	r	r	NOUN
ajlm-2374	180	10	,	,	PUNCT
ajlm-2374	180	11	najjuma	najjuma	PROPN
ajlm-2374	180	12	jn	jn	PROPN
ajlm-2374	180	13	,	,	PUNCT
ajlm-2374	180	14	tusubira	tusubira	PROPN
ajlm-2374	180	15	d	d	PROPN
ajlm-2374	180	16	,	,	PUNCT
ajlm-2374	180	17	randall	randall	PROPN
ajlm-2374	180	18	tc	tc	PROPN
ajlm-2374	180	19	.	.	PUNCT
ajlm-2374	180	20	association	association	NOUN
ajlm-2374	180	21	between	between	ADP
ajlm-2374	180	22	obesity	obesity	NOUN
ajlm-2374	180	23	and	and	CCONJ
ajlm-2374	180	24	cervical	cervical	ADJ
ajlm-2374	180	25	intraepithelial	intraepithelial	ADJ
ajlm-2374	180	26	neoplasia	neoplasia	NOUN
ajlm-2374	180	27	:	:	PUNCT
ajlm-2374	180	28	results	result	VERB
ajlm-2374	180	29	from	from	ADP
ajlm-2374	180	30	a	a	DET
ajlm-2374	180	31	case	case	NOUN
ajlm-2374	180	32	control	control	NOUN
ajlm-2374	180	33	study	study	NOUN
ajlm-2374	180	34	in	in	ADP
ajlm-2374	180	35	south	south	PROPN
ajlm-2374	180	36	western	western	PROPN
ajlm-2374	180	37	uganda	uganda	PROPN
ajlm-2374	180	38	.	.	PUNCT
ajlm-2374	181	1	bmc	bmc	PROPN
ajlm-2374	181	2	womens	womens	PROPN
ajlm-2374	181	3	health	health	NOUN
ajlm-2374	181	4	.	.	PUNCT
ajlm-2374	182	1	2023;23(1):1–8	2023;23(1):1–8	X
ajlm-2374	182	2	.	.	PUNCT
ajlm-2374	183	1	https://doi.org/10.1186/s12905-023-02315-1	https://doi.org/10.1186/s12905-023-02315-1	PROPN
ajlm-2374	183	2	ssedyabane	ssedyabane	PROPN
ajlm-2374	183	3	f	f	PROPN
ajlm-2374	183	4	,	,	PUNCT
ajlm-2374	183	5	randall	randall	PROPN
ajlm-2374	183	6	tc	tc	PROPN
ajlm-2374	183	7	,	,	PUNCT
ajlm-2374	183	8	tusubira	tusubira	PROPN
ajlm-2374	183	9	d	d	NOUN
ajlm-2374	183	10	,	,	PUNCT
ajlm-2374	183	11	et	et	PROPN
ajlm-2374	183	12	al	al	PROPN
ajlm-2374	183	13	.	.	PROPN
ajlm-2374	183	14	serum	serum	PROPN
ajlm-2374	183	15	lipids	lipids	PROPN
ajlm-2374	183	16	,	,	PUNCT
ajlm-2374	183	17	insulin	insulin	NOUN
ajlm-2374	183	18	-	-	PUNCT
ajlm-2374	183	19	like	like	ADJ
ajlm-2374	183	20	growth	growth	NOUN
ajlm-2374	183	21	factor	factor	NOUN
ajlm-2374	183	22	binding	bind	VERB
ajlm-2374	183	23	protein-3	protein-3	ADJ
ajlm-2374	183	24	and	and	CCONJ
ajlm-2374	183	25	treatment	treatment	NOUN
ajlm-2374	183	26	outcomes	outcome	NOUN
ajlm-2374	183	27	in	in	ADP
ajlm-2374	183	28	women	woman	NOUN
ajlm-2374	183	29	with	with	ADP
ajlm-2374	183	30	and	and	CCONJ
ajlm-2374	183	31	without	without	ADP
ajlm-2374	183	32	cervical	cervical	ADJ
ajlm-2374	183	33	lesions	lesion	NOUN
ajlm-2374	183	34	in	in	ADP
ajlm-2374	183	35	south	south	ADJ
ajlm-2374	183	36	western	western	ADJ
ajlm-2374	183	37	uganda	uganda	PROPN
ajlm-2374	183	38	:	:	PUNCT
ajlm-2374	183	39	a	a	DET
ajlm-2374	183	40	cohort	cohort	NOUN
ajlm-2374	183	41	study	study	NOUN
ajlm-2374	183	42	.	.	PUNCT
ajlm-2374	184	1	pathol	pathol	VERB
ajlm-2374	184	2	lab	lab	NOUN
ajlm-2374	184	3	med	med	ADJ
ajlm-2374	184	4	int	int	NOUN
ajlm-2374	184	5	.	.	PUNCT
ajlm-2374	185	1	2023;2023:91–105	2023;2023:91–105	NOUN
ajlm-2374	185	2	.	.	PUNCT
ajlm-2374	186	1	https://doi.org/10.2147/plmi.s447545	https://doi.org/10.2147/plmi.s447545	PROPN
ajlm-2374	186	2	agmon	agmon	PROPN
ajlm-2374	186	3	e	e	PROPN
ajlm-2374	186	4	,	,	PUNCT
ajlm-2374	186	5	stockwell	stockwell	PROPN
ajlm-2374	186	6	br	br	PROPN
ajlm-2374	186	7	.	.	PUNCT
ajlm-2374	186	8	lipid	lipid	NOUN
ajlm-2374	186	9	homeostasis	homeostasis	NOUN
ajlm-2374	186	10	and	and	CCONJ
ajlm-2374	186	11	regulated	regulated	ADJ
ajlm-2374	186	12	cell	cell	NOUN
ajlm-2374	186	13	death	death	NOUN
ajlm-2374	186	14	.	.	PUNCT
ajlm-2374	187	1	curr	curr	PROPN
ajlm-2374	187	2	opin	opin	NOUN
ajlm-2374	187	3	chem	chem	NOUN
ajlm-2374	187	4	biol	biol	NOUN
ajlm-2374	187	5	.	.	PUNCT
ajlm-2374	188	1	2017;39:83–89	2017;39:83–89	NUM
ajlm-2374	188	2	.	.	PUNCT
ajlm-2374	189	1	https://doi.org/10.1016/j.cbpa.2017.06.002	https://doi.org/10.1016/j.cbpa.2017.06.002	NOUN
ajlm-2374	189	2	huang	huang	PROPN
ajlm-2374	189	3	c	c	PROPN
ajlm-2374	189	4	,	,	PUNCT
ajlm-2374	189	5	freter	freter	PROPN
ajlm-2374	189	6	c.	c.	PROPN
ajlm-2374	189	7	lipid	lipid	PROPN
ajlm-2374	189	8	metabolism	metabolism	NOUN
ajlm-2374	189	9	,	,	PUNCT
ajlm-2374	189	10	apoptosis	apoptosis	NOUN
ajlm-2374	189	11	and	and	CCONJ
ajlm-2374	189	12	cancer	cancer	NOUN
ajlm-2374	189	13	therapy	therapy	NOUN
ajlm-2374	189	14	.	.	PUNCT
ajlm-2374	190	1	int	int	PROPN
ajlm-2374	190	2	j	j	PROPN
ajlm-2374	190	3	mol	mol	ADP
ajlm-2374	190	4	sci	sci	PROPN
ajlm-2374	190	5	.	.	PUNCT
ajlm-2374	191	1	2015;16(1):924–949	2015;16(1):924–949	X
ajlm-2374	191	2	.	.	PUNCT
ajlm-2374	191	3	https://doi.org/10.3390/ijms16010924	https://doi.org/10.3390/ijms16010924	PROPN
ajlm-2374	191	4	munir	munir	PROPN
ajlm-2374	191	5	r	r	PROPN
ajlm-2374	191	6	,	,	PUNCT
ajlm-2374	191	7	lisec	lisec	PROPN
ajlm-2374	191	8	j	j	PROPN
ajlm-2374	191	9	,	,	PUNCT
ajlm-2374	191	10	swinnen	swinnen	PROPN
ajlm-2374	191	11	jv	jv	PROPN
ajlm-2374	191	12	,	,	PUNCT
ajlm-2374	191	13	zaidi	zaidi	PROPN
ajlm-2374	191	14	n.	n.	PROPN
ajlm-2374	191	15	lipid	lipid	PROPN
ajlm-2374	191	16	metabolism	metabolism	NOUN
ajlm-2374	191	17	in	in	ADP
ajlm-2374	191	18	cancer	cancer	NOUN
ajlm-2374	191	19	cells	cell	NOUN
ajlm-2374	191	20	under	under	ADP
ajlm-2374	191	21	metabolic	metabolic	NOUN
ajlm-2374	191	22	stress	stress	NOUN
ajlm-2374	191	23	.	.	PUNCT
ajlm-2374	192	1	br	br	PROPN
ajlm-2374	192	2	j	j	PROPN
ajlm-2374	192	3	cancer	cancer	NOUN
ajlm-2374	192	4	.	.	PUNCT
ajlm-2374	193	1	2019;120(12):1090–1098	2019;120(12):1090–1098	NUM
ajlm-2374	193	2	.	.	PUNCT
ajlm-2374	194	1	https://doi.org/10.1038/s41416-019-0451-4	https://doi.org/10.1038/s41416-019-0451-4	NOUN
ajlm-2374	194	2	beloribi	beloribi	NOUN
ajlm-2374	194	3	-	-	PUNCT
ajlm-2374	194	4	djefaflia	djefaflia	NOUN
ajlm-2374	194	5	s	s	PART
ajlm-2374	194	6	,	,	PUNCT
ajlm-2374	194	7	vasseur	vasseur	PROPN
ajlm-2374	194	8	s	s	PROPN
ajlm-2374	194	9	,	,	PUNCT
ajlm-2374	194	10	guillaumond	guillaumond	PROPN
ajlm-2374	194	11	f.	f.	PROPN
ajlm-2374	194	12	lipid	lipid	PROPN
ajlm-2374	194	13	metabolic	metabolic	NOUN
ajlm-2374	194	14	reprogramming	reprogramme	VERB
ajlm-2374	194	15	in	in	ADP
ajlm-2374	194	16	cancer	cancer	NOUN
ajlm-2374	194	17	cells	cell	NOUN
ajlm-2374	194	18	.	.	PUNCT
ajlm-2374	195	1	oncogenesis	oncogenesis	NOUN
ajlm-2374	195	2	.	.	PUNCT
ajlm-2374	196	1	2016;5(1):e189	2016;5(1):e189	NOUN
ajlm-2374	196	2	.	.	PUNCT
ajlm-2374	197	1	https://doi.org/10.1038/oncsis.2015.49	https://doi.org/10.1038/oncsis.2015.49	PROPN
ajlm-2374	197	2	zhao	zhao	PROPN
ajlm-2374	197	3	y	y	PROPN
ajlm-2374	197	4	-	-	PUNCT
ajlm-2374	197	5	y	y	PROPN
ajlm-2374	197	6	,	,	PUNCT
ajlm-2374	197	7	miao	miao	NOUN
ajlm-2374	197	8	h	h	PROPN
ajlm-2374	197	9	,	,	PUNCT
ajlm-2374	197	10	cheng	cheng	PROPN
ajlm-2374	197	11	x	x	PROPN
ajlm-2374	197	12	-	-	PUNCT
ajlm-2374	197	13	l	l	PROPN
ajlm-2374	197	14	,	,	PUNCT
ajlm-2374	197	15	wei	wei	PROPN
ajlm-2374	197	16	f.	f.	PROPN
ajlm-2374	197	17	lipidomics	lipidomics	PROPN
ajlm-2374	197	18	:	:	PUNCT
ajlm-2374	197	19	novel	novel	NOUN
ajlm-2374	197	20	insight	insight	NOUN
ajlm-2374	197	21	into	into	ADP
ajlm-2374	197	22	the	the	DET
ajlm-2374	197	23	biochemical	biochemical	ADJ
ajlm-2374	197	24	mechanism	mechanism	NOUN
ajlm-2374	197	25	of	of	ADP
ajlm-2374	197	26	lipid	lipid	ADJ
ajlm-2374	197	27	metabolism	metabolism	NOUN
ajlm-2374	197	28	and	and	CCONJ
ajlm-2374	197	29	dysregulation	dysregulation	NOUN
ajlm-2374	197	30	-	-	PUNCT
ajlm-2374	197	31	associated	associate	VERB
ajlm-2374	197	32	disease	disease	NOUN
ajlm-2374	197	33	.	.	PUNCT
ajlm-2374	198	1	chem	chem	NOUN
ajlm-2374	198	2	biol	biol	PROPN
ajlm-2374	198	3	interact	interact	VERB
ajlm-2374	198	4	.	.	PUNCT
ajlm-2374	199	1	2015;240:220–238	2015;240:220–238	NUM
ajlm-2374	199	2	.	.	PUNCT
ajlm-2374	200	1	https://doi.org/10.1016/j.cbi.2015.09.005	https://doi.org/10.1016/j.cbi.2015.09.005	VERB
ajlm-2374	200	2	nam	nam	PROPN
ajlm-2374	200	3	m	m	PROPN
ajlm-2374	200	4	,	,	PUNCT
ajlm-2374	200	5	jung	jung	PROPN
ajlm-2374	200	6	y	y	PROPN
ajlm-2374	200	7	,	,	PUNCT
ajlm-2374	200	8	hwang	hwang	PROPN
ajlm-2374	200	9	g	g	PROPN
ajlm-2374	200	10	-	-	PUNCT
ajlm-2374	200	11	s.	s.	PROPN
ajlm-2374	200	12	a	a	DET
ajlm-2374	200	13	metabolomics	metabolomic	NOUN
ajlm-2374	200	14	-	-	PUNCT
ajlm-2374	200	15	driven	drive	VERB
ajlm-2374	200	16	approach	approach	NOUN
ajlm-2374	200	17	reveals	reveal	VERB
ajlm-2374	200	18	metabolic	metabolic	NOUN
ajlm-2374	200	19	responses	response	NOUN
ajlm-2374	200	20	and	and	CCONJ
ajlm-2374	200	21	mechanisms	mechanism	NOUN
ajlm-2374	200	22	in	in	ADP
ajlm-2374	200	23	the	the	DET
ajlm-2374	200	24	rat	rat	NOUN
ajlm-2374	200	25	heart	heart	NOUN
ajlm-2374	200	26	following	follow	VERB
ajlm-2374	200	27	myocardial	myocardial	ADJ
ajlm-2374	200	28	infarction	infarction	NOUN
ajlm-2374	200	29	.	.	PUNCT
ajlm-2374	201	1	int	int	NOUN
ajlm-2374	201	2	j	j	PROPN
ajlm-2374	201	3	cardiol	cardiol	NOUN
ajlm-2374	201	4	.	.	PUNCT
ajlm-2374	202	1	2017;227:239–246	2017;227:239–246	NUM
ajlm-2374	202	2	.	.	PUNCT
ajlm-2374	203	1	https://doi.org/10.1016/j.ijcard.2016.11.127	https://doi.org/10.1016/j.ijcard.2016.11.127	PROPN
ajlm-2374	203	2	nam	nam	PROPN
ajlm-2374	203	3	m	m	PROPN
ajlm-2374	203	4	,	,	PUNCT
ajlm-2374	203	5	choi	choi	PROPN
ajlm-2374	203	6	m	m	PROPN
ajlm-2374	203	7	-	-	PUNCT
ajlm-2374	203	8	s	s	PROPN
ajlm-2374	203	9	,	,	PUNCT
ajlm-2374	203	10	choi	choi	PROPN
ajlm-2374	203	11	j	j	PROPN
ajlm-2374	203	12	-	-	PROPN
ajlm-2374	203	13	y	y	PROPN
ajlm-2374	203	14	,	,	PUNCT
ajlm-2374	203	15	et	et	PROPN
ajlm-2374	203	16	al	al	PROPN
ajlm-2374	203	17	.	.	PROPN
ajlm-2374	203	18	effect	effect	NOUN
ajlm-2374	203	19	of	of	ADP
ajlm-2374	203	20	green	green	ADJ
ajlm-2374	203	21	tea	tea	NOUN
ajlm-2374	203	22	on	on	ADP
ajlm-2374	203	23	hepatic	hepatic	ADJ
ajlm-2374	203	24	lipid	lipid	NOUN
ajlm-2374	203	25	metabolism	metabolism	NOUN
ajlm-2374	203	26	in	in	ADP
ajlm-2374	203	27	mice	mouse	NOUN
ajlm-2374	203	28	fed	feed	VERB
ajlm-2374	203	29	a	a	DET
ajlm-2374	203	30	high	high	ADJ
ajlm-2374	203	31	-	-	PUNCT
ajlm-2374	203	32	fat	fat	NOUN
ajlm-2374	203	33	diet	diet	NOUN
ajlm-2374	203	34	.	.	PUNCT
ajlm-2374	204	1	j	j	PROPN
ajlm-2374	204	2	nutr	nutr	PROPN
ajlm-2374	204	3	biochem	biochem	PROPN
ajlm-2374	204	4	.	.	PUNCT
ajlm-2374	205	1	2018;51:1–7	2018;51:1–7	NUM
ajlm-2374	205	2	.	.	PUNCT
ajlm-2374	206	1	https://doi.org/10.1016/j.jnutbio.2017.09.002	https://doi.org/10.1016/j.jnutbio.2017.09.002	PROPN
ajlm-2374	206	2	nam	nam	PROPN
ajlm-2374	206	3	m	m	PROPN
ajlm-2374	206	4	,	,	PUNCT
ajlm-2374	206	5	seo	seo	PROPN
ajlm-2374	206	6	s	s	PROPN
ajlm-2374	206	7	-	-	PUNCT
ajlm-2374	206	8	s	s	PROPN
ajlm-2374	206	9	,	,	PUNCT
ajlm-2374	206	10	jung	jung	PROPN
ajlm-2374	206	11	s	s	PROPN
ajlm-2374	206	12	,	,	PUNCT
ajlm-2374	206	13	et	et	PROPN
ajlm-2374	206	14	al	al	PROPN
ajlm-2374	206	15	.	.	PROPN
ajlm-2374	207	1	comparable	comparable	ADJ
ajlm-2374	207	2	plasma	plasma	NOUN
ajlm-2374	207	3	lipid	lipid	NOUN
ajlm-2374	207	4	changes	change	NOUN
ajlm-2374	207	5	in	in	ADP
ajlm-2374	207	6	patients	patient	NOUN
ajlm-2374	207	7	with	with	ADP
ajlm-2374	207	8	high	high	ADJ
ajlm-2374	207	9	-	-	PUNCT
ajlm-2374	207	10	grade	grade	NOUN
ajlm-2374	207	11	cervical	cervical	ADJ
ajlm-2374	207	12	intraepithelial	intraepithelial	ADJ
ajlm-2374	207	13	neoplasia	neoplasia	NOUN
ajlm-2374	207	14	and	and	CCONJ
ajlm-2374	207	15	patients	patient	NOUN
ajlm-2374	207	16	with	with	ADP
ajlm-2374	207	17	cervical	cervical	ADJ
ajlm-2374	207	18	cancer	cancer	NOUN
ajlm-2374	207	19	.	.	PUNCT
ajlm-2374	208	1	j	j	PROPN
ajlm-2374	208	2	proteome	proteome	PROPN
ajlm-2374	208	3	res	re	NOUN
ajlm-2374	208	4	.	.	PUNCT
ajlm-2374	209	1	2020;20(1):740–750	2020;20(1):740–750	X
ajlm-2374	209	2	.	.	PUNCT
ajlm-2374	209	3	https://doi.org/10.1021/acs.jproteome.0c00640	https://doi.org/10.1021/acs.jproteome.0c00640	ADJ
ajlm-2374	209	4	koundouros	koundouro	NOUN
ajlm-2374	209	5	n	n	CCONJ
ajlm-2374	209	6	,	,	PUNCT
ajlm-2374	209	7	poulogiannis	poulogiannis	PROPN
ajlm-2374	209	8	g.	g.	NOUN
ajlm-2374	209	9	reprogramming	reprogramming	NOUN
ajlm-2374	209	10	of	of	ADP
ajlm-2374	209	11	fatty	fatty	NOUN
ajlm-2374	209	12	acid	acid	ADJ
ajlm-2374	209	13	metabolism	metabolism	NOUN
ajlm-2374	209	14	in	in	ADP
ajlm-2374	209	15	cancer	cancer	NOUN
ajlm-2374	209	16	.	.	PUNCT
ajlm-2374	210	1	br	br	PROPN
ajlm-2374	210	2	j	j	PROPN
ajlm-2374	210	3	cancer	cancer	NOUN
ajlm-2374	210	4	.	.	PUNCT
ajlm-2374	211	1	2020;122(1):4–22	2020;122(1):4–22	NUM
ajlm-2374	211	2	.	.	PUNCT
ajlm-2374	212	1	https://doi.org/10.1038/s41416-019-0650-z	https://doi.org/10.1038/s41416-019-0650-z	PROPN
ajlm-2374	212	2	jiang	jiang	PROPN
ajlm-2374	213	1	q	q	PROPN
ajlm-2374	213	2	,	,	PUNCT
ajlm-2374	213	3	wang	wang	PROPN
ajlm-2374	213	4	l	l	PROPN
ajlm-2374	213	5	,	,	PUNCT
ajlm-2374	213	6	jin	jin	PROPN
ajlm-2374	213	7	m	m	PROPN
ajlm-2374	213	8	,	,	PUNCT
ajlm-2374	213	9	shou	shou	PROPN
ajlm-2374	213	10	y	y	PROPN
ajlm-2374	213	11	,	,	PUNCT
ajlm-2374	213	12	zhu	zhu	PROPN
ajlm-2374	213	13	h	h	NOUN
ajlm-2374	213	14	,	,	PUNCT
ajlm-2374	213	15	li	li	PROPN
ajlm-2374	213	16	a.	a.	PROPN
ajlm-2374	213	17	the	the	DET
ajlm-2374	213	18	clinical	clinical	ADJ
ajlm-2374	213	19	value	value	NOUN
ajlm-2374	213	20	of	of	ADP
ajlm-2374	213	21	lipid	lipid	ADJ
ajlm-2374	213	22	abnormalities	abnormality	NOUN
ajlm-2374	213	23	in	in	ADP
ajlm-2374	213	24	early	early	ADJ
ajlm-2374	213	25	stage	stage	NOUN
ajlm-2374	213	26	cervical	cervical	ADJ
ajlm-2374	213	27	cancer	cancer	NOUN
ajlm-2374	213	28	.	.	PUNCT
ajlm-2374	214	1	int	int	PROPN
ajlm-2374	215	1	j	j	PROPN
ajlm-2374	215	2	gen	gen	PROPN
ajlm-2374	215	3	med	med	PROPN
ajlm-2374	215	4	.	.	PUNCT
ajlm-2374	216	1	2022;15:3903	2022;15:3903	NUM
ajlm-2374	216	2	.	.	PUNCT
ajlm-2374	217	1	https://doi.org/10.2147/ijgm.s352934	https://doi.org/10.2147/ijgm.s352934	PROPN
ajlm-2374	217	2	mwangi	mwangi	PROPN
ajlm-2374	217	3	gf	gf	PROPN
ajlm-2374	217	4	,	,	PUNCT
ajlm-2374	217	5	niyonzima	niyonzima	PROPN
ajlm-2374	217	6	n	n	CCONJ
ajlm-2374	217	7	,	,	PUNCT
ajlm-2374	217	8	atwine	atwine	ADJ
ajlm-2374	217	9	r	r	NOUN
ajlm-2374	217	10	,	,	PUNCT
ajlm-2374	217	11	tusubira	tusubira	PROPN
ajlm-2374	217	12	d	d	NOUN
ajlm-2374	217	13	,	,	PUNCT
ajlm-2374	217	14	mugyenyi	mugyenyi	PROPN
ajlm-2374	217	15	gr	gr	PROPN
ajlm-2374	217	16	,	,	PUNCT
ajlm-2374	217	17	ssedyabane	ssedyabane	PROPN
ajlm-2374	217	18	f.	f.	PROPN
ajlm-2374	217	19	dyslipidemia	dyslipidemia	PROPN
ajlm-2374	217	20	:	:	PUNCT
ajlm-2374	217	21	prevalence	prevalence	NOUN
ajlm-2374	217	22	and	and	CCONJ
ajlm-2374	217	23	association	association	NOUN
ajlm-2374	217	24	with	with	ADP
ajlm-2374	217	25	precancerous	precancerous	ADJ
ajlm-2374	217	26	and	and	CCONJ
ajlm-2374	217	27	cancerous	cancerous	ADJ
ajlm-2374	217	28	lesions	lesion	NOUN
ajlm-2374	217	29	of	of	ADP
ajlm-2374	217	30	the	the	DET
ajlm-2374	217	31	cervix	cervix	NOUN
ajlm-2374	217	32	;	;	PUNCT
ajlm-2374	217	33	a	a	DET
ajlm-2374	217	34	pilot	pilot	NOUN
ajlm-2374	217	35	study	study	NOUN
ajlm-2374	217	36	.	.	PUNCT
ajlm-2374	218	1	lipids	lipids	ADP
ajlm-2374	218	2	health	health	NOUN
ajlm-2374	218	3	dis	dis	PROPN
ajlm-2374	218	4	.	.	PUNCT
ajlm-2374	219	1	2024;23(1):3	2024;23(1):3	NUM
ajlm-2374	219	2	.	.	PUNCT
ajlm-2374	220	1	https://doi.org/10.1186/s12944-023-01997-8	https://doi.org/10.1186/s12944-023-01997-8	NUM
ajlm-2374	220	2	ahn	ahn	PROPN
ajlm-2374	220	3	hk	hk	PROPN
ajlm-2374	220	4	,	,	PUNCT
ajlm-2374	220	5	shin	shin	PROPN
ajlm-2374	220	6	jw	jw	PROPN
ajlm-2374	220	7	,	,	PUNCT
ajlm-2374	220	8	ahn	ahn	PROPN
ajlm-2374	220	9	hy	hy	PROPN
ajlm-2374	220	10	,	,	PUNCT
ajlm-2374	220	11	et	et	PROPN
ajlm-2374	220	12	al	al	PROPN
ajlm-2374	220	13	.	.	PROPN
ajlm-2374	220	14	metabolic	metabolic	NOUN
ajlm-2374	220	15	components	component	NOUN
ajlm-2374	220	16	and	and	CCONJ
ajlm-2374	220	17	recurrence	recurrence	NOUN
ajlm-2374	220	18	in	in	ADP
ajlm-2374	220	19	early	early	ADJ
ajlm-2374	220	20	-	-	PUNCT
ajlm-2374	220	21	stage	stage	NOUN
ajlm-2374	220	22	cervical	cervical	ADJ
ajlm-2374	220	23	cancer	cancer	NOUN
ajlm-2374	220	24	.	.	PUNCT
ajlm-2374	221	1	tumor	tumor	PROPN
ajlm-2374	221	2	biol	biol	PROPN
ajlm-2374	221	3	.	.	PUNCT
ajlm-2374	222	1	2015;36(3):2201–2207	2015;36(3):2201–2207	NOUN
ajlm-2374	222	2	.	.	PUNCT
ajlm-2374	223	1	https://doi.org/10.1007/s13277-014-2831-y	https://doi.org/10.1007/s13277-014-2831-y	PROPN
ajlm-2374	223	2	kim	kim	PROPN
ajlm-2374	223	3	m	m	PROPN
ajlm-2374	223	4	,	,	PUNCT
ajlm-2374	223	5	kim	kim	PROPN
ajlm-2374	223	6	i	i	PROPN
ajlm-2374	223	7	-	-	PUNCT
ajlm-2374	223	8	h	h	PROPN
ajlm-2374	223	9	,	,	PUNCT
ajlm-2374	223	10	lim	lim	PROPN
ajlm-2374	223	11	mk	mk	PROPN
ajlm-2374	223	12	,	,	PUNCT
ajlm-2374	223	13	kim	kim	PROPN
ajlm-2374	223	14	y	y	PROPN
ajlm-2374	223	15	,	,	PUNCT
ajlm-2374	223	16	park	park	PROPN
ajlm-2374	223	17	b.	b.	PROPN
ajlm-2374	223	18	increased	increase	VERB
ajlm-2374	223	19	prevalence	prevalence	NOUN
ajlm-2374	223	20	of	of	ADP
ajlm-2374	223	21	metabolic	metabolic	NOUN
ajlm-2374	223	22	syndrome	syndrome	NOUN
ajlm-2374	223	23	in	in	ADP
ajlm-2374	223	24	adult	adult	NOUN
ajlm-2374	223	25	cancer	cancer	NOUN
ajlm-2374	223	26	survivors	survivor	NOUN
ajlm-2374	223	27	:	:	PUNCT
ajlm-2374	223	28	asian	asian	ADJ
ajlm-2374	223	29	first	first	ADJ
ajlm-2374	223	30	report	report	NOUN
ajlm-2374	223	31	in	in	ADP
ajlm-2374	223	32	community	community	NOUN
ajlm-2374	223	33	setting	setting	NOUN
ajlm-2374	223	34	.	.	PUNCT
ajlm-2374	224	1	cancer	cancer	NOUN
ajlm-2374	224	2	epidemiol	epidemiol	PROPN
ajlm-2374	224	3	.	.	PUNCT
ajlm-2374	225	1	2019;58:130–136	2019;58:130–136	ADJ
ajlm-2374	225	2	.	.	PUNCT
ajlm-2374	226	1	https://doi.org/10.1016/j.canep.2018.12.006	https://doi.org/10.1016/j.canep.2018.12.006	NOUN
ajlm-2374	226	2	obsa	obsa	NOUN
ajlm-2374	226	3	ms	ms	NOUN
ajlm-2374	226	4	,	,	PUNCT
ajlm-2374	226	5	ataro	ataro	ADJ
ajlm-2374	226	6	g	g	NOUN
ajlm-2374	226	7	,	,	PUNCT
ajlm-2374	226	8	awoke	awake	VERB
ajlm-2374	226	9	n	n	CCONJ
ajlm-2374	226	10	,	,	PUNCT
ajlm-2374	226	11	et	et	PROPN
ajlm-2374	226	12	al	al	PROPN
ajlm-2374	226	13	.	.	PUNCT
ajlm-2374	227	1	determinants	determinant	NOUN
ajlm-2374	227	2	of	of	ADP
ajlm-2374	227	3	dyslipidemia	dyslipidemia	NOUN
ajlm-2374	227	4	in	in	ADP
ajlm-2374	227	5	africa	africa	PROPN
ajlm-2374	227	6	:	:	PUNCT
ajlm-2374	227	7	a	a	DET
ajlm-2374	227	8	systematic	systematic	ADJ
ajlm-2374	227	9	review	review	NOUN
ajlm-2374	227	10	and	and	CCONJ
ajlm-2374	227	11	meta	meta	ADJ
ajlm-2374	227	12	-	-	PUNCT
ajlm-2374	227	13	analysis	analysis	NOUN
ajlm-2374	227	14	.	.	PUNCT
ajlm-2374	228	1	front	front	PROPN
ajlm-2374	228	2	cardiovasc	cardiovasc	PROPN
ajlm-2374	228	3	med	me	VERB
ajlm-2374	228	4	.	.	PUNCT
ajlm-2374	229	1	2022;8:778891	2022;8:778891	NUM
ajlm-2374	229	2	.	.	PUNCT
ajlm-2374	230	1	https://doi.org/10.3389/fcvm.2021.778891	https://doi.org/10.3389/fcvm.2021.778891	PROPN
ajlm-2374	230	2	fleiss	fleiss	PROPN
ajlm-2374	230	3	jl	jl	PROPN
ajlm-2374	230	4	,	,	PUNCT
ajlm-2374	230	5	levin	levin	PROPN
ajlm-2374	230	6	b	b	PROPN
ajlm-2374	230	7	,	,	PUNCT
ajlm-2374	230	8	paik	paik	PROPN
ajlm-2374	230	9	mc	mc	PROPN
ajlm-2374	230	10	.	.	PROPN
ajlm-2374	230	11	statistical	statistical	ADJ
ajlm-2374	230	12	methods	method	NOUN
ajlm-2374	230	13	for	for	ADP
ajlm-2374	230	14	rates	rate	NOUN
ajlm-2374	230	15	and	and	CCONJ
ajlm-2374	230	16	proportions	proportion	NOUN
ajlm-2374	230	17	.	.	PUNCT
ajlm-2374	231	1	john	john	PROPN
ajlm-2374	231	2	wiley	wiley	PROPN
ajlm-2374	231	3	&	&	CCONJ
ajlm-2374	231	4	sons	sons	PROPN
ajlm-2374	231	5	:	:	PUNCT
ajlm-2374	231	6	hoboken	hoboken	PROPN
ajlm-2374	231	7	,	,	PUNCT
ajlm-2374	231	8	new	new	PROPN
ajlm-2374	231	9	jersey	jersey	PROPN
ajlm-2374	231	10	,	,	PUNCT
ajlm-2374	231	11	united	united	PROPN
ajlm-2374	231	12	states	states	PROPN
ajlm-2374	231	13	;	;	PUNCT
ajlm-2374	231	14	2013	2013	NUM
ajlm-2374	231	15	.	.	PUNCT
ajlm-2374	232	1	cheung	cheung	PROPN
ajlm-2374	232	2	yb	yb	PROPN
ajlm-2374	232	3	,	,	PUNCT
ajlm-2374	232	4	ma	ma	PROPN
ajlm-2374	232	5	x	x	PROPN
ajlm-2374	232	6	,	,	PUNCT
ajlm-2374	232	7	lam	lam	PROPN
ajlm-2374	232	8	k	k	PROPN
ajlm-2374	232	9	,	,	PUNCT
ajlm-2374	232	10	li	li	PROPN
ajlm-2374	232	11	j	j	PROPN
ajlm-2374	232	12	,	,	PUNCT
ajlm-2374	232	13	milligan	milligan	PROPN
ajlm-2374	232	14	p.	p.	NOUN
ajlm-2374	232	15	bias	bias	PROPN
ajlm-2374	232	16	control	control	NOUN
ajlm-2374	232	17	in	in	ADP
ajlm-2374	232	18	the	the	DET
ajlm-2374	232	19	analysis	analysis	NOUN
ajlm-2374	232	20	of	of	ADP
ajlm-2374	232	21	case	case	NOUN
ajlm-2374	232	22	–	–	PUNCT
ajlm-2374	232	23	control	control	NOUN
ajlm-2374	232	24	studies	study	NOUN
ajlm-2374	232	25	with	with	ADP
ajlm-2374	232	26	incidence	incidence	ADJ
ajlm-2374	232	27	density	density	NOUN
ajlm-2374	232	28	sampling	sample	VERB
ajlm-2374	232	29	.	.	PUNCT
ajlm-2374	233	1	int	int	NOUN
ajlm-2374	233	2	j	j	PROPN
ajlm-2374	233	3	epidemiol	epidemiol	PROPN
ajlm-2374	233	4	.	.	PUNCT
ajlm-2374	234	1	2019;48(6):1981–1991	2019;48(6):1981–1991	NUM
ajlm-2374	234	2	.	.	PUNCT
ajlm-2374	235	1	https://doi.org/10.1093/ije/dyz116	https://doi.org/10.1093/ije/dyz116	PROPN
ajlm-2374	235	2	fedder	fedder	NOUN
ajlm-2374	235	3	do	do	VERB
ajlm-2374	235	4	,	,	PUNCT
ajlm-2374	235	5	koro	koro	PROPN
ajlm-2374	235	6	ce	ce	PROPN
ajlm-2374	235	7	,	,	PUNCT
ajlm-2374	235	8	l’italien	l’italien	PROPN
ajlm-2374	235	9	gj	gj	PROPN
ajlm-2374	235	10	.	.	PUNCT
ajlm-2374	236	1	new	new	ADJ
ajlm-2374	236	2	national	national	ADJ
ajlm-2374	236	3	cholesterol	cholesterol	PROPN
ajlm-2374	236	4	education	education	PROPN
ajlm-2374	236	5	program	program	NOUN
ajlm-2374	236	6	iii	iii	NUM
ajlm-2374	236	7	guidelines	guideline	NOUN
ajlm-2374	236	8	for	for	ADP
ajlm-2374	236	9	primary	primary	ADJ
ajlm-2374	236	10	prevention	prevention	NOUN
ajlm-2374	236	11	lipid	lipid	NOUN
ajlm-2374	236	12	-	-	PUNCT
ajlm-2374	236	13	lowering	lower	VERB
ajlm-2374	236	14	drug	drug	NOUN
ajlm-2374	236	15	therapy	therapy	NOUN
ajlm-2374	236	16	:	:	PUNCT
ajlm-2374	236	17	projected	project	VERB
ajlm-2374	236	18	impact	impact	NOUN
ajlm-2374	236	19	on	on	ADP
ajlm-2374	236	20	the	the	DET
ajlm-2374	236	21	size	size	NOUN
ajlm-2374	236	22	,	,	PUNCT
ajlm-2374	236	23	sex	sex	NOUN
ajlm-2374	236	24	,	,	PUNCT
ajlm-2374	236	25	and	and	CCONJ
ajlm-2374	236	26	age	age	NOUN
ajlm-2374	236	27	distribution	distribution	NOUN
ajlm-2374	236	28	of	of	ADP
ajlm-2374	236	29	the	the	DET
ajlm-2374	236	30	treatment	treatment	NOUN
ajlm-2374	236	31	-	-	PUNCT
ajlm-2374	236	32	eligible	eligible	ADJ
ajlm-2374	236	33	population	population	NOUN
ajlm-2374	236	34	.	.	PUNCT
ajlm-2374	237	1	circulation	circulation	NOUN
ajlm-2374	237	2	.	.	PUNCT
ajlm-2374	238	1	2002;105(2):152–156	2002;105(2):152–156	NUM
ajlm-2374	238	2	.	.	PUNCT
ajlm-2374	239	1	https://doi.org/10.1161/hc0202.101971	https://doi.org/10.1161/hc0202.101971	PROPN
ajlm-2374	239	2	nayar	nayar	PROPN
ajlm-2374	239	3	r	r	PROPN
ajlm-2374	239	4	,	,	PUNCT
ajlm-2374	239	5	wilbur	wilbur	PROPN
ajlm-2374	239	6	dc	dc	PROPN
ajlm-2374	239	7	.	.	PUNCT
ajlm-2374	240	1	the	the	DET
ajlm-2374	240	2	bethesda	bethesda	NOUN
ajlm-2374	240	3	system	system	NOUN
ajlm-2374	240	4	for	for	ADP
ajlm-2374	240	5	reporting	report	VERB
ajlm-2374	240	6	cervical	cervical	ADJ
ajlm-2374	240	7	cytology	cytology	NOUN
ajlm-2374	240	8	:	:	PUNCT
ajlm-2374	240	9	definitions	definition	NOUN
ajlm-2374	240	10	,	,	PUNCT
ajlm-2374	240	11	criteria	criterion	NOUN
ajlm-2374	240	12	,	,	PUNCT
ajlm-2374	240	13	and	and	CCONJ
ajlm-2374	240	14	explanatory	explanatory	ADJ
ajlm-2374	240	15	notes	note	NOUN
ajlm-2374	240	16	:	:	PUNCT
ajlm-2374	240	17	springer	springer	NOUN
ajlm-2374	240	18	.	.	PUNCT
ajlm-2374	241	1	international	international	ADJ
ajlm-2374	241	2	publishing	publishing	NOUN
ajlm-2374	241	3	:	:	PUNCT
ajlm-2374	241	4	cham	cham	PROPN
ajlm-2374	241	5	;	;	PUNCT
ajlm-2374	241	6	2015	2015	NUM
ajlm-2374	241	7	.	.	PUNCT
ajlm-2374	242	1	kopin	kopin	PROPN
ajlm-2374	242	2	l	l	PROPN
ajlm-2374	242	3	,	,	PUNCT
ajlm-2374	242	4	lowenstein	lowenstein	PROPN
ajlm-2374	242	5	cj	cj	PROPN
ajlm-2374	242	6	.	.	PUNCT
ajlm-2374	243	1	dyslipidemia	dyslipidemia	NOUN
ajlm-2374	243	2	.	.	PUNCT
ajlm-2374	244	1	ann	ann	PROPN
ajlm-2374	244	2	intern	intern	PROPN
ajlm-2374	244	3	med	me	VERB
ajlm-2374	244	4	.	.	PUNCT
ajlm-2374	245	1	2017;167(11):itc81	2017;167(11):itc81	NUM
ajlm-2374	245	2	–	–	PUNCT
ajlm-2374	245	3	itc96	itc96	ADJ
ajlm-2374	245	4	.	.	PUNCT
ajlm-2374	246	1	https://doi.org/10.7326/aitc201712050	https://doi.org/10.7326/aitc201712050	PROPN
ajlm-2374	246	2	garvey	garvey	PROPN
ajlm-2374	246	3	wt	wt	PROPN
ajlm-2374	246	4	,	,	PUNCT
ajlm-2374	246	5	mechanick	mechanick	ADJ
ajlm-2374	246	6	ji	ji	PROPN
ajlm-2374	246	7	.	.	PROPN
ajlm-2374	246	8	proposal	proposal	NOUN
ajlm-2374	246	9	for	for	ADP
ajlm-2374	246	10	a	a	DET
ajlm-2374	246	11	scientifically	scientifically	ADV
ajlm-2374	246	12	correct	correct	ADJ
ajlm-2374	246	13	and	and	CCONJ
ajlm-2374	246	14	medically	medically	ADV
ajlm-2374	246	15	actionable	actionable	ADJ
ajlm-2374	246	16	disease	disease	NOUN
ajlm-2374	246	17	classification	classification	NOUN
ajlm-2374	246	18	system	system	NOUN
ajlm-2374	246	19	(	(	PUNCT
ajlm-2374	246	20	icd	icd	NOUN
ajlm-2374	246	21	)	)	PUNCT
ajlm-2374	246	22	for	for	ADP
ajlm-2374	246	23	obesity	obesity	NOUN
ajlm-2374	246	24	.	.	PUNCT
ajlm-2374	247	1	obesity	obesity	NOUN
ajlm-2374	247	2	.	.	PUNCT
ajlm-2374	248	1	2020;28(3):484–492	2020;28(3):484–492	X
ajlm-2374	248	2	.	.	PUNCT
ajlm-2374	249	1	https://doi.org/10.1002/oby.22727	https://doi.org/10.1002/oby.22727	PROPN
ajlm-2374	249	2	cohen	cohen	PROPN
ajlm-2374	249	3	ss	ss	PROPN
ajlm-2374	249	4	,	,	PUNCT
ajlm-2374	249	5	park	park	PROPN
ajlm-2374	249	6	y	y	PROPN
ajlm-2374	249	7	,	,	PUNCT
ajlm-2374	249	8	signorello	signorello	PROPN
ajlm-2374	249	9	lb	lb	PROPN
ajlm-2374	249	10	,	,	PUNCT
ajlm-2374	249	11	et	et	PROPN
ajlm-2374	249	12	al	al	PROPN
ajlm-2374	249	13	.	.	PUNCT
ajlm-2374	250	1	a	a	DET
ajlm-2374	250	2	pooled	pooled	ADJ
ajlm-2374	250	3	analysis	analysis	NOUN
ajlm-2374	250	4	of	of	ADP
ajlm-2374	250	5	body	body	NOUN
ajlm-2374	250	6	mass	mass	NOUN
ajlm-2374	250	7	index	index	NOUN
ajlm-2374	250	8	and	and	CCONJ
ajlm-2374	250	9	mortality	mortality	NOUN
ajlm-2374	250	10	among	among	ADP
ajlm-2374	250	11	african	african	ADJ
ajlm-2374	250	12	americans	americans	PROPN
ajlm-2374	250	13	.	.	PUNCT
ajlm-2374	251	1	plos	plos	PROPN
ajlm-2374	251	2	one	one	NUM
ajlm-2374	251	3	.	.	PUNCT
ajlm-2374	252	1	2014;9(11):e111980	2014;9(11):e111980	PROPN
ajlm-2374	252	2	.	.	PUNCT
ajlm-2374	253	1	krupp	krupp	PROPN
ajlm-2374	253	2	k	k	PROPN
ajlm-2374	253	3	,	,	PUNCT
ajlm-2374	253	4	adsul	adsul	PROPN
ajlm-2374	253	5	p	p	PROPN
ajlm-2374	253	6	,	,	PUNCT
ajlm-2374	253	7	wilcox	wilcox	PROPN
ajlm-2374	253	8	ml	ml	PROPN
ajlm-2374	253	9	,	,	PUNCT
ajlm-2374	253	10	et	et	PROPN
ajlm-2374	253	11	al	al	PROPN
ajlm-2374	253	12	.	.	PUNCT
ajlm-2374	253	13	prevalence	prevalence	NOUN
ajlm-2374	253	14	and	and	CCONJ
ajlm-2374	253	15	correlates	correlate	VERB
ajlm-2374	253	16	of	of	ADP
ajlm-2374	253	17	metabolic	metabolic	NOUN
ajlm-2374	253	18	syndrome	syndrome	NOUN
ajlm-2374	253	19	among	among	ADP
ajlm-2374	253	20	rural	rural	ADJ
ajlm-2374	253	21	women	woman	NOUN
ajlm-2374	253	22	in	in	ADP
ajlm-2374	253	23	mysore	mysore	PROPN
ajlm-2374	253	24	,	,	PUNCT
ajlm-2374	253	25	india	india	PROPN
ajlm-2374	253	26	.	.	PUNCT
ajlm-2374	254	1	indian	indian	PROPN
ajlm-2374	254	2	heart	heart	NOUN
ajlm-2374	254	3	j.	j.	PROPN
ajlm-2374	254	4	2020;72(6):582–588	2020;72(6):582–588	PROPN
ajlm-2374	254	5	.	.	PUNCT
ajlm-2374	255	1	https://doi.org/10.1016/j.ihj.2020.09.015	https://doi.org/10.1016/j.ihj.2020.09.015	PROPN
ajlm-2374	255	2	omodanisi	omodanisi	PROPN
ajlm-2374	255	3	ei	ei	PROPN
ajlm-2374	255	4	,	,	PUNCT
ajlm-2374	255	5	tomose	tomose	NOUN
ajlm-2374	255	6	y	y	NOUN
ajlm-2374	255	7	,	,	PUNCT
ajlm-2374	255	8	okeleye	okeleye	NOUN
ajlm-2374	255	9	bi	bi	NOUN
ajlm-2374	255	10	,	,	PUNCT
ajlm-2374	255	11	ntwampe	ntwampe	PROPN
ajlm-2374	255	12	sk	sk	VERB
ajlm-2374	255	13	,	,	PUNCT
ajlm-2374	255	14	aboua	aboua	PROPN
ajlm-2374	255	15	yg	yg	PROPN
ajlm-2374	255	16	.	.	PUNCT
ajlm-2374	256	1	prevalence	prevalence	NOUN
ajlm-2374	256	2	of	of	ADP
ajlm-2374	256	3	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	256	4	among	among	ADP
ajlm-2374	256	5	type	type	NOUN
ajlm-2374	256	6	2	2	NUM
ajlm-2374	256	7	diabetes	diabetes	NOUN
ajlm-2374	256	8	mellitus	mellitus	NOUN
ajlm-2374	256	9	patients	patient	NOUN
ajlm-2374	256	10	in	in	ADP
ajlm-2374	256	11	the	the	DET
ajlm-2374	256	12	western	western	ADJ
ajlm-2374	256	13	cape	cape	NOUN
ajlm-2374	256	14	,	,	PUNCT
ajlm-2374	256	15	south	south	PROPN
ajlm-2374	256	16	africa	africa	PROPN
ajlm-2374	256	17	.	.	PUNCT
ajlm-2374	257	1	int	int	PROPN
ajlm-2374	258	1	j	j	PROPN
ajlm-2374	258	2	environ	environ	PROPN
ajlm-2374	258	3	res	re	VERB
ajlm-2374	258	4	public	public	ADJ
ajlm-2374	258	5	health	health	NOUN
ajlm-2374	258	6	.	.	PUNCT
ajlm-2374	259	1	2020;17(23):8735	2020;17(23):8735	NUM
ajlm-2374	259	2	.	.	PUNCT
ajlm-2374	259	3	https://doi.org/10.3390/ijerph17238735	https://doi.org/10.3390/ijerph17238735	NOUN
ajlm-2374	259	4	oldewage	oldewage	PROPN
ajlm-2374	259	5	-	-	PUNCT
ajlm-2374	259	6	theron	theron	PROPN
ajlm-2374	259	7	wh	wh	PROPN
ajlm-2374	259	8	,	,	PUNCT
ajlm-2374	259	9	egal	egal	PROPN
ajlm-2374	259	10	a.	a.	NOUN
ajlm-2374	259	11	prevalence	prevalence	NOUN
ajlm-2374	259	12	of	of	ADP
ajlm-2374	259	13	and	and	CCONJ
ajlm-2374	259	14	contributing	contribute	VERB
ajlm-2374	259	15	factors	factor	NOUN
ajlm-2374	259	16	to	to	PART
ajlm-2374	259	17	dyslipidaemia	dyslipidaemia	VERB
ajlm-2374	259	18	in	in	ADP
ajlm-2374	259	19	low	low	ADJ
ajlm-2374	259	20	-	-	PUNCT
ajlm-2374	259	21	income	income	NOUN
ajlm-2374	259	22	women	woman	NOUN
ajlm-2374	259	23	aged	age	VERB
ajlm-2374	259	24	18	18	NUM
ajlm-2374	259	25	-	-	SYM
ajlm-2374	259	26	90	90	NUM
ajlm-2374	259	27	years	year	NOUN
ajlm-2374	259	28	in	in	ADP
ajlm-2374	259	29	the	the	DET
ajlm-2374	259	30	peri	peri	NOUN
ajlm-2374	259	31	-	-	PUNCT
ajlm-2374	259	32	urban	urban	ADJ
ajlm-2374	259	33	vaal	vaal	NOUN
ajlm-2374	259	34	region	region	NOUN
ajlm-2374	259	35	.	.	PUNCT
ajlm-2374	260	1	s	s	PROPN
ajlm-2374	260	2	afr	afr	PROPN
ajlm-2374	260	3	j	j	PROPN
ajlm-2374	260	4	clin	clin	PROPN
ajlm-2374	260	5	nutr	nutr	PROPN
ajlm-2374	260	6	.	.	PUNCT
ajlm-2374	261	1	2013;26(1):23–29	2013;26(1):23–29	PROPN
ajlm-2374	261	2	.	.	PUNCT
ajlm-2374	262	1	https://doi.org/10.1080/16070658.2013.11734436	https://doi.org/10.1080/16070658.2013.11734436	PROPN
ajlm-2374	262	2	noubiap	noubiap	PROPN
ajlm-2374	262	3	jj	jj	PROPN
ajlm-2374	262	4	,	,	PUNCT
ajlm-2374	262	5	bigna	bigna	PROPN
ajlm-2374	262	6	jj	jj	PROPN
ajlm-2374	262	7	,	,	PUNCT
ajlm-2374	262	8	nansseu	nansseu	PROPN
ajlm-2374	262	9	jr	jr	PROPN
ajlm-2374	262	10	,	,	PUNCT
ajlm-2374	262	11	et	et	PROPN
ajlm-2374	262	12	al	al	PROPN
ajlm-2374	262	13	.	.	PUNCT
ajlm-2374	263	1	prevalence	prevalence	NOUN
ajlm-2374	263	2	of	of	ADP
ajlm-2374	263	3	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2374	263	4	among	among	ADP
ajlm-2374	263	5	adults	adult	NOUN
ajlm-2374	263	6	in	in	ADP
ajlm-2374	263	7	africa	africa	PROPN
ajlm-2374	263	8	:	:	PUNCT
ajlm-2374	263	9	a	a	DET
ajlm-2374	263	10	systematic	systematic	ADJ
ajlm-2374	263	11	review	review	NOUN
ajlm-2374	263	12	and	and	CCONJ
ajlm-2374	263	13	meta	meta	ADJ
ajlm-2374	263	14	-	-	PUNCT
ajlm-2374	263	15	analysis	analysis	NOUN
ajlm-2374	263	16	.	.	PUNCT
ajlm-2374	264	1	lancet	lancet	NOUN
ajlm-2374	264	2	glob	glob	PROPN
ajlm-2374	264	3	health	health	NOUN
ajlm-2374	264	4	.	.	PUNCT
ajlm-2374	265	1	2018;6(9):e998	2018;6(9):e998	NOUN
ajlm-2374	265	2	–	–	PUNCT
ajlm-2374	265	3	e1007	e1007	PROPN
ajlm-2374	265	4	.	.	PROPN
ajlm-2374	265	5	https://doi.org/10.1016/s2214-109x(18)30275-4	https://doi.org/10.1016/s2214-109x(18)30275-4	PROPN
ajlm-2374	265	6	frontela	frontela	PROPN
ajlm-2374	265	7	-	-	PUNCT
ajlm-2374	265	8	noda	noda	PROPN
ajlm-2374	265	9	m	m	PROPN
ajlm-2374	265	10	,	,	PUNCT
ajlm-2374	265	11	delgado	delgado	NOUN
ajlm-2374	265	12	-	-	PUNCT
ajlm-2374	265	13	herrera	herrera	PROPN
ajlm-2374	265	14	dc	dc	PROPN
ajlm-2374	265	15	,	,	PUNCT
ajlm-2374	265	16	cabrera	cabrera	NOUN
ajlm-2374	265	17	-	-	PUNCT
ajlm-2374	265	18	rode	rode	NOUN
ajlm-2374	265	19	e	e	NOUN
ajlm-2374	265	20	,	,	PUNCT
ajlm-2374	265	21	et	et	PROPN
ajlm-2374	265	22	al	al	PROPN
ajlm-2374	265	23	.	.	PROPN
ajlm-2374	265	24	association	association	PROPN
ajlm-2374	265	25	between	between	ADP
ajlm-2374	265	26	components	component	NOUN
ajlm-2374	265	27	of	of	ADP
ajlm-2374	265	28	the	the	DET
ajlm-2374	265	29	metabolic	metabolic	NOUN
ajlm-2374	265	30	syndrome	syndrome	NOUN
ajlm-2374	265	31	and	and	CCONJ
ajlm-2374	265	32	degree	degree	NOUN
ajlm-2374	265	33	of	of	ADP
ajlm-2374	265	34	cervical	cervical	ADJ
ajlm-2374	265	35	squamous	squamous	ADJ
ajlm-2374	265	36	intraepithelial	intraepithelial	ADJ
ajlm-2374	265	37	lesions	lesion	NOUN
ajlm-2374	265	38	in	in	ADP
ajlm-2374	265	39	cuban	cuban	ADJ
ajlm-2374	265	40	women	woman	NOUN
ajlm-2374	265	41	.	.	PUNCT
ajlm-2374	266	1	diabetes	diabetes	VERB
ajlm-2374	266	2	metab	metab	ADJ
ajlm-2374	266	3	syndr	syndr	NOUN
ajlm-2374	266	4	.	.	PUNCT
ajlm-2374	267	1	2019;13(2):1443–1448	2019;13(2):1443–1448	PUNCT
ajlm-2374	267	2	.	.	PUNCT
ajlm-2374	268	1	https://doi.org/10.1016/j.dsx.2019.02.011	https://doi.org/10.1016/j.dsx.2019.02.011	PROPN
ajlm-2374	268	2	penaranda	penaranda	PROPN
ajlm-2374	268	3	ek	ek	PROPN
ajlm-2374	268	4	,	,	PUNCT
ajlm-2374	268	5	shokar	shokar	NOUN
ajlm-2374	268	6	n	n	CCONJ
ajlm-2374	268	7	,	,	PUNCT
ajlm-2374	268	8	ortiz	ortiz	PROPN
ajlm-2374	268	9	m.	m.	NOUN
ajlm-2374	268	10	relationship	relationship	NOUN
ajlm-2374	268	11	between	between	ADP
ajlm-2374	268	12	metabolic	metabolic	NOUN
ajlm-2374	268	13	syndrome	syndrome	NOUN
ajlm-2374	268	14	and	and	CCONJ
ajlm-2374	268	15	history	history	NOUN
ajlm-2374	268	16	of	of	ADP
ajlm-2374	268	17	cervical	cervical	ADJ
ajlm-2374	268	18	cancer	cancer	NOUN
ajlm-2374	268	19	among	among	ADP
ajlm-2374	268	20	a	a	DET
ajlm-2374	268	21	us	us	PROPN
ajlm-2374	268	22	national	national	ADJ
ajlm-2374	268	23	population	population	NOUN
ajlm-2374	268	24	.	.	PUNCT
ajlm-2374	269	1	isrn	isrn	PROPN
ajlm-2374	269	2	oncol	oncol	ADJ
ajlm-2374	269	3	.	.	PUNCT
ajlm-2374	270	1	2013;2013:840964	2013;2013:840964	NUM
ajlm-2374	270	2	.	.	PUNCT
ajlm-2374	271	1	https://doi.org/10.1155/2013/840964	https://doi.org/10.1155/2013/840964	PROPN
ajlm-2374	271	2	ulmer	ulmer	PROPN
ajlm-2374	271	3	h	h	PROPN
ajlm-2374	271	4	,	,	PUNCT
ajlm-2374	271	5	borena	borena	ADJ
ajlm-2374	271	6	w	w	PROPN
ajlm-2374	271	7	,	,	PUNCT
ajlm-2374	271	8	rapp	rapp	PROPN
ajlm-2374	271	9	k	k	PROPN
ajlm-2374	271	10	,	,	PUNCT
ajlm-2374	271	11	et	et	PROPN
ajlm-2374	271	12	al	al	PROPN
ajlm-2374	271	13	.	.	PROPN
ajlm-2374	271	14	serum	serum	PROPN
ajlm-2374	271	15	triglyceride	triglyceride	PROPN
ajlm-2374	271	16	concentrations	concentration	NOUN
ajlm-2374	271	17	and	and	CCONJ
ajlm-2374	271	18	cancer	cancer	NOUN
ajlm-2374	271	19	risk	risk	NOUN
ajlm-2374	271	20	in	in	ADP
ajlm-2374	271	21	a	a	DET
ajlm-2374	271	22	large	large	ADJ
ajlm-2374	271	23	cohort	cohort	NOUN
ajlm-2374	271	24	study	study	NOUN
ajlm-2374	271	25	in	in	ADP
ajlm-2374	271	26	austria	austria	PROPN
ajlm-2374	271	27	.	.	PUNCT
ajlm-2374	272	1	br	br	PROPN
ajlm-2374	272	2	j	j	PROPN
ajlm-2374	272	3	cancer	cancer	NOUN
ajlm-2374	272	4	.	.	PUNCT
ajlm-2374	273	1	2009;101(7):1202–1206	2009;101(7):1202–1206	NUM
ajlm-2374	273	2	.	.	NOUN
ajlm-2374	273	3	https://doi.org/10.1038/sj.bjc.6605264	https://doi.org/10.1038/sj.bjc.6605264	PROPN
ajlm-2374	273	4	tulinius	tulinius	PROPN
ajlm-2374	273	5	h	h	PROPN
ajlm-2374	273	6	,	,	PUNCT
ajlm-2374	273	7	sigfússon	sigfússon	NOUN
ajlm-2374	273	8	n	n	PROPN
ajlm-2374	273	9	,	,	PUNCT
ajlm-2374	273	10	sigvaldason	sigvaldason	PROPN
ajlm-2374	273	11	h	h	PROPN
ajlm-2374	273	12	,	,	PUNCT
ajlm-2374	273	13	bjarnadóttir	bjarnadóttir	ADP
ajlm-2374	273	14	k	k	PROPN
ajlm-2374	273	15	,	,	PUNCT
ajlm-2374	273	16	tryggvadottir	tryggvadottir	PROPN
ajlm-2374	273	17	l.	l.	PROPN
ajlm-2374	273	18	risk	risk	NOUN
ajlm-2374	273	19	factors	factor	NOUN
ajlm-2374	273	20	for	for	ADP
ajlm-2374	273	21	malignant	malignant	ADJ
ajlm-2374	273	22	diseases	disease	NOUN
ajlm-2374	273	23	:	:	PUNCT
ajlm-2374	273	24	a	a	DET
ajlm-2374	273	25	cohort	cohort	NOUN
ajlm-2374	273	26	study	study	NOUN
ajlm-2374	273	27	on	on	ADP
ajlm-2374	273	28	a	a	DET
ajlm-2374	273	29	population	population	NOUN
ajlm-2374	273	30	of	of	ADP
ajlm-2374	273	31	22,946	22,946	NUM
ajlm-2374	273	32	icelanders	icelanders	PROPN
ajlm-2374	273	33	.	.	PUNCT
ajlm-2374	274	1	cancer	cancer	NOUN
ajlm-2374	274	2	epidemiol	epidemiol	PROPN
ajlm-2374	274	3	biomarkers	biomarkers	PROPN
ajlm-2374	274	4	prev	prev	X
ajlm-2374	274	5	.	.	PUNCT
ajlm-2374	275	1	1997;6(11):863–873	1997;6(11):863–873	NUM
ajlm-2374	275	2	.	.	PUNCT
ajlm-2374	276	1	trabert	trabert	PROPN
ajlm-2374	276	2	b	b	PROPN
ajlm-2374	276	3	,	,	PUNCT
ajlm-2374	276	4	wentzensen	wentzensen	PROPN
ajlm-2374	276	5	n	n	CCONJ
ajlm-2374	276	6	,	,	PUNCT
ajlm-2374	276	7	felix	felix	PROPN
ajlm-2374	276	8	as	as	ADP
ajlm-2374	276	9	,	,	PUNCT
ajlm-2374	276	10	et	et	PROPN
ajlm-2374	276	11	al	al	PROPN
ajlm-2374	276	12	.	.	PROPN
ajlm-2374	276	13	metabolic	metabolic	PROPN
ajlm-2374	276	14	syndrome	syndrome	NOUN
ajlm-2374	276	15	and	and	CCONJ
ajlm-2374	276	16	risk	risk	NOUN
ajlm-2374	276	17	of	of	ADP
ajlm-2374	276	18	endometrial	endometrial	ADJ
ajlm-2374	276	19	cancer	cancer	NOUN
ajlm-2374	276	20	in	in	ADP
ajlm-2374	276	21	the	the	DET
ajlm-2374	276	22	united	united	PROPN
ajlm-2374	276	23	states	states	PROPN
ajlm-2374	276	24	:	:	PUNCT
ajlm-2374	276	25	a	a	DET
ajlm-2374	276	26	study	study	NOUN
ajlm-2374	276	27	in	in	ADP
ajlm-2374	276	28	the	the	DET
ajlm-2374	276	29	seer	seer	NOUN
ajlm-2374	276	30	–	–	PUNCT
ajlm-2374	276	31	medicare	medicare	PROPN
ajlm-2374	276	32	linked	link	VERB
ajlm-2374	276	33	database	database	NOUN
ajlm-2374	276	34	.	.	PUNCT
ajlm-2374	277	1	cancer	cancer	NOUN
ajlm-2374	277	2	epidemiol	epidemiol	PROPN
ajlm-2374	277	3	biomarkers	biomarker	NOUN
ajlm-2374	277	4	prev	prev	AUX
ajlm-2374	277	5	.	.	PUNCT
ajlm-2374	278	1	2015;24(1):261–267	2015;24(1):261–267	NUM
ajlm-2374	278	2	.	.	PUNCT
ajlm-2374	279	1	https://doi.org/10.1158/1055-9965.epi-14-0923	https://doi.org/10.1158/1055-9965.epi-14-0923	X
ajlm-2374	280	1	huang	huang	PROPN
ajlm-2374	280	2	x	x	PROPN
ajlm-2374	280	3	,	,	PUNCT
ajlm-2374	280	4	zhao	zhao	PROPN
ajlm-2374	280	5	q	q	PROPN
ajlm-2374	280	6	,	,	PUNCT
ajlm-2374	280	7	yang	yang	PROPN
ajlm-2374	280	8	p	p	PROPN
ajlm-2374	280	9	,	,	PUNCT
ajlm-2374	280	10	et	et	PROPN
ajlm-2374	280	11	al	al	PROPN
ajlm-2374	280	12	.	.	PROPN
ajlm-2374	280	13	metabolic	metabolic	PROPN
ajlm-2374	280	14	syndrome	syndrome	NOUN
ajlm-2374	280	15	and	and	CCONJ
ajlm-2374	280	16	risk	risk	NOUN
ajlm-2374	280	17	of	of	ADP
ajlm-2374	280	18	cervical	cervical	ADJ
ajlm-2374	280	19	human	human	ADJ
ajlm-2374	280	20	papillomavirus	papillomavirus	PROPN
ajlm-2374	280	21	incident	incident	NOUN
ajlm-2374	280	22	and	and	CCONJ
ajlm-2374	280	23	persistent	persistent	ADJ
ajlm-2374	280	24	infection	infection	NOUN
ajlm-2374	280	25	.	.	PUNCT
ajlm-2374	281	1	medicine	medicine	NOUN
ajlm-2374	281	2	(	(	PUNCT
ajlm-2374	281	3	baltimore	baltimore	PROPN
ajlm-2374	281	4	)	)	PUNCT
ajlm-2374	281	5	.	.	PUNCT
ajlm-2374	282	1	2016;95(9):e2905	2016;95(9):e2905	NUM
ajlm-2374	282	2	.	.	PUNCT
ajlm-2374	283	1	https://doi.org/10.1097/md.0000000000002905	https://doi.org/10.1097/md.0000000000002905	VERB
ajlm-2374	283	2	molokwu	molokwu	PROPN
ajlm-2374	283	3	jc	jc	PROPN
ajlm-2374	283	4	,	,	PUNCT
ajlm-2374	283	5	penaranda	penaranda	NOUN
ajlm-2374	283	6	e	e	NOUN
ajlm-2374	283	7	,	,	PUNCT
ajlm-2374	284	1	lopez	lopez	PROPN
ajlm-2374	284	2	ds	ds	PROPN
ajlm-2374	284	3	,	,	PUNCT
ajlm-2374	284	4	et	et	PROPN
ajlm-2374	284	5	al	al	PROPN
ajlm-2374	284	6	.	.	PROPN
ajlm-2374	284	7	association	association	PROPN
ajlm-2374	284	8	of	of	ADP
ajlm-2374	284	9	metabolic	metabolic	NOUN
ajlm-2374	284	10	syndrome	syndrome	NOUN
ajlm-2374	284	11	and	and	CCONJ
ajlm-2374	284	12	human	human	ADJ
ajlm-2374	284	13	papillomavirus	papillomavirus	NOUN
ajlm-2374	284	14	infection	infection	NOUN
ajlm-2374	284	15	in	in	ADP
ajlm-2374	284	16	men	man	NOUN
ajlm-2374	284	17	and	and	CCONJ
ajlm-2374	284	18	women	woman	NOUN
ajlm-2374	284	19	residing	reside	VERB
ajlm-2374	284	20	in	in	ADP
ajlm-2374	284	21	the	the	DET
ajlm-2374	284	22	united	united	PROPN
ajlm-2374	284	23	states	states	PROPN
ajlm-2374	284	24	.	.	PUNCT
ajlm-2374	285	1	cancer	cancer	NOUN
ajlm-2374	285	2	epidemiol	epidemiol	PROPN
ajlm-2374	285	3	biomarkers	biomarker	NOUN
ajlm-2374	285	4	prev	prev	X
ajlm-2374	285	5	.	.	PUNCT
ajlm-2374	286	1	2017;26(8):1321–1327	2017;26(8):1321–1327	NUM
ajlm-2374	286	2	.	.	PUNCT
ajlm-2374	287	1	chung	chung	PROPN
ajlm-2374	288	1	s	s	PROPN
ajlm-2374	288	2	-	-	PUNCT
ajlm-2374	288	3	h	h	NOUN
ajlm-2374	288	4	,	,	PUNCT
ajlm-2374	288	5	franceschi	franceschi	PROPN
ajlm-2374	288	6	s	s	PROPN
ajlm-2374	288	7	,	,	PUNCT
ajlm-2374	288	8	lambert	lambert	PROPN
ajlm-2374	288	9	pf	pf	PROPN
ajlm-2374	288	10	.	.	PUNCT
ajlm-2374	288	11	estrogen	estrogen	NOUN
ajlm-2374	288	12	and	and	CCONJ
ajlm-2374	288	13	erα	erα	NOUN
ajlm-2374	288	14	:	:	PUNCT
ajlm-2374	288	15	culprits	culprit	NOUN
ajlm-2374	288	16	in	in	ADP
ajlm-2374	288	17	cervical	cervical	ADJ
ajlm-2374	288	18	cancer	cancer	NOUN
ajlm-2374	288	19	?	?	PUNCT
ajlm-2374	289	1	trends	trend	NOUN
ajlm-2374	289	2	endocrinol	endocrinol	VERB
ajlm-2374	289	3	metab	metab	NOUN
ajlm-2374	289	4	.	.	PUNCT
ajlm-2374	290	1	2010;21(8):504–511	2010;21(8):504–511	NUM
ajlm-2374	290	2	.	.	PUNCT
ajlm-2374	291	1	https://doi.org/10.1016/j.tem.2010.03.005	https://doi.org/10.1016/j.tem.2010.03.005	PROPN
ajlm-2374	291	2	baker	baker	PROPN
ajlm-2374	291	3	r	r	PROPN
ajlm-2374	291	4	,	,	PUNCT
ajlm-2374	291	5	dauner	dauner	NOUN
ajlm-2374	291	6	jg	jg	PROPN
ajlm-2374	291	7	,	,	PUNCT
ajlm-2374	291	8	rodriguez	rodriguez	PROPN
ajlm-2374	291	9	ac	ac	PROPN
ajlm-2374	291	10	,	,	PUNCT
ajlm-2374	291	11	et	et	PROPN
ajlm-2374	291	12	al	al	PROPN
ajlm-2374	291	13	.	.	PROPN
ajlm-2374	291	14	increased	increase	VERB
ajlm-2374	291	15	plasma	plasma	NOUN
ajlm-2374	291	16	levels	level	NOUN
ajlm-2374	291	17	of	of	ADP
ajlm-2374	291	18	adipokines	adipokine	NOUN
ajlm-2374	291	19	and	and	CCONJ
ajlm-2374	291	20	inflammatory	inflammatory	ADJ
ajlm-2374	291	21	markers	marker	NOUN
ajlm-2374	291	22	in	in	ADP
ajlm-2374	291	23	older	old	ADJ
ajlm-2374	291	24	women	woman	NOUN
ajlm-2374	291	25	with	with	ADP
ajlm-2374	291	26	persistent	persistent	ADJ
ajlm-2374	291	27	hpv	hpv	ADJ
ajlm-2374	291	28	infection	infection	NOUN
ajlm-2374	291	29	.	.	PUNCT
ajlm-2374	292	1	cytokine	cytokine	NOUN
ajlm-2374	292	2	.	.	PUNCT
ajlm-2374	293	1	2011;53(3):282–285	2011;53(3):282–285	PROPN
ajlm-2374	293	2	.	.	PUNCT
ajlm-2374	293	3	https://doi.org/10.1016/j.cyto.2010.11.014	https://doi.org/10.1016/j.cyto.2010.11.014	PROPN
ajlm-2374	293	4	lee	lee	PROPN
ajlm-2374	293	5	dy	dy	PROPN
ajlm-2374	293	6	,	,	PUNCT
ajlm-2374	293	7	lee	lee	PROPN
ajlm-2374	293	8	tsjo	tsjo	PROPN
ajlm-2374	293	9	,	,	PUNCT
ajlm-2374	293	10	science	science	NOUN
ajlm-2374	293	11	g.	g.	PROPN
ajlm-2374	293	12	associations	association	NOUN
ajlm-2374	293	13	between	between	ADP
ajlm-2374	293	14	metabolic	metabolic	NOUN
ajlm-2374	293	15	syndrome	syndrome	NOUN
ajlm-2374	293	16	and	and	CCONJ
ajlm-2374	293	17	gynecologic	gynecologic	ADJ
ajlm-2374	293	18	cancer	cancer	NOUN
ajlm-2374	293	19	.	.	PUNCT
ajlm-2374	294	1	obstet	obstet	PROPN
ajlm-2374	294	2	gynecol	gynecol	PROPN
ajlm-2374	294	3	sci	sci	PROPN
ajlm-2374	294	4	.	.	PUNCT
ajlm-2374	295	1	2020;63(3):215–224	2020;63(3):215–224	NUM
ajlm-2374	295	2	.	.	PUNCT
ajlm-2374	296	1	https://doi.org/10.5468/ogs.2020.63.3.215	https://doi.org/10.5468/ogs.2020.63.3.215	VERB
ajlm-2374	296	2	cowey	cowey	PROPN
ajlm-2374	296	3	s	s	SYM
ajlm-2374	296	4	,	,	PUNCT
ajlm-2374	296	5	hardy	hardy	ADJ
ajlm-2374	296	6	rw	rw	NOUN
ajlm-2374	296	7	.	.	PUNCT
ajlm-2374	297	1	the	the	DET
ajlm-2374	297	2	metabolic	metabolic	NOUN
ajlm-2374	297	3	syndrome	syndrome	NOUN
ajlm-2374	297	4	:	:	PUNCT
ajlm-2374	297	5	a	a	DET
ajlm-2374	297	6	high	high	ADJ
ajlm-2374	297	7	-	-	PUNCT
ajlm-2374	297	8	risk	risk	NOUN
ajlm-2374	297	9	state	state	NOUN
ajlm-2374	297	10	for	for	ADP
ajlm-2374	297	11	cancer	cancer	NOUN
ajlm-2374	297	12	?	?	PUNCT
ajlm-2374	297	13	am	be	AUX
ajlm-2374	297	14	j	j	NOUN
ajlm-2374	297	15	pathol	pathol	NOUN
ajlm-2374	297	16	.	.	PUNCT
ajlm-2374	298	1	2006;169(5):1505–1522	2006;169(5):1505–1522	NUM
ajlm-2374	298	2	.	.	PUNCT
ajlm-2374	299	1	https://doi.org/10.2353/ajpath.2006.051090	https://doi.org/10.2353/ajpath.2006.051090	PRON
ajlm-2374	299	2	so	so	ADV
ajlm-2374	299	3	ka	ka	PROPN
ajlm-2374	299	4	,	,	PUNCT
ajlm-2374	299	5	kim	kim	PROPN
ajlm-2374	299	6	sa	sa	PROPN
ajlm-2374	299	7	,	,	PUNCT
ajlm-2374	299	8	lee	lee	PROPN
ajlm-2374	299	9	yk	yk	PROPN
ajlm-2374	299	10	,	,	PUNCT
ajlm-2374	299	11	et	et	PROPN
ajlm-2374	299	12	al	al	PROPN
ajlm-2374	299	13	.	.	PUNCT
ajlm-2374	299	14	risk	risk	NOUN
ajlm-2374	299	15	factors	factor	NOUN
ajlm-2374	299	16	for	for	ADP
ajlm-2374	299	17	cytological	cytological	ADJ
ajlm-2374	299	18	progression	progression	NOUN
ajlm-2374	299	19	in	in	ADP
ajlm-2374	299	20	hpv	hpv	PROPN
ajlm-2374	299	21	16	16	NUM
ajlm-2374	299	22	infected	infect	VERB
ajlm-2374	299	23	women	woman	NOUN
ajlm-2374	299	24	with	with	ADP
ajlm-2374	299	25	asc	asc	PROPN
ajlm-2374	299	26	-	-	PUNCT
ajlm-2374	299	27	us	us	PROPN
ajlm-2374	299	28	or	or	CCONJ
ajlm-2374	299	29	lsil	lsil	PROPN
ajlm-2374	299	30	:	:	PUNCT
ajlm-2374	299	31	the	the	DET
ajlm-2374	299	32	korean	korean	ADJ
ajlm-2374	299	33	hpv	hpv	PROPN
ajlm-2374	299	34	cohort	cohort	PROPN
ajlm-2374	299	35	.	.	PUNCT
ajlm-2374	300	1	obstet	obstet	PROPN
ajlm-2374	300	2	gynecol	gynecol	PROPN
ajlm-2374	300	3	sci	sci	PROPN
ajlm-2374	300	4	.	.	PUNCT
ajlm-2374	301	1	2018;61(6):662–668	2018;61(6):662–668	X
ajlm-2374	301	2	.	.	PUNCT
ajlm-2374	302	1	https://doi.org/10.5468/ogs.2018.61.6.662	https://doi.org/10.5468/ogs.2018.61.6.662	PROPN
ajlm-2374	302	2	bodily	bodily	PROPN
ajlm-2374	302	3	j	j	PROPN
ajlm-2374	302	4	,	,	PUNCT
ajlm-2374	302	5	laimins	laimins	PROPN
ajlm-2374	302	6	la	la	PROPN
ajlm-2374	302	7	.	.	PUNCT
ajlm-2374	302	8	persistence	persistence	NOUN
ajlm-2374	302	9	of	of	ADP
ajlm-2374	302	10	human	human	ADJ
ajlm-2374	302	11	papillomavirus	papillomavirus	NOUN
ajlm-2374	302	12	infection	infection	NOUN
ajlm-2374	302	13	:	:	PUNCT
ajlm-2374	302	14	keys	key	NOUN
ajlm-2374	302	15	to	to	ADP
ajlm-2374	302	16	malignant	malignant	ADJ
ajlm-2374	302	17	progression	progression	NOUN
ajlm-2374	302	18	.	.	PUNCT
ajlm-2374	303	1	trends	trend	NOUN
ajlm-2374	303	2	microbiol	microbiol	PROPN
ajlm-2374	303	3	.	.	PUNCT
ajlm-2374	304	1	2011;19(1):33–39	2011;19(1):33–39	X
ajlm-2374	304	2	.	.	PUNCT
ajlm-2374	305	1	https://doi.org/10.1016/j.tim.2010.10.002	https://doi.org/10.1016/j.tim.2010.10.002	NOUN